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Abstract 
Tropane alkaloids, containing the 8-azabicyclo[3.2.1]octane ring system, are widespread in 
Nature. This thesis describes the total synthesis of the tropane alkaloid ferrugine, isolated from 
the arboreal species Darlingiana ferruginea and attempted synthesis of ferruginine, isolated from 
the arboreal species D. darlingiana. Formation of a bridged 6-azabicyclic-[3.2.2]-ring system was 
achieved using a transannular photomediated cyclisation of a carbamoyl radical, generated from a 
carbamoyl diethyldithiocarbamate, onto an unactivated pendant alkene, followed by group 
transfer of the dithiocarbamate moiety. The carbamoyl radical cyclisation precursor was 
synthesised from a known seven-membered ring carboxylic acid. The diastereomeric 
dithiocarbamates converged to a single alkene upon thermal elimination. Addition of 
phenyllithium to the amide followed by base-mediated skeletal rearrangement resulted in the total 
synthesis of the natural product ferrugine, and using a similar strategy the core structure of 
ferruginine was secured.  
The stemona alkaloid stemofoline is characterised by a complex azatricyclic ring system unique 
to this class of natural products. Synthetic efforts have been made toward the synthesis of a 
cyclisation precursor required for the assembly of this azatricyclic framework, via a proposed 
tandem 7-endo-trig/5-exo-trig carbamoyl radical cyclisation. The synthesis commenced with the 
commercially available dimethyl 3,3-thiodipropanoate which was further elaborated and coupled  
with  5-hepten-2-one to provide an advanced intermediate enone. Addition of ammonia gave a 
pyrroline which was condensed with triphosgene followed by sodium diethyldithiocarbamate to 
produce a carbamoyl radical precursor. Unfortunately, efforts towards oxidation and elimination 
of the sulfide to obtain an α,β-unsaturated ketone proved ineffective. 
Attempted carbamoyl radical cyclisation-dithiocarbamate group transfer onto enones and nitriles 
are also presented.  
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1. FERRUGININE: BACKGROUND AND SIGNIFICANCE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2 
 
Tropane alkaloids 
Tropane alkaloids are nitrogenous bicyclic organic compounds which have the 8-
azabicyclo[3.2.1]octane skeleton. The nitrogen bridge is between C1 and C5, two asymmetric 
carbons but tropane is optically inactive due to symmetry (fig 1).  
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Fig 1 
Currently there are over two hundred tropane alkaloids known to occur in natural sources.1 They 
are naturally found in many members of the plant families including Solanaceae, 
Erythroxylaceae, Con-VolVulaceae, Proteaceae, Rhizophoraceae, Brassicaceae, and 
Euphorbiaceae. They are known for their toxic and important medicinal properties.2-5 Atropine, 
the racemic form of (-)-hyoscyamine, was first isolated from atropa belladonna in 1833, while (-
)-hyoscyamine was also isolated in the same year from hyoscyamus niger.1 These tropane 
alkaloids are muscarinic receptor agonist that are involved in constriction of the pupil and 
vasodilation. They are also responsible for moderating the heartbeat and stimulating secretions. 
While the notorious cocaine, isolated from the dried leaves of erythroxylum coca, can be used for 
its anaesthetic properties and can also be prepared from its precursor and metabolite, ecogonine 
(fig 2).2,3  
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Fig 2 
Ferrugine: isolation and biological activity   
The tropane alkaloid (+)-ferruginine (1) was isolated from the arboreal species Darlingiana 
ferruginea6 and D. darlingiana,7 and its unnatural isomer (-)-ferruginine (2) has been prepared 
from cocaine.6 Ferruginine is found to be a good agonist for the nicotine acetylcholine receptor 
(nAchR). Due to its biological activity coupled with an interesting molecular architecture, it has 
generated considerable synthetic interest culminating in several racemic and enantiospecific 
syntheses.7-15  
 
 
From hereon, a comprehensive review of the syntheses of ferruginine will be presented outlining 
the key chemical transformations involved.  
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Davies synthesis of ferruginine.
8 
Davies and co-workers successfully constructed the tropane alkaloid skeleton, 8-
azabicyclo[3.2.1]octa-2,6-diene (3), by rhodium acetate-catalysed decomposition of 
vinyldiazomethane (2), a precursor to vinylcarbenoids, in the presence of N-(alkoxy-
carbonyl)pyrroles (1) (scheme 1).16-18 Initially when the reaction was performed under normal 
conditions, azabicyclic diene (3) along with the unexpected side product (4) were isolated in a 
55:45 ratio respectively. 
+
4
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MeO2C
N
CO2Me
N2
CO2Me +
1 2 3
CHCHCH2CO2MeN
CO2MeMeO2C
Rh(OAc)4
Scheme 1 
It was later discovered that the reactivity could be controlled, and ultimately the formation of 
alkylated pyrrole (4) could be suppressed by choosing the appropriate solvent and catalyst.19 
Therefore, using rhodium hexanoate in a non polar solvent such as hexane, smoothly provided 
the desired azabicyclic diene (3) in 75% isolated yield. Alternatively, the formation of alkylated 
pyrrole (4) was preferred when an electron-withdrawing ligand such as trifluoroacetate was used 
in polar solvents. The hypothesised mechanism of this transformation is believed to occur via a 
[4+3] cycloaddition between pyrroles and vinylcarbenoids, either via a concerted pathway or 
tandem cyclopropanation-Cope rearrangement, the latter being more acceptable (scheme 2).17 
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Equipped with suitable conditions for the construction of azabicyclic motifs, the Davies group 
embarked on the synthesis of the tropane alkaloid ferruginine utilising this methodology. Hence, 
the synthesis began with the decomposition of mono functionalised vinyldiazoethane (2) with 
rhodium acetate to form the reactive carbenoid intermediate which was reacted in situ with 
excess N-((2-(trimethyl-silyl)ethoxy)carbonyl)pyrrole (5) in refluxing toluene to form the bicyclic 
system (6). Efficient regioselective catalytic hydrogenation of the less polar double bond of the 
azabicyclic diene furnished (7). This advanced intermediate (7) was uneventfully converted to the 
natural product ferruginine in racemic form, firstly by deprotection with TBAF to give (8), and 
finally a reductive methylation with aqueous formaldehyde in the presence of sodium 
cyanoborohydride (scheme 3).   
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Scheme 3 
Reagents & conditions: a) Rh2(OOct)4, toluene, reflux, 24 h, 73%; b) RhCl(PPh3)3 (cat), H2, 
EtOH, 12 h, 96%; c) TBAF, THF, 12 h, 75%; d) aq CH2O, NaBH3CN, MeCN, 97%. 
In summary, a racemic synthesis of ferruginine has been accomplished utilising rhodium(II) 
acetate-catalysed decomposition of vinyldiazomethanes in the presence of N-(alkoxy-
carbonyl)pyrroles.  
Rigby’s synthesis of (+)-ferruginine.
9
 
Rigby and co-workers embarked on a journey to synthesise (+)-ferruginine using asymmetric 
induction in the metal promoted higher order [6+2] cycloaddition methodology, previously 
developed in their laboratories.20  They proposed that cycloaddition of azepines (9) with a 
suitable auxiliary-based dienophile (10) would provide the non racemic adduct (11). Adduct (11) 
would then be subjected to a suitable ring contraction to furnish the bicyclic tropane alkaloid 
skeleton (12) of ferruginine (scheme 4).21-23  
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Scheme 4 
Cycloaddition of azepine complex (13) with the acrylate derivative of (R)-(-)-pentolactone (14) 
proceeded smoothly to afford exclusively the endo-adduct (15). However, cycloaddition of 
azepine complex (13) with an alternative acrylate derivative, (-)-8-phenylmenthyl (16), provided 
the much anticipated endo adduct (17), accompanied by the minor exo adduct (18). A general 
observation from Rigby’s earlier work in this field showed the formation of exo adducts are very 
rare from these high order cycloadditon pathways, presumably via an epimerisation on the 
initially formed endo adduct (17) leading to the less favoured exo product (18) (scheme 5). 
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Scheme 5 
Reagents & conditions: a) hν, (15, 59%, 53% de), (17, 58%, 98% de) and (18, 15%, 98% de)  
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The enantiomerically pure endo-cycloadduct (19) was then subjected to oxidative 
rearrangement24 conditions using thallium trinitrate in methanol to yield exclusively a single 
enantiomer of tropane alkaloid (20) in excellent yield. Saponification of (20) with LiOH followed 
by Barton thiohydroxymate ester decarboxylation gave methyl carbamate (21), which was 
subjected to further chemical transformations to install the α,β-unsaturated moiety, and complete 
the synthesis of (+)-ferruginine (scheme 6). 
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Scheme 6 
Reagents & conditions: a) Ti(ONO2)3.H2O, MeOH, 85%; b) LiOH, MeOH/H2O, 84%; c) i-
BuCO2Cl, NMO, N-hydroxypyridine-2-thione, Et3N, t-BuSH, hν 49%; d) TFA, H2O/acetone; e) 
MeMgBr, Et2O; f) LiAlH4, Et2O; g) Dess-Martin periodinane, CH2Cl2, 28%. 
In conclusion, Rigby and co-workers have successfully completed the asymmetric synthesis of 
(+)-ferruginine utilising a chromium promoted higher order [6+2] cycloaddition, followed by 
thallium mediated oxidative rearrangement. This is an attractive approach for the synthesis of 
enantiomerically pure tropane alkaloid skeletons starting from azepine complex (13).  
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Rapoport’s synthesis of (+)-ferruginine & (-)-ferruginine.
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Rapoport and co-workers expanded on their earlier work on anatoxin25, 26 and epibatimine27 by 
targeting the syntheses of (+)-ferruginine and its unnatural isomer (-)-ferruginine via 
intramolecular iminium ion cyclisation of keto-acid derivatives, derived from L-glutamic acid.  
The key vinylogous carbamate intermediate (23) was subjected to an exo-face hydrogenation 
using Pd/C followed by rebenzylation of pyrrole using benzyl bromide afforded cis pyrrolidine 
(24) in 82% over two steps. Acidic cleavage of the tertiary butyl ester provided the prerequisite 
keto acid species (25) in 95% as a 7:3 mixture of diastereomers. Decarbonylation and iminium 
ion cyclisation gave the azabicyclic systems (26) and (27) in a 2:1 ratio, respectively, which were 
unambiguously assigned by extensive spectroscopic analysis. It is noteworthy that under the 
cyclisation conditions, the stereocentre at C2 did not epimerise, thus, each diastereomer of the 
keto acid (3) will only lead to one diastereomer (4) or (5). Therefore, the intramolecular iminium 
ion cyclisation proceeded with high levels of stereoselectivity, and an opportunity to pursue an 
enantiospecific synthesis of ferruginine had arisen. A change in protecting group strategy was 
employed by hydrogenation of benzyl groups and reprotection as butyl carbamates (28) and (29), 
respectively (scheme 7).  
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Scheme 7 
Reagents & conditions: a) H2, Pd/C, MeOH; b) BnBr, K2CO3, 82% over two steps; c) HCl/H2O, 
95%, 7:3 mixture of diastereomers; d) (COCl)2, 1,2 DCE/ toluene, (26), 62%, (27), 27%; e) H2, 
Pd/C; f) (Boc)2O, (28), 93%, (29), 97%.  
Hydrolysis of bicyclic ester (28) and (29) delivered epimeric mixtures of acids (30) and (31) as a 
7:1 and 2:1 ratio of S and R, respectively. Reductive decarboxylation of acids (30) and (31) was 
best achieved by photolysis of the corresponding thioxamate esters to furnish epimeric methyl 
ketones (32) as a 9:1 and 2:1 ratio, respectively. Conjugated methyl ketone (33) was obtained via 
formation of the thermodynamic silyl enol ether using TBSCl, alpha selenation with phenyl 
selenyl chloride, oxidation to the selenoxide with mCPBA and elimination. Finally, acidic 
deprotection of butyl carbamate followed by reductive methylation of the resultant free amine 
furnished the desired (+)-ferruginine (scheme 8).    
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Scheme 8 
Reagents & conditions: a) KOH, H2O, i-PrOH, (30), 93%, (31), 100%; b) t-BuOCOCl, hν, t-
BuSH, 79% from (30), 81% from (31); c) NaH, TBSCl; d) PhSeCl; e)  mCPBA, K2CO3; f) TFA, 
93%; g) NaBH3CN, CH2O.   
Having completed the total synthesis of (+)-ferruginine, the group envisaged the synthesis of its 
unnatural enantiomeric fom (-)-ferruginine using similar strategy. Carboxylic acids (34) and (35) 
were obtained via selective enolisation of methyl ketones (28) and (29) by treatment with 
KHMDS and TMSCl, followed by oxidative cleavage of the resultant enol ethers. Radical 
decarboxylation28, 29 of carboxylic acid groups furnished the corresponding methyl esters (36) and 
(37), which were transformed into α,β-unsaturated methyl ester (38) via kinetic selenation, 
oxidation and subsequent elimination (scheme 9).  
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Scheme 9 
Reagents & conditions: a) KHMDS, TMSCl; b) O3, Me2S, (34), 79%, (35), 84%; c) t-BuCO2Cl, 
hν, t-BuSH, (36), 66%, (37), 70% ; d) LDA, PhSeCl; e) NaIO4, 84% from (36), 88% from (37). 
The concluding steps involved the conversion of conjugated methyl ester (38) to methyl ketone 
(40) via hydrolysis and formation of isoxazolidine (39), which was subsequently displaced by 
methyllithium to deliver (40). The synthesis was completed by acidic deprotection of the 
carbamate group of (40) followed by a reductive methylation to yield the unnatural (-)-
ferruginine (scheme 10). 
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Reagents & conditions: a) KOH, H2O, i-PrOH, 100%; b) isoxazolidine, 87%; c) MeLi, 92%; d) 
TFA, 93%; e) NaBH3CN, CH2O, 73%.   
In conclusion, Rapport and co-workers have successfully completed enantioselective syntheses of 
(+)-ferrugine and (-)-ferruginine. They effectively utilised an iminium ion cyclisation 
methodology to acquire the tropane alkaloid framework in a stereospecific manner.  
Ham’s formal synthesis of (rac)-ferruginine.
11
 
Intramolecular aminocarbonylation has been a valuable tool for the construction of biologically 
important alkaloids and related products.30-33 Ham and co-workers have successfully applied this 
methodology in the formal synthesis of the tropane alkaloid ferruginine.  
Their synthesis began with the treatment of known heptenone (41) with hydroxylamine to give an 
oxime, which was reduced with lithium aluminium hydride to afford the free amine and 
subsequently protected as the methyl carbamate (42) with methyl chloroformate (scheme 11). 
Palladium catalysed intramolecular aminocarbonylation of (42) in the presence of palladium 
chloride, copper chloride and carbon monoxide under 1 atmosphere pressure furnished the 
azabicyclic skeleton of ferruginine as a single product (43) via the intermediate (44). Acidic 
deprotection of methyl carbamate with 30% hydrogen bromide followed by Boc protection of the 
free amine delivered the known azabicycle (45), whose conversion to ferruginine was earlier 
reported by Rapoport.34 
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Scheme 11 
Reagents & conditions: a) NH2OH.HCl, Na2CO3, MeOH, reflux, 85%; b) LiAlH4, THF, reflux, 
89%; c) methyl chloroformate, CH2Cl2, 39%; d) PdCl2 (0.1 eq), CuCl2, CO (1atm), MeOH, rt, 
49%; e) 30% HBr.HOAc, rt; f) (Boc)2O, dioxane, rt, 69% from (44). 
In conclusion, a formal synthesis of (rac)-ferruginine has been achieved through palladium 
catalysed intramolecular aminocarbonylation of methyl carbamate (42) to provide the tropane 
alkaloid (44), which was transformed to the known azabicycle (45). 
Husson’s synthesis of (+)-ferruginine.
12
 
Husson and co-workers envisaged an asymmetric synthesis of (+)-ferruginine based on an 
intramolecular α,β-unsaturated ketone cyclisation onto an acyl iminium species derived from 
non-racemic 2-cyano-5-oxazolopyrrolidine to obtain the functionalised azabicycle.  
The synthesis of ferruginine began with alkylation of (46) with bromoacetaldehyde diethyl acetal 
in the presence of LDA and HMPA to afford a diastereomeric mixture of cyano-
oxazolopyrrolidines (47) (scheme 12). Removal of the cyano functionality was best achieved 
using lithium in ammonia, where previous investigations into this reduction step proceeded with 
15 
 
complete stereoselectivity to furnish oxazolopyrrolidine (48).35, 36 Removal of the acetal 
protecting group followed by a Horner-Wandsworth-Emmons olefination37 provided the trans 
enone (49), the precursor to the iminium ion cyclisation. Cyclisation of (49) delivered bicyclic 
adduct (50) as a single stereoisomer, which was confirmed by extensive spectroscopic analysis. 
Hydrogenolysis released the free amine which was immediately methylated with formaldehyde 
and sodium cyanoborohydride to give methyl amine (51). The synthesis was completed through 
regioselective elimination of methanol using p-toluenesulfonic acid in benzene to install the 
enone. 
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Scheme 12 
Reagents & conditions: a) LDA, BrCH2CH(OEt)2, HMPA, 86%; b) Li/NH3, 66%; c) (10%) 
HCl; d) (MeO)2P(O)CH2COCH3, 86%; e) H2SO4, MeOH, 60 °C, 84%; f) H2/Pd(OH)2; g) CH2O, 
NaBH3CN, 62%; h; TsOH, C6H6, 68%.  
In summary, (+)-ferruginine was synthesised in seven steps with an overall yield of 20% starting 
from a chiral substrate. The azabicyclic motif of the tropane alkaloid natural product was 
constructed utilising an intramolecular α,β-unsaturated ketone cyclisation onto an acyl iminium 
species with complete stereoselectivity. 
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Bäckvall’s synthesis of (rac)-ferruginine.
13
 
Backvall and co-workers envisioned the tropane alkaloid skeleton of ferruginine could be 
obtained by means of Lewis-acid induced rearrangement of aziridino cyclopropanes, derived 
from 2-phenylsulfonyl 1,3-dienes. Preliminary studies from the group had demonstrated Lewis 
acid catalysed rearrangement of some 3,4-epoxy-1,2-methylene-2-(phenylsulfonyl)cycloalkanes38 
and their 3,4-aziridines analogues39 to bicyclic compounds. In the case of aziridine analogues, 
acid catalysed rearrangement led to the tropane alkaloid motif.  
Their synthesis of ferruginine began with the readily available 2-(phenylsulfonyl)-1,3-
cyclohexadiene (53), prepared from cyclohexadiene (52) according to previous literature 
methods.40, 41 Regioselective cyclopropanation of the electron deficient double bond of (53) 
proceeded smoothly using a nucleophilic cyclopropanating agent38 to give (54), which was 
transformed to the anti-epoxy cyclopropane (56) with complete stereoselectivity via bromohydrin 
(55). Epoxide (5) was converted to aziridine (57) via ring opening with sodium azide followed by 
treatment with triphenylphosphine, which was subsequently protected as the sulfonamide (58) 
(scheme 13). 
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Scheme 13 
Reagents and conditions: a) HgCl2, NaSO2Ph, 97%; b) Na2CO3, 2 M NaOH, 86%; c) Me3SOI, 
NaH, 95%, d) NBS, H2O, 98% (crude); e) 2 M NaOH, 75% from (54); f) NaN3, NH4Cl; g) PPh3, 
h) TsCl, NEt3, 51% from (56). 
Aziridino cyclopropane (58) was subjected to Lewis acid catalysed rearrangement conditions 
using boron trifluoroetherate which resulted in the formation of the tropane alkaloid skeleton 61, 
via the postulated intermediates (59) and (60) (scheme 14).38, 39 For successful Lewis acid 
induced rearrangement to occur, a syn relationship between aziridine and the cyclopropane is 
crucial as an anti relationship fails to deliver any desired products. 
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Scheme 14 
A Michael addition of nitroethane in the presence of DBU onto the tropane skeleton (61) led to 
nitrosulfone (62) as an inseperable 2:1 mixture of diastereomers, which were consequently 
transformed into ketosulfone (63) using a Nef reaction. Elimination of sulfone (63) was achieved 
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with potassium tert-butoxide to furnish enone (64). The final few steps in this synthetic sequence 
involved an acetal protection using Noyori’s reagent42 to give (65), which was essential for the 
de-tosylation of (65) with magnesium in methanol to afford free amine (66), and finally reductive 
methylation with formaldehyde and sodium cyanoborohydride successfully delivered the racemic 
natural product ferruginine, while acid-base extraction cleaved the acetal protecting group in the 
subsequent work (scheme 15). 
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Scheme 15 
Reagents & conditions: a) EtNO2, DBU, 91%; b) H2O2, K2CO3, 98%; c) t-BuOK, THF, 87%; d) 
Me3SiOTf, 1,2-bis-((trimethylsilyl)oxy)ethane, 63%; e) Mg, MeOH, ultrasound; f) CH2O, 
NaCNBH3, 75% from (65). 
In conclusion, Bäckvall’s group have demonstrated the scope of the Lewis acid promoted 
rearrangement of aziridino cyclopropanes (58) derived from 2-phenylsulfonyl 1,3-dienes (53) to 
the synthesis of ferruginine.  Critical to the success of this transformation was the syn 
relationship between aziridine and the cyclopropane species; an anti relationship proved totally 
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ineffective. This methodology has the potential to assemble a range of tropane alkaloid 
analogues. 
Node’s synthesis of (+)-ferruginine & (-)-ferruginine.
14
 
Node and co-workers utilised Robinson’s tropinone synthesis43 for the construction of azabicyclic 
diester (69) with the potential for a divergent asymmetric syntheses of both enantiomers of 
ferruginine, utilising a porcine liver esterase (PLE) catalysed asymmetric dealkoxycarbonylation 
strategy.44-47 PLE catalysed dealkoxycarbonylation of tropinone diester (69) selectively removed 
the ethylester functionality to furnish β-azabicyclic keto ester (70) in excellent enantiomeric 
excess of 96%, albeit in poor yield (scheme 16). Methyl ester exchange was achieved with 
sodium and methanol, followed by hydrogenolysis of the benzyl group to the free amine, which 
was subsequently protected as tert-butyl carbamate (71). Selective reduction of ketone (71) with 
tetrabutylammonium borohydride followed by acetylation and subsequent elimination of the 
resultant alcohol with trifluoroacetic anhydride and triethylamine furnished the known α,β-
methyl enonoate (72),48, 10 hence accomplishing a formal synthesis of the unnatural isomer (-)-
ferruginine. 
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Scheme 16 
Reagents & conditions: a) PLE (500 units), 1 M phosphate buffer, pH 8, DMSO, 24 h, rt, 38%, 
96% ee; b) Na, MeOH, 95%, c) 10% Pd/C, H2; d) (Boc)2O, Et3N, 95% over two steps; e) 
Bu4NBH4, 85%; f) (CF3CO)2O, Et3N, DMAP, CHCl3, 94%. 
Having successfully completed the formal synthesis of (-)-ferruginine, their next step was to 
complete the total synthesis of the natural (+)-ferruginine from azabicyclic β-keto ester (70). The 
benzyl protecting group of (70) was exchanged for butyl carbamate via hydrogenolysis and 
carbamoylation, which was followed by ester exchange with benzyl alcohol and DMAP to 
deliver (73) (scheme 17). Regioselective alkylation of ketone (73) with acetaldehyde provided 
(74), which was followed by hydrogenolysis and decarboxylation with catalytic hydrochloric acid 
furnished β-hydroxyl ketone (75) as a single diastereomer. Silylation of the secondary alcohol 
was followed by formation of enol triflate (76) using N-phenyl trifluoromethanesulfonimide. 
Palladium catalysed reduction of the enol triflate was achieved with palladium acetate and formic 
acid, which was directly followed by desilylation upon treatment with TBAF to furnish the 
homoallylic alcohol (77). The construction of the methyl enone moiety of ferruginine was 
achieved by PCC oxidation of alcohol (77) and subsequent double bond migration with DBU. 
Finally, the asymmetric synthesis of (+)-ferruginine was completed via deprotection of (78) using 
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trifluoroacetic acid, followed by reductive methylation using sodium cyanoborohydride and 
formaldehyde. 
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Scheme 17 
Reagents & conditions: a) Pd/C, H2; b) (Boc)2O, 83% over two steps; c) BnOH, DMAP, 
toluene, reflux, 98%; d) NaH, LDA, MeCHO, THF, 56%; e) Pd/C, H2; f) HCl (cat), 85% over 
two steps; g) TBSCl, imidazole, DMF, 95%; h) t-BuOK, PhNTf2, THF, 73%; i) Pd(OAc)2, PPh3, 
Et3N, HCO2H; j) TBAF, 66% over two steps; k) PCC; l) DBU, 83% over two steps; m) TFA; n) 
HCHO, NaBH3CN, 94% over two steps. 
In conclusion, Node and co-workers have developed divergent synthetic routes to (+)-ferruginine 
and its unnatural isomer (-)-ferruginine utilising a PLE catalysed asymmetric 
dealkoxycarbonylation of the readily available tropinone diester (69), to deliver azabicyclic β-
keto ester (70) in optically pure form. 
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Aggarwal’s synthesis of (+)-ferruginine.
15
  
Ring-closing metathesis is a very powerful tool in organic synthesis and has been successfully 
employed for the construction of cyclic and fused bicyclic systems.49-53 However, there is less 
precedent for the construction of bridged bicycles using this methodology.54 In light of this 
knowledge, Aggarwal and co-workers devised an enyne ring closing metathesis tactic for the 
construction of azabicycle system, derived from chiral Boc protected pyrrole. The added 
advantage of this approach is the incorporation of the double bond within the bicycle required for 
the natural product ferruginine, thus avoiding tedious chemistry for its insertion. 
 The synthesis began with the commercially available non racemic L-pyroglutamic acid (79) 
which was converted into aminal (80) in a 95:5 ratio of cis/trans isomers over four steps using 
previously described literature procedures.55 Aminal (80) was treated with boron trifluoroetherate 
in the presence of allyltrimethylsilane to furnish the desired cis allylated pyrrole (81). 
Chemoselective reduction of the benzyl ester with lithium aluminium hydride gave aldehyde 
(82), which was subsequently homologated with the modified Gilbert reagent56 to give the 
required enyne (83), setting the stage for the key ring-closing metathesis (scheme 18). 
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Scheme 18 
Reagents & conditions: a) BF3.OEt2, allyltrimethylsilane, -78 °C to rt, Et2O, 15 h, 93% (8:2, cis: 
trans); b) LiAlH4, THF, 0 °C, 78%; c) CH3COCN2PO(OEt)2, K2CO3, MeOH, 1.5 h, rt, 93%. 
Ring-closing metathesis was initially attempted with the more active Grubbs second generation 
catalyst, but this gave very low yields of the desired bicycle (84), accompanied by a major by-
product. Therefore, the group decided to monitor the progress of the metathesis by GC-MS and 
found after an initial build of the required product, there was a steady decline. This indicated that 
the active catalyst was destroying the product, and thus the alternative, less active Grubbs first 
generation catalyst was employed to furnish the desired azabicyclic compound (84) in high yield. 
Finally, a Wacker oxidation of (84) to the methyl ketone (85) followed by reductive methylation 
furnished the tropane alkaloid (+)-ferruginine (scheme 19). 
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Scheme 19 
Reagents & conditions: a) Grubbs I (10 mol%), CH2Cl2, 50 °C, 10 h, 86%; b) PdCl2, CuCl2, 
H2O, DMF, 6 h, 81%; c) TFA, CH2Cl2, rt, 3 h, then K2CO3, 93%; d) CH2O, NaBH3CN, MeCN, 
15 min, 97%. 
In conclusion, Aggarwal and co-workers have developed an asymmetric synthesis of (+)-
ferruginine in 12 steps with an overall yield of 27% beginning with the inexpensive 
commercially available L-pyroglutamic acid. Enyne metathesis was achieved with the less active 
Grubbs 1st generation catalyst as the more active 2nd generation catalyst decomposed the desired 
product. Although there is less precedent for the construction of fused bridged bicycles using this 
approach, this enyne strategy could be applied in obtaining alternative enones, which are found in 
many bridged azabicyclic systems and natural products.   
Bick’s synthesis of (-)-ferrugine.
7
 
Having established the stereochemistry of (-)-ferrugine, Bick and co-workers confirmed the 
stereochemistry synthetically to eliminate any ambiguity. Hydrogentaion of the electron deficient 
double bond of anhydroecgonine ethyl ester (86), prepared from cocaine6 was achieved using 
Pd/C to deliver the hydroecgonine ethyl ester (87) accompanied by the undesirable isomer (88) 
(scheme 20). Ester hydrolysis of (87) followed by subsequent treatment with oxalylchloride 
provided hydroecgonine acid chloride (90). Finally, synthesis of (-)-ferrugine was accomplished 
upon treatment with Ph2Cd in a 23.6% overall isolated yield from (86). 
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 Scheme 20 
Reagents & conditions: a) H2, Pd/C (10 mol%), EtOH, rt, 3 h.; b) H2O, reflux, 8 h; c) 
oxalylchloride, DCM, 0 °C-rt, 30 min; d) Ph2Cd, DCM, 0 °C-rt, 30 min, 26% from (86) 
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2. AIMS AND OBJECTIVES 
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Carbamoyl radical chemistry 
The application of radicals in organic synthesis has become increasingly popular over the last 
forty years. Radicals have numerous advantages over ionic based processes in synthesis, such as, 
their lower propensity for rearrangement, relatively fast reactions rates under mild conditions, 
they can also operate under polar and hindered environment, and their tolerance to a wide range 
of functional groups.57 Despite the many well documented advantages of free radical reactions in 
organic chemistry, the majority of examples still rely on the use of highly toxic tributyl tin 
hydride (Bu3SnH) in stoichiometric amounts. Furthermore, the products can be difficult to 
completely free from tin side products. Also a common problem with Bu3SnH reactions is the 
premature reduction of radical internediates by the reagent prior to cyclisation. Consequently, 
such reactions require high dilutions along with slow addition of tributyltin reagents to reaction 
mixtures to prevent competing reduction.58 
 A major area of current research is the development of processes which seek to either alleviate 
the problems associated with toxic tin residues, or remove the need for tin completely.59, 60 The 
Grainger group is involved in this field and is developing tin free radical methodology and 
applying it in natural product synthesis.61 One of the modern pioneers in the development of tin 
free radical methodology is Zard and co-workers who have extensively developed the generation 
of a variety of radicals from xanthates,62, 63 which are precursors to acyl,64, 65 alkoxycarbonyl,66 
and a variety of carbon66-71 and nitrogen-centred57-73 radicals that have found numerous synthetic 
applications.65-78  
Carbamoyl radicals (91) or aminoacyl radicals are reactive intermediates that have been 
generated under tin free conditions from xanthates (92),62, 63 cobaltsalophens (93),80 selenium 
carbamates (94), and oxime oxalate amides (95) (scheme 21),83 along with systems with a 
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tendency for aromatisation (96)86 and S-4 pentynyl carbamothioates (97).87  Such reactions have 
found limited application in natural product synthesis. However, Myers and co-workers utilised a 
carbamoyl radical generated from carbamoylcyclohexadienyl system as a key step in the 
synthesis of stephacedin B.88    
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Scheme 21 
Previous work within the Grainger group sought to generate carbamoyl radicals from xanthate 
precursors, but unfortunately such precursors could only be isolated in poor yields, despite 
successful carbamoyl radical cyclisations. This study prompted research into an alternative 
carbamoyl radical precursor and eventually dithiocarbamates were employed as a suitable source 
of carbamoyl radicals.88 Carbamoyl dithiocarbamates are easy to synthesise in two high yielding 
steps from secondary amines, such as (98), firstly by treatment with triphosgene and pyridine to 
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provide carbamoyl chloride (99), which was immediately  converted to the corresponding  
carbamoyl dithiocarbamate (100) upon treatment with commercially available and inexpensive 
sodium diethyldithiocarbamate trihydrate salt (scheme 22).88      
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Scheme 22 
Reagents & conditions: (a) triphosgene (0.33 eq), pyridine (1.5 eq), toluene, rt, 1 h; (b) sodium 
diethyldithiocarbamate trihydrate (4 eq), acetone, > 95%. 
Irradiation of carbamoyl dithiocarbamate (100) with 500 W halogen lamp generated carbamoyl 
radical (101) which underwent a 5-exo-trig cyclisation onto a pendant alkene to give a primary 
radical (102) (scheme 23). Dithiocarbamate group transfer onto radical (102) afforded a stable 
tertiary radical (103), which upon fragmentation furnished the desired functionalised lactam 
(104) and regenerated carbamoyl radical (101) to continue the chain process. An alternative 
competing pathway for carbamoyl radical is the reaction with (100) prior to cyclisation to give a 
new tertiary carbon-centred radical (105). However, this route is degenerative and thus fragments 
back to give carbamoyl radical (101) along with the carbamoyl dithiocarbamate (100). As a 
consequence, this degenerative pathway increases the lifetime of radical (101) which can 
preferentially cyclise to the desired product, and also allowing more difficult intramolecular 
radical cyclisations to take place such as seven and eight-membered rings, cis fused β-lactams, 
and spirobicyclic γ-lactams in good to excellent yields.88 
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Scheme 23 
This methodology was successfully applied by the Grainger group in the formal synthesis of (-)-
aphanorphine, a biologically active benzazepine alkaloid isolated from the freshwater blue-green 
alga aphanizomenon flos-aquae,89 and similar in structure to natural and non-natural analgesics 
such as morphine, eptazocine and pentazocine (fig 3). 61 
 
31 
 
HO
O
OH
H
N
Me
H
N Me
Me
H
HO
(-)-aphanorphine
Me
H
HO
N Me
H
HO
N
Me
Me
eptazocine
pentazocine morphine
 
Fig 3 
Irradiation of the cyclisation precursor (106) using 500 W halogen lamp generated the reactive 
carbamoyl radical (107), which underwent a regioselective 5-exo-trig cyclisation onto the  alkene 
to form a new carbon centred radical (108). Subsequent dithiocarbamate group transfer furnished 
the desired lactam (109) as a single regio and stereoisomer in 71% isolated yield. Further 
manipulations led to the synthesis of the benzazepine alkaloid aphanorphine (scheme 24). 61 
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Scheme 24 
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Proposed synthesis of ferrugine and ferruginine 
The primary aim of this project is to build upon the Grainger group’s early work on 
dithiocarbamate group transfer carbamoyl radical cyclisation and apply this methodology to the 
syntheses of the tropane alkaloids ferruginine and ferrugine, and the more complex stemofoline 
(fig 4). 
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Fig 4 
Syntheses of the tropane alkaloid framework of the two natural products ferruginine and 
ferrugine are proposed based upon carbamoyl radical cyclisation followed by group transfer of 
the dithiocarbamate functionality. It is envisaged that irradiation of dithiocarbamate (110), will 
generate carbamoyl radical (111), which will cyclise onto the pendant alkene to give a new 
carbon centred radical (112). Radical (112) will then undergo a dithiocarbamate group transfer 
with (110) to furnish the lactam (113) (scheme 25).   
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33 
 
Thermal elimination of dithiocarbamate (113) with diphenyl ether will result in bicyclic amide 
(114) which will be subsequently treated with phenyllithium to deliver the tropane alkaloid 
ferrugine via a proposed one pot multistep transformation (scheme 26). Finally, the synthesis of 
ferruginine is envisioned using a similar one pot multistep transformation to deliver the tropane 
alkaloid framework (115), by treatment of (114) with methyllithium, which will be subsequently 
oxidised to deliver the desired natural product. 
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Scheme 26 
Preliminary investigations into the feasibility of the proposed radical cyclisation have been 
previously carried out in the Grainger group.205 
The structurally intricate stemona alkaloid, stemofoline would provide the ultimate test to 
showcase the group’s carbamoyl radical cyclisation dithiocarbamate group transfer methodology.  
Radical Cyclisations 
Radical cyclisation reactions are dominated by the 5-exo-trig pathway to provide kinetic primary 
radicals rather than the more stable secondary radicals obtained via 6-endo-trig pathway in the 
absence of other factors.90, 91 For example, the primary radical in (116) cyclises at a much faster 
34 
 
rate via 5-exo-trig to form a new primary radical (117), which is thermodynamically less stable 
than the secondary radical (118), formed via a 6-endo-trig cyclisation. This observation is 
rationalised on stereoelectronic grounds as the singly occupied molecular orbital (SOMO) 
interacts more favourably with the lowest unoccupied molecular orbital (LUMO) of alkenes 
(scheme 27).92   
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Scheme 27 
However, depending on the steric and electronics properties of the system, 6-endo-trig pathway 
can be favoured. For example, an alkyl substituent on alkene (121) would hinder the formation of 
primary radical (122) due to unfavourable steric interactions with the methyl substituent, and 
therefore, would favour the stable tertiary radical (123) (scheme 28).91, 92 
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Scheme 28 
35 
 
Also, the incorporation of electron withdrawing groups can enhance the formation of larger ring 
systems for example in the ester-substituted double bond in (126). The net effect of the ester 
group will make the terminal double bond electron deficient and thus more electrophilic. 
Therefore, 6-endo-trig cyclisation is predominantly favoured due to the polar effect of the ester 
group over 5-exo-trig to give (128) by lowering the LUMO of the alkene.92 The ester substituent 
substantially hinders the formation of the primary radical (127) via 5-exo-trig mode and thus, 
leads to the formation of a tertiary radical (128) which is also stabilised by the electron 
withdrawing nature of the ester group (scheme 29).93, 94 
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Scheme 29 
Proposed synthesis of stemofoline 
It is hypothesised that the core skeleton of stemofoline will be obtained via a tandem 7-endo-trig 
cyclisation/transannular 5-exo-trig cyclisation/intermolecular group transfer strategy. Carbamoyl 
radical species (132) could be generated by irradiating the cyclisation precursor (131) using a 500 
W halogen lamp. Electronics of the electron deficient alkene should dictate a 7-endo-trig 
cyclisation mode rather than 6-exo-trig, as it is anticipated the nucleophilic carbamoyl radical 
will preferentially add to the less hindered terminus of the electron deficient double bond. This 
should lead to a stabilised secondary radical (133) which should undergo 5-exo-trig cyclisation to 
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generate a new carbon centred radical (134), which should finally undergo a dithiocarbamate 
group transfer to furnish the tricyclic core of stemofoline (135). Furthermore, if the tandem 
cyclisation and group transfer is successful, the correct functionality would be present in the 
tricyclic core for further elaboration en route to the synthesis of the complex stemona alkaloid, 
stemofoline (scheme 30). Therefore, the primary aim of this project is to synthesise the 
cyclisation precursor (131) in racemic form to investigate this tandem cyclisation strategy.  
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Scheme 30 
Carbamoyl radical cyclisation-dithiocarbamate group transfer onto nitriles will also be 
investigated. Upon generation of carbamoyl radical (137) by irradiating carbamoyl 
dithiocarbamate (136), it is anticipated this reactive intermediate will cyclise onto the nitrile, via 
a 5-exo-dig pathway, to give nitrogen-centred radical (138). This new radical (138) will then be 
captured via dithiocarbamate group transfer to furnish the desired product (139), regenerating the 
carbamoyl radical (136) to continue the chain process (scheme 31). 
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Using a similar approach, study of carbamoyl radical cyclisations onto enone species will be 
investigated. Photo or chemical induced initiation of carbamoyl dithiocarbamate enone (140) will 
generate carbamoyl radical (141) (scheme 32). This species will undergo an intramolecular 
cyclisation onto the terminal enone through a 7-endo-trig mode to produce a new radical, which 
will be captured by the dithiocarbamate group to provide the functionalised lactam (142), along 
with the regeneration of carbamoyl radical (141) to continue the chain process.  
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3. TOTAL SYNTHESIS OF FERRUGINE AND ATTEMPTED SYNTHESIS OF 
FERRUGININE 
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Synthesis of cyclisation precursor via carbamoyl chloride. 
The synthesis of the radical cyclisation precursor (110) began with preparation of the known 
seven-membered ring carboxylic acid (146).95 Deprotection of dimethylamine hydrochloride  
with aqueous sodium hydroxide released the volatile amine, which was immediately condensed 
and reacted with cyclopentanone  to afford enamine (143) in 86% after distillation (scheme 33).  
A Michael addition of enamine (143) onto acrolein followed by an intramolecular Mannich 
reaction resulted in the bicyclic ketoamine intermediate (144). Treatment of ketoamine (144) with 
iodomethane in acetonitrile furnished ammonium salt (145). Basic reflux in aqueous sodium 
hydroxide followed by acidification with concentrated hydrochloric acid furnished the desired 
carboxylic acid (146) via a nucleophilic addition Grob fragmentation sequence, unfortunately in 
poor yields, compared with the 56% reported in literature.95 Disappointingly, attempts made 
towards increasing the yield by varying conditions  proved unsuccessful. 
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Scheme 33 
Reagents & conditions: (a) NaOH, H2O -78 °C then cyclopentanone, 81%; (b) acrolein, 0 °C; 
(c) MeI, MeCN; (d) aq (20%) NaOH, 23%. 
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The Curtius rearrangement is a powerful reaction for the construction of carbamates form 
carboxylic acid derivatives. The classical route entails the formation of an acid chloride (148) 
from carboxylic acid (147), which is converted into an acyl azide (149). Curtius rearrangement of 
azide (149) gives an isocyanate (150), which is subsequently trapped by an alcohol to furnish a 
carbamate (151) (scheme 34). 95, 96 
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More recently, Yamada et al. reported the synthesis of carbamates from carboxylic acids in a one 
pot transformation using diphenylphosphory azide (DPPA).97 This route was synthetically more 
appealing and this transformation was investigated using compound (146) (scheme 35).98-101 
Initially, carboxylic acid (146) was dissolved in 1,2-dichloroethane and treated with Hünig’s base 
followed by addition of DPPA. The reaction mixture was then heated to reflux for 20 min, 
ethanol added and further refluxed for five hours. Unfortunately, the desired carbamate was only 
isolated in very low yields since purification proved problematic. Since monitoring by TLC was 
difficult, infra-red (IR) spectroscopy was used to observe the formation and disappearance of the 
C-N acyl azide (152) stretch (2130 cm-1). Gratifyingly, after two hours in refluxing 1,2-
dichloroethane complete disappearance of the acyl azide peak was observed with formation of an 
isocyanate peak (153). At this point solvent was removed in vacuo to leave the crude isocyanate 
(153) which was then dissolved in ethanol and the resultant mixture heated to reflux for 3.5 days 
to afford the desired carbamate (154) in 77% isolated yield. Duggan et al. reported the formation 
of carbamates from isocyanates under mild reaction conditions by using copper salts to accelerate 
this transformation.102 However, employing two equivalents of copper (II) chloride with ethanol 
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at ambient temperature for 16 hours resulted in the formation of carbamate (154) in a lower 
overall yield (50% at best).   
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Scheme 35 
Reagents & conditions: a) DIPEA (2 eq), DPPA (2 eq), 1,2-DCE, reflux, 2 h; b) EtOH, rt, 3.5 d, 
77%.  
Chemoselective reduction of carbamate (154) with excess lithium aluminium hydride in refluxing 
diethyl ether furnished the volatile amine (155). Treatment of amine (155) with sub-
stoichiometric amounts of triphosgene and a slight excess of pyridine under typical reaction 
conditions previously developed in the Grainger group88 yielded the crude carbamoyl chloride 
(156), which was used directly in the next synthetic step without further purification. Subsequent 
displacement of carbamoyl chloride (156) with sodium diethyldithiocarbamate trihydrate 
provided the desired cyclisation precursor, carbamoyl dithiocarbamate (110) in less than 30% 
isolated yield over two steps. Careful analysis of the reaction progress by TLC showed amine 
(155) was only partially consumed to carbamoyl chloride (156), and also the subsequent 
displacement reaction of (156) with sodium diethyldithiocarbamate trihydrate resulted in 
incomplete consumption of the carbamoyl chloride species. These intriguing observations suggest 
intermediates (155) and (156) are not as reactive as typical amines and carbamoyl chlorides 
previously studied in the Grainger group. On that basis, the standard conditions employed by the 
Grainger group had to be modified in order to optimise this particular synthetic sequence. After 
careful optimisation of the reaction conditions, the cyclisation precursor (110) was obtained in a 
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modest 63% over two steps. This was achieved by treatment of amine (155) with sub-
stoichiometric amounts of triphosgene and slight excess of pyridine in refluxing THF. After 16 
hours, amine (155) was completely consumed and the crude carbamoyl chloride (156) was then 
treated with sodium diethyldithiocarbamate trihydrate in refluxing acetone overnight to furnish 
the desired carbamoyl dithiocarbamate (110) in 63% isolated yield over  two steps  (scheme 36). 
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  Scheme 36 
Reagents & conditions: a) LiAlH4, Et2O, reflux, 4 h, quant; b) triphosgene (0.33 eq), pyridine 
(1.5 eq), THF, reflux, 16 h; c) sodium diethyldithiocarbamate trihydrate (4 eq), acetone, 16 h, 
63% over two steps. 
Route to cyclisation precursor via imidazolide 
Given the modest yield of carbamoyl dithiocarbamate (110) achieved, an alternative route to the 
cyclisation precursor was considered. Batey et al. reported that carbamoyl imidazolium salts can 
be used as useful alternatives to carbamoyl chlorides.103 Initial treatment of amine (155) with 
slight excess of carbonyldiimidazole (CDI) in dichloromethane failed to produce any imidazolide 
(20) (table 1, entry 1). The use of a basic catalyst also proved unsuccessful. However, the use of 
two equivalents of CDI and potassium carbonate in refluxing dichloromethane provided the 
desired imadazolide (157) in 55% yield after column chromatography (table 1, entry 2). The 
optimal conditions for this conversion required a large excess of CDI and potassium carbonate in 
a higher boiling solvent, THF, to provide imidazolide (157) in 80% yield (table 1, entry 5).  
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Entry  Reagents  Temperature Time (h) Yield (%) 
1 CDI (1.1 eq), 
DCM 
Rt 16 No reaction 
2 CDI (1.1 eq),   
DMAP (10%), 
DCM 
Rt 16 No reaction 
3 CDI (2 eq), 
K2CO3 (2 eq), 
DCM 
Reflux 16 55  
4 CDI (2 eq), THF Reflux 16 61  
5 CDI (5 eq), 
K2CO3 (5 eq) 
THF 
Reflux 16 80  
Table 1: conversion of amine (155) to imidazolide (157)  
Imidazolide (157) was activated with a large excess of iodomethane to provide imidazolium salt 
(158). Subsequent treatment with sodium diethyldithiocarbamate in refluxing acetone furnished 
the cyclisation precursor, carbamoyl dithiocarbamate (110) in 75% isolated yield (scheme 36). 
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Scheme 36 
Reagents & conditions: a) CDI (5 eq), K2CO3 (5 eq), THF, reflux, 16 h, 80%; b) MeI (50 eq), 
85%; c) sodium diethyldithiocarbamate trihydrate (2 eq), acetone, reflux, 5 h, 75%. 
Disappointingly, this alternative approach to the cyclisation precursor (110) via the imidazolium 
salt (158) was lower yielding (51%), 12% lower than the initial approach via the carbamoyl 
chloride. Therefore on that basis, cyclisation precursor (110) would be synthesised via carbamoyl 
chloride (156). 
Synthesis of an eight-membered ring cyclisation precursor 
During the synthesis of the cyclisation precursor (110) en route to the natural products 
ferruginine and ferrugine, it was decided to broaden the investigation of the photocyclisation-
group transfer reaction by increasing the size of the ring system. This required synthesis of a new 
cyclisation precursor (159), an eight-membered ring system with the potential to provide a 
mixture of regio-and stereoisomers from carbamoyl radical cyclisation-dithiocarbamate group 
transfer. 
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Synthesis of carbamoyl dithiocarbamate cyclisation precursor (159) began with amine (160), 
synthesised according to literature procedures.104 Treatment of amine (160) with sub-
stoichiometric amounts of triphosgene and excess of pyridine afforded carbamoyl chloride (161), 
which was used in the next step without further purification. Subsequent displacement of chloride 
with sodium diethyldithiocarbamate trihydrate provided the prerequisite cyclisation precursor 
(159) in moderate yield (scheme 37).  
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Scheme 37 
Reagents & conditions: a) triphosgene (0.33 eq), pyridine (1.5 eq), toluene, rt, 1 h; b) sodium 
diethyldithiocarbamate trihydrate (4 eq), acetone, rt, 16 h 39% over two steps. 
The poor reaction yields once again prompted us to consider a substitute to carbamoyl chlorides, 
and as before, the use of carbonyldiimidazole (CDI) species was examined.103  Amine (160) was 
therefore submitted to the optimum reaction conditions for the preparation of carbamoyl 
dithiocarbamate cyclisation precursor (159), which furnished the desired imidazolide (162) in 
75% isolated yield. Activation of imidazolide (162) with excess iodomethane furnished the 
imidazolium salt (163) in excellent yield, and subsequent displacement with sodium 
diethyldithiocarbamate in refluxing acetone provided the required cyclisation precursor (159) in 
68% yield after column chromatography (scheme 38). The overall yield for this transformation 
was a moderate 50% over three steps, an improvement of 11% over the previous carbamoyl 
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chloride route. Therefore, for the purpose of this study, the alternative imidazolium approach was 
adopted for the synthesis of carbamoyl dithiocarbamate (159).  
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Scheme 38 
Reagents & conditions: a) CDI (5 eq), K2CO3 (5 eq), THF, reflux, 16 h, 75%; b) MeI (50 eq), 
97%; c) sodium diethyldithiocarbamate trihydrate (2 eq), acetone, reflux, 16 h, 68%, (50% from 
amine 160). 
Carbamoyl radical cyclisation 
Having established a route to the cyclisation precursors (110) and (159), photocyclisations were 
attempted. Irradiation of a solution of carbamoyl dithiocarbamate (110) in cyclohexane with a 
500 W halogen lamp88 (which generated enough heat to bring the mixture to reflux) afforded the 
desired cyclised dithiocarbamates (164) and (165) in 64% and 10% isolated yields, respectively 
(scheme 39). The relative stereochemistry of the major diastereomer (164) was confirmed by X-
Ray crystallography (fig 5).105 
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Scheme 39 
Reagents & conditions: a) 500 W halogen lamp, cyclohexane, reflux, 5 h, (164) 64% and (165) 
10%. 
 
Fig 5: X-Ray crystal structure of major diastereomer (164) (30% probability ellipsoids) 
Irradiation of the carbamoyl diethyldithiocarbamate (110) using the halogen lamp homolytically 
cleaves the carbon-sulfur bond to generate carbamoyl radical (111) which undergoes a 
transannular cyclisation onto the pendant alkene, to generate a new carbon-centred radical (112). 
The newly formed species is functionalised by a group transfer of the dithiocarbamate (110), to 
furnish a tertiary radical (166), which fragments to provide the dithiocarbamate diastereomers 
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(113), and in turn regenerates the carbamoyl radical (111) to continue the chain process (scheme 
40).  
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Scheme 40 
In similar fashion, irradiation of a solution of carbamoyl diethydithiocarbamate (159) in 
cyclohexane with a 500 W halogen lamp proceeded to provide diastereomers (167) and (168) in 
46% and 18% yields respectively (scheme 41). 
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This particular transannular cyclisation was highly regioselective but only moderately 
stereoselective. X-Ray crystallographic analysis on the minor diastereomer (168) confirmed the 
regio- and stereochemistry, which also shows the dithiocarbamate group on the same side as the 
amide junction (fig 6). This can be attributed to the preferential formation a six-membered rings, 
which occurs at a much faster rate than seven- membered ring formation. Cyclisation to form 
larger ring sizes usually results in poor orbital overlap and increased ring strain.  
 
Fig 6: X-Ray crystal structure of minor diastereomer (168) (30% probability ellipsoids) 
Irradiation of a solution of carbamoyl dithiocarbamate (159) generated carbamoyl radical (169) 
which cyclised onto the alkene to generate a secondary radical (170). Radical (170) was further 
functionalised and captured by dithiocarbamate group transfer to form a tertiary radical (171). 
Fragmentation of radical (171) proceeded to provide the diastereomers (172), which also 
regenerated the carbamoyl radical (169) to continue the chain process (scheme 42).  
 
50 
 
N
O
Me
NO
Me
S
S
Et2N
O
N
Me
S
S
Et2N
O
N
Me
NO
Me
dithiocarbamate group transfer
f ragmentation
NO
Me
S
S
Et2N transannular cyclisation
169
170
171
172
159  
Scheme 42 
Thermal elimination of dithiocarbamates 
Previously in the group, thermal elimination of dithiocarbamate groups were carried out by 
refluxing a solution of dithiocarbamates in diphenyl ether (bp 259 °C).61, 88 Therefore, in a similar 
fashion, a solution of dithiocarbamate (164) in diphenyl ether was heated at reflux for 2 hours to  
provide  the bicyclic alkene (173) in 88% yield after column chromatography.  
Upon completion of the reaction, the mixture was allowed to cool to room temperature and 
subjected directly to column chromatography. The non-polar diphenyl ether was firstly removed 
by eluting with petrol, before increasing the polarity of the eluent system (petrol/EtOAc) to afford 
the desired alkene (173). Similarly, thermal elimination of dithiocarbamate (165) also proceeded 
smoothly to afford alkene (173) in 70% isolated yield after purification. Once the individual 
yields were obtained from the thermal elimination reactions, a mixture of diastereomers (164) 
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and (165) (6:1) were subjected to thermal elimination conditions which converged to alkene 
(173) in 86% yield after column chromatography.  
Thermal elimination of dithiocarbamate groups of diastereomers (167) and (168) in refluxing 
diphenyl ether resulted in alkene (174) in an identical 80% yield. The structure of (174) was 
elucidated by X-Ray crystallographic analysis (fig 7), and also confirms the regio-and 
stereochemical assignment of major diastereoisomer (167). Also a mixture of diastereomers 
(2.5:1), in refluxing diphenyl ether converged to alkene (174) in 73% isolated yield after 
purification (scheme 43). 
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Fig 7: X-Ray crystal structure of alkene (174) from thermal elimination (30% probability 
ellipsoids) 
Tandem carbamoyl radical cyclisation-thermal elimination 
The possibility of achieving a tandem carbamoyl radical cyclisation- thermal elimination pathway 
to obtain the bicyclic alkene (173) was investigated. This could be achieved by irradiating a 
solution of cyclisation precursor in diphenyl ether with a 500 W halogen lamp. The anticipated 
thermal elimination of dithiocarbamate group should proceed after radical cyclisation has 
occurred to furnish the required alkene species. This was conditional on the 500 W halogen 
lamps generating enough heat to bring the high boiling diphenyl ether to reflux, which was 
indeed the case. The reaction progress was carefully monitored by TLC, and was completed after 
seven hours. Purification by column chromatography proved slightly more difficult than before as 
unwanted byproducts from the carbamoyl radical cyclisation reaction were carried through. 
However, the desired alkene (173) was ultimately obtained in a relatively poor isolated yield of 
36% after column chromatography. Equally, the tandem carbamoyl radical cyclisation- thermal 
elimination reaction was carried out on the eight-membered cyclisation precursor (159) in 
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refluxing diphenyl ether, which proceeded smoothly in four hours  to deliver alkene (174) in a  
much better 60% isolated yield after column chromatography (scheme 44). 
Overall, this one pot transformation to obtain alkene (173) from cyclisation precursors (110) 
proved less efficient, with a lower overall yield of 36% compared with 64% from two steps, a 
decrease of 27%. However, the overall yield for alkene (174) from cyclisation precursor (159) 
was higher at 60%, an increase of 9% from 51% over the two step sequence.    
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Scheme 44 
Completion of the synthesis of ferrugine 
The synthesis of ferrugine was completed through treatment of 6-azabicyclo[3.2.2]non-2-ene 
(173) using a large excess of phenyllithium followed by quenching with an aqueous solution of 
sodium hydroxide. This directly led to the formation of the 8-azabicyclo[3.2.1] octane ring 
system, ferrugine, as a single diastereomer, in a one-pot, multistep transformation, with no 
byproducts being observed from the over addition of phenyllithium. This conversion is believed 
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to occur through an initial nucleophilc attack of phenyllithium onto the amide which presumably 
led to hemiaminal (175), which upon aqueous work-up liberated the intermediate amino ketone 
(176). Treatment of amino ketone (176) with 5% sodium hydroxide shifted the double bond into 
conjugation with the phenyl ketone to give (177), and finally an intramolecular conjugate 
addition proceeded to furnish the tropane alkaloid ferrugine (scheme 45), whose structure and 
relative stereochemistry was confirmed by X-Ray crystallography of the corresponding 
perchlorate salt (fig 8).106 Initial comparison with literature data showed discrepancies in 1H 
NMR chemical shift values, which suggested the incorrect relative stereochemistry was 
obtained.6, 7 This inconsistency with literature values prompted the growth of the corresponding 
perchlorate crystal to be unambiguously assigned by X-Ray analysis. 
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Fig 8: X-Ray of ferrugine perchlorate salt (30% probability ellipsoids) 
Initially, this multistep transformation was attempted using a combination of phenyllithium and 
phenylmagnesium chloride with a Lewis acid, cerium chloride.107, 108 It was hoped that activation 
of the amide ring with cerium chloride would lead to a successful phenyl addition to the bicyclic 
amide junction. However, this combination proved ineffective with starting material being 
recovered on each occasion (table 2, entries 1-4). Attention then turned to adding a large excess 
of phenyllithium and phenylmagnesium chloride to a solution of amide (173) in THF. 
Unfortunately even with up to 5 eq of both reagents, the reaction was again unsuccessful with the 
starting material being recovered (table 2, entries 5-6). Only when 10 eq of phenyllithium was 
added drop-wise to a solution of amide (173) in THF at 0 °C resulted in the disappearance of 
amide (173) by TLC after 1 hour. This was an encouraging indication of phenyl group insertion 
onto the amide (173). At this point, the reaction mixture was quenched with water and 
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immediately basified with an aqueous solution of sodium hydroxide until a pH of 14 was 
reached. The resultant mixture was stirred overnight at room temperature to deliver the tropane 
alkaloid natural product, ferrugine. Purification proved slightly difficult at first due to the polar 
nature of the amine. To alleviate this problem, purification was carried out on basified neutral 
alumina which resulted in a 66% isolated yield (table 2, entry 8).106  
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Entry Reagents Temperature Time 
(h) 
Yield (%) 
1 PhLi/CeCl3 (1.5 
eq), THF 
0 °C to reflux 16 No reaction 
2 PhMgCl/CeCl3 
(1.5 eq), THF 
0 °C to reflux 16 No reaction 
3 PhLi/CeCl3 (2 eq), 
THF 
0 °C to reflux 16 No reaction 
4 PhMgCl/CeCl3 (2 
eq), THF 
0 °C to reflux 16 No reaction 
5 PhLi (5 eq), THF 0 °C to rt 16 No reaction 
6 PhMgCl (5 eq), 
THF 
0 °C to rt 16 No reaction 
7 PhMgCl (10 eq), 
THF 
0 °C to rt 16 No reaction 
8 PhLi (10 eq), THF, 
then H2O, NaOH 
(5%) 
0 °C to rt 16 66  
Table 2: attempted conversion of 173 to ferrugine 
Attempted synthesis of ferruginine 
Having successfully completed the synthesis of ferrugine, attention turned to the related natural 
product, ferruginine. Preparation of the tropane framework (178) of ferruginine was envisaged 
from amide (173) via the already established one pot multistep sequence using methyllithium in 
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place of phenyllithium.106 Finally, completion of the synthesis would require an oxidation step to 
introduce the conjugated enone system found in the natural product (scheme 46).   
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Scheme 46 
Amide (173) was treated with methyllithium at 0 °C as the synthesis of the tropane alkaloid 
skeleton (178) was carefully monitored by TLC which showed complete consumption of starting 
amide (173) after one hour. The reaction mixture was subsequently quenched with water and 
basified with aqueous sodium hydroxide. The resultant mixture was slowly warmed to room 
temperature and stirred for six hours to furnish a 6:1 mixture of stereoisomers (178) and (179), 
separable by column chromatography in combined 89% yield (scheme 47).106 This 
transformation presumably occurs via a similar mechanistic pathway described earlier (scheme 
14). Stereochemical assignment of the major isomer was confirmed by the 1H NMR coupling 
constant between the di-axial hydrogens of C2 and C3 in (178) of 11 Hz, which is in the typical 
range for an axial-axial coupling constant (9-13 Hz). Unfortunately, the minor isomer (179) could 
not be isolated in a pure form, with impurities observed in the 1H NMR spectrum. However, upon 
treatment with aqueous sodium hydroxide, the minor stereoisomer (179) epimerised to the 
original 6:1 mixture, thus indicating a clear thermodynamic preference for stereoisomer (178).  
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Scheme 47 
Reagents & conditions:  MeLi (2 eq) THF, 0 °C, 1 h; then H2O, aq NaOH (5%), 6 h, rt.  
The synthesis of an α,β-unsaturated carbonyl moiety from a carbonyl compound is often a 
challenging transformation. Traditionally this particular transformation relies heavily upon one of 
the following two methods; 1) the palladium catalysed oxidation of a silyl enol ether,109 or 2) 
treatment of carbonyl compounds with highly toxic selenium reagents such as PhSeCl followed 
by oxidation and spontaneous elimination of the corresponding sulfoxide to deliver α,β-
unsaturated carbonyl systems.110 
Nicolaou and co-workers have reported the use of non-toxic hypervalent iodine (V) complexes to 
produce α,β-unsaturated carbonyl systems in a one step conversion, without the need for prior 
silyl enol ether formation.111 The use of iodosobenzoic acid (IBX) has been reported to promote 
the oxidation of alcohols into carbonyls, and further oxidation results in α,β-unsaturated 
system.112 IBX is also used for the oxidation of secondary amines and hydroxylamines to produce 
imines and oximes respectively,113 and also in the oxidation of benzylic carbon atoms under mild 
conditions with DMSO as a solvent.111 Complexation of IBX with ligands such as N-oxides, in 
particular MPO,114 can dramatically affect the reaction profile, and is heavily used. The 
hypothesised mode of action involving IBX proceeds via a single electron transfer mechanism 
(scheme 48) as opposed to an ionic process (scheme 49).111 
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Although this was encouraging precedent for the one-pot transformation of ketones into α,β-
unsaturated carbonyl motifs, there is only one report of such an oxidation occurring in a molecule 
containing a nitrogen atom.115 With this in mind, tropane alkaloid skeleton (178) was treated with 
a pre-complexed mixture of IBX and MPO in DMSO at room temperature (table 3, entry 1). 
Unfortunately, even after seven days at room temperature, this failed to yield any of the desired 
α,β-unsaturated ketone, ferruginine. Pre-complexation of IBX and NMO were also attempted but 
once again failed to deliver the natural product (table 3, entry 2). Due to the lack of reactivity at 
room temperature, reactions were then performed at elevated temperatures ranging from 50 °C to 
80 °C. Once again, these reactions failed to deliver the desired compound (table 3, entries 3 and 
4), whereas using excess NMO or MPO at 80 °C to force reactivity only led to decomposition 
(table 3, entries 5 and 6).   
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Entry Reagents Solvent Conditions Outcome 
1 2.4 equiv 
IBX/MPO  
DMSO 
(0.6M) 
r.t up to 7 d No reaction 
 
2 2.4 equiv 
IBX/NMO  
DMSO (0.6 
M) 
r.t up to 7 d No reaction 
3 2.4 equiv 
IBX/MPO  
DMSO 
(0.6M) 
50 °C 2 d to  
60 °C 2 d 
No reaction 
4 2.4 equiv 
IBX/NMO  
DMSO 
(0.6M) 
50° C 2 d to 
60 °C 2 d. 
No reaction 
5 4.8 equiv 
IBX/MPO 
DMSO 
(0.6M) 
80 °C 6 h decomposition 
6 4.8 equiv 
IBX/MPO 
DMSO 
(0.6M) 
80 °C 6 h decomposition 
Table 3: attempted oxidation of ketone (178) 
With very little to no reaction at all, it was then decided to try a slightly different approach by 
protecting the nitrogen lone pair as this might be hindering the reaction. Investigation began with 
in situ amine protection using sub-stoichiometric amounts of acetic acid followed by treatment 
with IBX pre-complexed with MPO or NMO. Disappointingly, this approach also proved 
unsuccessful following similar reactivity trends as before, with up to 4.8 equivalents of reagents 
at 80 °C led to decomposition (table 4, entries 1-5). The free amine was also protected in situ 
with boron trifluoroetherate and subjected to the usual reaction conditions, which again failed to 
provide the natural product (table 4, entries 6 and 7).      
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Entry Reagents Solvent Conditions Outcome 
1 2.4 equiv IBX/ 
AcOH (10 mol%) 
DMSO (0.6M) r.t  7 d No reaction 
2 2.4 equiv IBX/  
AcOH (10 mol%) 
DMSO (0.6M) 50 °C 2 d to  60 
°C 2 d 
No reaction 
3 4.8 equiv IBX, 
AcOH (10 mol%) 
DMSO (0.6M) 80 °C 6 h decomposition 
4 2.4 equiv IBX/ 
MPO, AcOH (10 
mol%) 
DMSO (0.6M) r.t to 60 °C No reaction 
5 2.4 equiv 
IBX/NMO, AcOH 
(10 mol%) 
DMSO (0.6M) r.t to 60 °C No reaction 
6 2.4 equiv IBX/ 
MPO, BF3.OEt 
DMSO (0.6M) rt to 60 °C, 2 d No reaction-
decomposition 
7 2.4 equiv 
IBX/NMO,  BF3.OEt 
DMSO (0.6M) rt to 60 °C, 2 d No reaction-
decomposition 
Table 4: attempted oxidation of ketone (178) 
Having exhausted all possible methods for this one pot transformation to form the desired α,β-
unsaturated ketone, attention then turned to the traditional two-step procedure. 
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Investigation began with the intention of functionalising the tropane alkaloid skeleton (178) by 
formation of a silyl enol ether (180),116-123 which upon palladium mediated oxidation would result 
in ferruginine (scheme 50).  
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Scheme 50 
Treatment of tropane alkaloid (178) with trimethylsilyl chloride (TMSCl) and triethylamine in 
DMF, classical conditions for the formation of thermodynamic silyl enol ethers, gave no reaction 
at ambient temperatures, and complete decomposition of starting material upon raising the 
temperature slowly up to 100 °C (table 5, entry 1).123 The use of slight excess of alkaloid (178) 
with lithium diisopropylamine (LDA) and TMSCl resulted in the formation of multiple spots by 
TLC. Encouragingly, a new clean spot emerged by TLC from the use of excess LDA and TMSCl 
(table 5, entry 3). Disappointingly however, isolation proved tricky and spectroscopic data from 
the impure product indicated the incorrect silyl enol ether was formed (methylene protons were 
observed in the 1H NMR spectrum). At this point with this particular outcome, further progress 
was halted.116, 118-121 Variation of bases and silylating agents under various conditions also proved 
unsuccessful as the desired outcome was not achieved, mostly leading to multiple spots by TLC 
or complete decomposition of starting material (table 5, entries 4-8).117, 122, 123  
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Entry Reagents Solvent Conditions Outcome 
1 Et3N (2.5 eq), TMSCl 
(1.3 eq) 
DMF rt to 100 °C Decomposition 
2 LDA (0.9 eq), TMSCl 
(3 eq) 
THF -78 °C, 30 min 
to rt, 30 min 
Multiple spots 
3 LDA (2 eq), TMSCl 
(3 eq) 
THF -78 °C, 30 min 
to rt, 30 min 
product not 
observed by 1H 
NMR spectra 
4 NaHMDS (2.5 eq), 
TMSI (2 eq) 
DCM -20 °C to rt, o/n Multiple spots 
5 TBDMSCl (3 eq), 
NaH  (3 eq) 
THF rt, 7 h Multiple spots 
6 TBDMSCl ( 1.1 eq), 
NaHMDS (1.05 eq) 
THF -78 °C to rt, o/n No product 
observed by 1H 
NMR spectra 
7 TBDMSCl (5.1 eq), 
NaH  (5 eq) 
THF rt, o/n Multiple spots 
8 
tBuOK (1.5 eq), 
Me2SO4 (1.5 eq)  
DMSO rt, 2 h Decomposition 
9 
tBuOK (1.05-2.10 eq), 
allyl chloroformate 
(1.2-2.4 eq) 
DMF 0 °C to 125 °C No reaction to 
decomposition 
Table 5: attempted enolisation of ketone (178) 
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An alternative approach to this transformation is the use of highly toxic selenium reagents to give 
selenide (181), which would be oxidised to selenoxide with mCPBA followed by a spontaneous 
elimination to furnish the natural product, ferruginine (scheme 51).109, 124, 125 
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PhSe-X
 
Scheme 51 
Treatment of alkaloid (178) with excess triethylamine and phenylselenium chloride in various 
solvents failed to deliver any encouraging results.109, 124 This reaction proved unsuccessful due to 
the observed lack of reactivity to complete degradation (table 6, entries 1-3). Changing from 
phenylselenium chloride to phenylselenium bromide also proved unsuccessful with no reactivity 
observed in refluxing THF (table 6, entry 4).125     
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Entry Reagents Solvent Conditions Outcome 
1 Et3N (4 eq) PhSeCl 
(3 eq) 
THF rt to reflux, 2 d No reaction 
2 Et3N (4 eq) PhSeCl 
(3 eq) 
DMF rt to reflux, 6 h decomposition 
3 Et3N (4 eq) PhSeCl 
(3 eq) 
EtOAc reflux, 3 d No reaction 
4 Et3N (2.5 eq), 
PhSeBr (1.2 eq) 
THF reflux, 2 d No reaction 
Table 6: attempted functionalisation of ketone (178) 
A different strategy to form the required α,β-unsaturated system is via functionalisation of the 
tropane alkaloid (178) to incorporate a leaving group X adjacent to the ketone. This 
functionalised species (182) would then be subjected to base-promoted elimination to furnish the 
desired compound (scheme 52). Introduction of a halogen group α to the ketone was attempted by 
firstly treating (178) with thionyl chloride in carbon tetrachloride.126 Unfortunately after two days 
at room temperature, there was no reaction and starting material was recovered (table 7, entry 1). 
Attempted bromination with molecular bromine was also unproductive with only starting 
material recovered (table 7, entries 2 and 3), while reactions with N-bromo-succinimide resulted 
in a complicated mixture and eventual decomposition of (178) (table 7, entries 4 and 5).127   
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Scheme 52 
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Entry Reagents Solvent Conditions Yield [%] 
1 SOCl2   CCl4 rt, 2 d No reaction 
2 Br2, AcOH CCl4 rt, 2 d No reaction 
3 Br2, HBr, 
AcOH 
CHCl3 rt, o/n No reaction 
4 NBS (1.56 eq),  CCl4 Reflux, 25 min Multiple spots 
5 NBS (1.56 eq), 
PhCO3H (30%) 
CCl4 70 °C, 2 h decomposition 
Table 7: attempted functionalisation of ketone (178) 
Conclusion and future work 
In summary, the synthesis of the tropane alkaloid ferrugine was accomplished in 7 steps from the 
known carboxylic acid (146) in 21% overall yield.  The synthesis of ferrugine has demonstrated, 
and extended the synthetic utility of carbamoyl radical cyclisation-dithiocarbamate group transfer 
reactions. Carbamoyl radical cyclisation precursors (110) and (159) were synthesised in good 
yields via carbamoyl chloride and imidazolium salts, respectively. Carbamoyl radical cyclisation-
group transfer proceeded with moderate selectivity to give diastereomers (164) and (165) which 
converged into bicyclic alkene (173) upon thermal elimination in diphenyl ether. Similarly 
irradiation of the eight-membered cyclisation precursor (159) resulted in the formation of 
diastereoisomers (167) and (168), which also converged to a single bicyclic alkene (174). Finally, 
an in situ multistep transformation of amide (173) with phenyllithium furnished ferrugine.  
 Unfortunately, efforts towards the synthesis of ferruginine from the tropane alkaloid skeleton 
(178) proved unsuccessful, as attempted oxidation to the α,β-unsaturated carbonyl system of the 
natural product using various reagents and conditions failed. The inability to functionalise 
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alkaloid (178) could be attributed to the exposed lone pair of the free amine having a detrimental 
outcome to the reaction progress. 
Previous work toward the syntheses of ferruginine showed that the nitrogen lone pair remained 
fully protected as the Boc group throughout the synthesis, eliminating the possibility of 
unfavourable lone-pair interactions. Once the ferruginine framework has been accomplished 
(including the double bond), subsequent Boc deprotection and reductive methylation completed 
the synthesis. With the attempted synthesis of ferruginine, there may have been an alternative 
outcome had we protected the nitrogen lone pair as the Boc group earlier in the synthesis before 
attempting to install the α,β-unsaturated carbonyl motif, and hence, completing a formal 
synthesis. 
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4. STEMOFOLINE: BACKGROUND & SIGNIFICANCE 
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Stemona alkaloids 
The extracts of several plants from the stemonaceae family are known as a rich source of 
structurally complex stemona alkaloids. Traditionally they have been used in Asian countries 
such as China, Japan and Thailand for treatment of respiratory diseases, antihelminits and also as 
domestic insecticides.128 Currently there are around one hundred stemona alkaloids known in the 
literature of which around thirty have been fully elucidated by X-Ray crystallographic analyses, 
with the remainder analysed according to their spectroscopic data.128 The complex structure of 
the stemona alkaloids consist of polycyclic saturated ring systems  with a common pyrrolo[1,2-
a]azepine core, with the majority consisting of at least one α-methyl-γ-butyralactone substructure 
attached to the azabicyclic unit. Due to their structural diversity and complexity, they have been 
recently classified into eight sub-categories and their basic skeletal structure along with the most 
representitive member of the stemona alkaloids are shown in figure 9.129 The central pyrrolo[1,2-
a]azepine core structure is present in the stenine, stemoamide, tuberrostemopironine, 
stemonamine, parvistemoline and stemofoline groups, while stemocurtisine contains the less 
common  pyrrolo[1,2-a]azepine structure. The final group of the stemona alkaloids are 
categorised in the miscellaneous group, where the pyrrolo[1,2-a]azepine systems are hidden or 
completely  lacking the azabicyclic constituent.   
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Fig 9 
Due to their intricate molecular architecture coupled with their biological importance, the 
stemona alkaloids have attracted and motivated the synthetic community to develop novel 
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strategies for the construction of their molecular framework culminating in a number of 
completed total syntheses.129-169 
Stemofoline: isolation and biological activity  
Stemofoline was isolated by Irie and co-workers from stemona japonica,170 and its structure and 
absolute configuration was fully elucidated by X-Ray crystallography of its hydrobromide 
monohydrate which revealed a rigid pentacyclic core system along with α-methyl-γ-butyralactone 
substructure attached to the azabicyclic unit.170 Stemofoline has shown insecticidal activity 
against Plutella xylostella larvae and against neonate larvae of Spodopera litteralis.171 
Additionally, stemofoline has antifeedant activity against the larvae of the diamondback moth, a 
vegetable crop pest.172 
Owing to their captivating, rigid cage like structures and interesting biological activities, the 
structurally complex family of stemona alkaloids (fig 10) has attracted considerable synthetic 
interest over the last decade.168, 169, 173-183 Kende et al. were the first group to report the synthesis 
of a member of this class of compounds, by achieving the total synthesis of isostemofoline in 
1999.168 Since then, Overman et al. have successfully reported the syntheses of asparagamine A 
(didehydrostemofoline) and its geometrical isomer isodidehydrostemofoline.169  
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Fig 10 
From hereon, the total syntheses and synthetic efforts toward this sub class of stemona alkaloids 
will discussed, outlining the key chemical transformations involved.   
Overman’s synthesis of asparagamine A.
169
 
The synthesis of asparagamine A, isolated by Irie and co-workers from S.collinase,170 began with 
a [4+2] Diels-Alder cycloaddition between the activated Boc-protected pyrrole (183) as the diene 
and ethyl (E)-3-nitroacrylate as the dienophile to deliver the regioisomeric adducts (184) and 
(185) in a 6:1 ratio (Scheme 52). Attempted purification of the cycloadducts on silica gel resulted 
in retro-Diels-Alder reaction back to starting materials; therefore the cycloadducts were directly 
subjected to an exo-face Pd/C-catalysed hydrogenation which resulted in the azabicycloheptanes 
(186) and (187). The nitro group of the dienophile, which was crucial in facilitating the 
cycloaddition by minimising the energy levels of the HOMO and LUMO of the diene and the 
dienophile, respectivley, was subsequently eliminated from the major cycloadduct (186) by 
treatment with DBU to provide an α,β-unsaturated ester (188). Hydrogenation from the less-
hindered face yielded the axial ethyl ester (189). Silylation of the primary alcohol using TIPSOTf 
followed by DIBALH reduction of the ester furnished alcohol (190). Oxidation to the aldehyde 
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(191), formation of the enolsilane, and ozonolysis gave ketone (193). Stereoselective addition of 
vinyl Grignard to the top face of the ketone using Luche conditions gave allylic alcohol (194). 
Chemoselective deprotection of the Boc group upon treatment with TMSI provided the 
ammonium hydroiodide salt (195), required for the crucial transformation in obtaining the core 
structure of stemona alkaloids. 
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Scheme 52 
Reagents & conditions: (a) (E)-O2NCHCHCO2Et, rt; (b) H2, Pd/C, EtOAc, rt, (8), 73% & (9), 
13%; (c) DBU, CH2Cl2, rt; (d) TIPSOTf, 2,6-lutidine, CH2Cl2, rt; (e) DIBALH, MePh, -78 °C, 
51% (f) DMP, CH2Cl2, rt; (g) TIPSOTf, Et3N, CH2Cl2, -78 °C;  (h) O3, MeOH, CH2Cl2, -78 °C; 
72%; (i) CH2CHMgBr, CeCl3, THF, -78 °C; (j) TMSI, 2,6-lutidine, 0 °C- rt, MeOH; 85%. 
The key step in the synthesis of the core structure of asparagamine A is an Aza-Cope Mannich 
rearrangement (scheme 53).184 The core structure (198) was obtained by heating the iodide salt 
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(195) in excess paraformaldehyde which resulted in the formation of the formaldiminium ion 
derivative (196). A [3,3]-sigmatropic rearrangement between the two termini of the vinyl and 
iminium ion motifs of (196) furnished enol-iminium species (197). Finally an intramolecular 
Mannich cyclisation of (197) afforded azatricyclodecanone (198) in almost quantitative yield. 
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Scheme 53 
Desilylation of (198) using TBAF, followed by an activated DMSO oxidation of the primary 
alcohol (199), and treatment of the re sulting aldehyde under modified Julia olefination 
conditions185 afforded the more thermodynamically stable E isomer (200) exclusively (scheme 
54). Kinetically controlled alkylation of (200) with LDA and ethyl 2-iodoacetate resulted in a 
mixture of stereoisomers (201). The stereoisomers were epimerised under basic conditions with 
DBU to give the more energetically preferred equatorial keto-ester configuration (202). 
Deprotection of the methyl ether of (202) with BBr3, silylation of the resulting lactol, followed by 
methylation of the lithium ester enolate of (203) furnished α-methyl ester (204), which had the 
incorrect configuration at C* required for the natural product. This particular setback was 
overcome by the reduction of ester (204) to the corresponding primary alcohol, followed by 
Dess-Martin oxidation to the aldehyde (205). This was subsequently epimerised under basic 
conditions to yield a 94:6 mixture of stereoisomers separable by chromatography, to obtain the 
major epimer (206). 
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Scheme 54 
Reagents & conditions: (a) TBAF, THF, rt; (b) SO3Py, NEt3, DMSO, rt; (c) C7H5N4SO2n-Pr, 
KHMDS, DME, -55 °C, 70%; (d) LDA, THF, ICH2CO2Et, -10 °C; (e) DBU, MePh, 130 °C, 
67%; (f) BBr3, CH2Cl2, -78 °C to -10 °C, aq NaOH; (g) TMS-imid., 130 °C; (h) LDA. MeI, THF-
DMPU, -45 °C, 54%; (i) DIBALH, CH2Cl2, -78 °C; (j) DMP, rt; (k) DBU, CHCl3, rt, 54%. 
Introduction of the tetrahydrofuranylidene butenolide unit was achieved by nucleophilic attack of 
the lithiated form of 4-methoxy-3-methyl-2(5H) furanone (207) upon aldehyde (206), followed 
by cleavage of the silyl protecting group to furnish hemiacetal (208) (scheme 55). Hypervalent 
iodine (V) oxidation of (208) using IBX186 provided diol (209), which was condensed with 
thiophosgene to form thiocarbonate derivatives (210) and (211). These were subsequently 
transformed into asparagamine A, along with its geometrical isomer isodidehydrostemofoline by 
desulfurisation-decarboxylation, upon heating in excess trimethyl phosphite at 120 ºC  
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Scheme 55 
Reagents & conditions: (a) (207), n-BuLi, THF, -78 °C; (b), aq HCl, CHCl3, MeOH, rt, 93%; 
(c) IBX, DMSO, 55 °C, 55%; (d) CSCl2, DMAP, CH2Cl2, -50 °C, 68%; (e) (MeO)3P, 120  °C, 
(asparagamine A, 66%), (isodidehydrostemofoline, 64%).  
In conclusion, asparagamine A was synthesised in an overall yield of 3% over 27 steps starting 
from the Boc protected pyrrole (183). Undoubtedly the strategy adopted in this total synthetic 
route to obtain the skeleton of stemona alkaloids was based on a key disconnection of 
azatricyclodecanone (195). This was derived via a number of intermediates from formaldiminium 
derivative (193), by an aza-Cope-Mannich rearrangement. Although the product is racemic, there 
is scope for it to be rendered asymmetric. A Diels-Alder cycloaddition under the influence of a 
chiral Lewis acid/auxiliary at the beginning of the synthesis could be used to set the 
stereochemistry in (185) and (186), and hence lead to an asymmetric synthesis.  
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Kende’s total synthesis of Isostemofoline.
168
 
Kende and co-workers were the first to report the synthesis of this class of stemona alkaloids, 
utilising a [4+3] cycloaddition reaction between the activated Boc-protected pyrrole (212) and 
vinyl diazoester (213) to assemble the core structure. This was later followed by a triple tandem 
cyclisation to deliver the pentacyclic framework of the pyrrolizidine stemofoline alkaloids. 
N
OMOM
Boc
OTBDMS
CO2Me
N2
212 213   
The synthesis was initiated with a selective oxidation of 1,2-hexanediol (214), where the 
secondary alcohol is coverted to a ketone in the presence of a less sterically hindered primary 
alcohol followed by a MOM ether protection of the hydroxyl group to afford the MOM protected 
ketone (215).187 Regiospecific condensation of ketone (215) with dimethylhydrazone (216) in the 
presence of potassium ethoxide resulted in dienone (217).188 Boc protected pyrrole (212) was 
formed via a reductive cyclisation of dieneone (217) with sodium hydrosulfite in refluxing 
aqueous ethanol followed by a tert-butyl carbamate protection of the pyrrole using catalytic 
amounts of DMAP (scheme 56). 
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Scheme 56 
Reagents & conditions: (a) 13% aq NaOCl, HOAc, 65%; (b) MOMCl, (i-Pr)2NEt, CH2Cl2, 0 °C 
– rt, 93%, (c) KOEt, 80%; (d) Na2S2O4, EtOH, H2O, 90 °C, 35%; (e) (Boc)2O, 4-DMAP, CH3CN, 
72%. 
Synthesis of the core structure of the intricate alkaloid isostemofoline was accomplished via an 
elegant [4+3] cycloaddition between the Boc-protected pyrrole (212) and vinyl diazoester (213), 
in the presence of catalytic rhodium octanoate dimer, to furnish the bicyclic adduct (218).189 
Removal of the silicon protecting group with TBAF resulted in the enol methyl ester, which was 
subjected to hydrogenation over Pd/C from the less hindered exo face to form (219). This was 
followed by a nucleophilic decarbomethoxylation using water and DMSO at 150 °C to yield 
nortropinone (220).190 Nortropinone (220) was then subjected to a stereoselective base catalysed 
condensation with furfural using NaOMe in methanol to give the thermodynamically stable (E) 
α,β-unsaturated ketone (221). Alkylation of (221) using a lithium base in the presence of DMPU 
with allyl iodide yielded an undesirable 2.4:1 mixture of (222) and (223).  However, the 
unfavourable allyl enol ether (222) was converted into the desired α-allyl ketone (223) via an 
additional stereoselective Claisen rearrangement in refluxing toluene (scheme 57).191  
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Scheme 57 
Reagents & conditions: (f) rhodium octanoate dimer (10 mol%), pentane, reflux, 90%; (g) 
Bu4NF, THF, 65%; (h) H2, 5% Pd/C, MeOH, 90%; (i) H2O, DMSO, 150 °C, 90%, (j) furfural, 
NaOH, MeOH, H2O, reflux, 90%; (k) LiHMDS, 1.1 eq DMPU, THF, 0° C, allyl iodide, rt, 91%; 
(l) toluene, reflux, 86%.  
Selective oxidative cleavage of the terminal alkene in (223) using potassium osmate and sodium 
periodate followed by chemoselective reduction of the resultant aldehyde (224) using zinc 
borohydride192 and subsequent silicon protection of the primary alcohol resulted in the TIPS-
protected keto alcohol (225). The introduction of the methyl group with the correct 
stereochemistry was successfully achieved using a 1,4-Michael addition strategy with 
methyllithium in the presence of DMPU under very mild conditions to yield the 1,4-adduct 
(226).193 At this stage of the synthesis, the TIPS-protection was removed and replaced with a 
tosyl group to give (227) in order to serve as an excellent leaving group later in the synthesis as 
part of the triple cascade cyclisation. Ozonolysis of the α-methyl aldehyde (227) furnished 
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carboxylic acid (228). The next step in this synthesis was the conversion of (228) to aldehyde 
(229) which was achieved in three overall transformations through the formation of anhydride, 
chemoselective sodium borohydride reduction to the primary alcohol and Dess-Martin oxidation 
(scheme 58). 
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Scheme 58 
Reagents & conditions: (a) K2OsO4, NaIO4, Et2O, H2O, rt; (b) Zn(BH4)2, THF, -10 °C, 52%; (c) 
TIPSCl, imidazole, DMF, 93%; (d) 2.2 eq MeLi, 1.1 eq DMPU, Et2O, -40 °C, 85%; (e) Bu4NF, 
THF, 90%; (f) TsCl, pyridine, CHCl3, 90%; (g) O3, CH2Cl2; Me2S, 65%; (h) i-BuOCOCl, N-
methyl-morpholine, THF, 0 °C; (i) NaBH4, MeOH; (j) Dess-Martin periodinane, CH2Cl2, 30% 
overall. 
The final synthetic steps included the 1,2 addition of the lithium anion of 4-methoxy-3methyl-
(5)-furanone (230) to aldehyde (229) to install the butenolide functionality as a 2:1 mixture of 
seperable diasteromeric alcohols (231), which were oxidised with the Dess-Martin oxidant to 
give a 2:1 mixture of diastereomeric ketones (232). The ketone mixtures were treated with 
trifluoroacetic acid that led to a rigid cage-like hemiacetal structure (233) via a tandem triple 
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cyclisation. Dehydration of (233) with triflic anhydride proceeded to furnish the trans isomer 
isostemofoline, over the cis isomer asparagamine A, albeit in low yield owing to the formation of 
the retro-aldol adduct (234) (scheme 59). 
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Scheme 59 
Reagents & conditions: (k) THF, -78 °C, 56%; (l) Dess-Martin periodinane, CH2Cl2, 61%; (m) 
(i) CF3CO2H; (ii) saturated aq NaHCO3, 67%; (n) Tf2O, CH2Cl2, isostemofoline: 12%, (234) 
14%. 
In conclusion, the synthesis of isostemofoline was accomplished in 26 steps with an overall yield 
of 3% starting from 1,2 hexanediol. Kende and co-workers were the first to synthesise a member 
of the stemona alkaloid natural products utilising an elegant [4+3] cycloaddition strategy between 
pyrrole (212) and vinyl diazoester (213) to furnish the bicyclic adduct (214) motif of 
isostemofoline. Another highlight of this synthetic sequence was the triple cascade cyclisation of 
diastereomeric ketone (232) to hemiacetal (233) using trifluoroacetic acid. Although this was a 
remarkable effort by Kende to accomplish the first synthesis of these classes of stemona 
alkaloids, albeit in racemic form, there is an opportunity for this endeavour to be rendered 
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asymmetric by means of a chiral reagent in the highlighted [4+3] cycloaddition between pyrrole 
(212) and vinyl diazoester (213). 
Thomas’s efforts towards stemofoline.
178
 
Thomas and co-workers proposed a synthesis for the alkaloid stemofoline highlighting the use of 
iminium ion cyclisation methodology to obtain the azabicyclic skeleton (237).  Deprotection of 
the acetyl and butyl carbamate groups of (235) was predicted to give rise to a spontaneous 
cyclisation to form the cyclisation precursor butyl imine (236). Sequential treatment of imine 
(236) with methyl chlororformate followed by triethylamine would provide the azabicyclic core 
of stemofoline (237) (scheme 60).  
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Scheme 60 
Synthesis of cyclisation substrates began with racemic pyrrolidinone (238). Protection of the 
amine functionality as the butyl carbamate followed by treatment with butylmagnesium bromide 
gave butyl ketone (239). Acetal protection of ketone (239) and ozonolysis furnished aldehyde 
(240), which was transformed into ketoester (243) via an aldol condensation and oxidation.  
Ketosulfone (247) was similarly prepared by the addition of lithiated methyl phenylsulfone to 
aldehyde (240) followed by oxidation. Access to the allylated analogues (244) and (248), were 
also achieved using this approach (scheme 61). 
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Scheme 61 
Reagenets and conditions:  (a) (Boc)2O, DMAP, Et3N, 76%; 9b) BuMgBr, THF, 91%; (c) 
(CH2OH)2, pyH-OTs, benzene 81%; (d) O3, MeOH, then Ph3P, 90%; (e) MeCO2Me, LDA, -78 
°C, (241, 95%) or ethyl pent-4-enoate, LDA, -78 °C (242, 92%); (f) PDC (243, 73%) or Dess-
Martin (244, 59%; 247, 72%; 248, 66%); (g) PhSO2Me, LDA, -78 °C (245, 58%) or but-3-enyl 
phenylsulfone, LDA, -78 °C (246, 80%). 
With the cyclisation precursors in hand, the next step in the synthesis was to assemble the 
azabicyclic framework of stemofoline. This was successfully accomplished in modest yields 
firstly via a double deprotection of acetal and butyl carbamate groups with TFA, followed by 
sequential addition of acetylating agent and triethylamine to provide stereoselectively the 
azabicyclic species (249), (250), (251) and (252) (scheme 62). Unfortunately the unfavourable 
equatorially disposed allyl unit in (250) and (252) could not be further elaborated to build the 
third ring of stemofoline. In light of this knowledge, the group decided to make further 
elaboration to ketoester (249) with a view of modifying the axial substituent to install the third 
ring of stemofoline.   
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Scheme 62 
Reagents and conditions: (a) i) TFA, ii) ClCO2Me, Et3N, 71%; (b) i) TFA, ii) ClCO2CH2CCl3, 
Et3N, (249, 71%), (250, 42%), (251, 51%), (252, 40%). 
A chemoselective DIBAL-H reduction of ketoester (253), obtained from reduction of (249) with 
sodium cyanoborohydride, produced the desired primary alcohol (254), along with the 
unexpected tricyclic aminoacetal (255), albeit in poor yield. This serendipitous discovery 
prompted the group’s investigation towards the construction the third ring of the alkaloid utilising 
the carbonyl carbon of the carbamate (scheme 63). 
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Scheme 63 
Construction of the third ring began with the selective reduction of ketoester (249) with zinc 
cyanoborohydride to give a 3:1 mixture of epimers in favour of the axial configuration. The axial 
alcohol was protected as the silyl ether (250), which was followed by chemoselective DIBAL-H 
reduction of the methyl ester. The resultant primary alcohol was treated with I2/PPh3 to furnish 
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the primary iodide (251), required for the installation of the third ring. A lithium-halogen 
exchange of iodide (251) with excess n-butyllithium led to the formation of lactam (253), via 
intermediate adduct (252), with loss of lithium methoxide. This lithium halogen exchange tactic 
provided a useful means of introducing the third ring of stemofoline by incorporating the 
carbamate functionality, albeit fortuitously. Lactam (253) was desilylated and a regioselective 
remote oxidisation using excess lead(IV) acetate to delivered the tetracyclic core (254) of the 
pyrrolizidine alkaloid stemofoline, together with ketone (255) as the minor product (scheme 64). 
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Scheme 64 
Reagents and conditions: (a) ZnCl2, NaBH3CN, Et2O 91% 75:25 mixture of epimers; (b) 
TBSOTf, 2,6 lutidine, 86%; (c) DIBAL-H, hexane, -78 °C to rt, 81%; (d) I2, PPh3, imid, 83%; (e) 
n-BuLi, -78 °C to rt, 81%; (f) TBAF, THF, rt, 99%; (g) Pb(OAc)4, benzene, reflux, (254), 35%, 
(255), 16%, (253), 12%.  
At some stage during the synthesis of stemofoline, lactam (255) would have to be reduced to the 
tricyclic ketoamine (262), therefore a procedure was developed for this transformation (scheme 
65). This was best achieved starting with acetal protection of ketoester (249) using 2-methoxy-
1,3-dioxolane and sub-stoichiometric amounts of p-toluene sulfonic acid to furnish ester (256). 
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Ester (256) was then converted to the tricyclic lactam (258) using previously developed 
chemistry via cyclisation of the primary iodide (257) with excess t-butyllithium. Lithium 
aluminium hydride reduction of (258) provided aminol (259) and attempts to deoxygenate the 
hydroxyl group using radical chemistry proved unsuccessful. This problem was overcome by 
treatment with thionyl chloride followed by subsequent reduction, presumably of the chloride 
intermediate (260), using lithium aluminium hydride to furnish the tricyclic amine (261), and a 
final hydrolysis of the acetal functionality with aqueous sulfuric acid resulted in the desired 
ketoamine (262). 
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Scheme 65 
Reagents and conditions: (a) 2-methoxy-1,3-dioxolane, TsOH, MeOH, toluene, 50 °C, 87%; (b) 
DIBAL-H, 55%; (c) I2, PPh3, imid, 78%; (d) t-BuLi, THF, -78 °C, 74%; (e) LiAlH4, Et2O, 83%; 
(f) SOCl2; (g) LiAlH4, 75%; h) 1% aq H2SO4, 90%. 
At this advanced stage of the synthesis of stemofoline, the group turned their attention on the 
assembly of the essential pentacyclic nucleus of the natural product. Their initial attempts were 
focused on allylating the ketoamine (262) and ketolactam (255) with a combination of allyl 
iodide/bromide with various bases. Allylation of ketoamine (255) with allyl iodide and potassium 
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hexamethyldisilazide resulted in an undesirable epimeric 8:2 mixture of (263) and (264) in 
modest yields. However, the desired epimer (264) was easily made available in good yields by 
epimerisation of (263) with potassium tert-butoxide. Alternatively, allylation of ketolactam (255) 
with allylbromide and lithium diisopropylamine proved less efficient (scheme 66). However, 
attempts to elaborate the terminal double bond via oxidative cleavage were unsuccessful along 
with alkylation of the aminoketone (262) using methyl bromoacetate. Thus, this approach was 
abandoned. With this setback in mind, the group decided to assemble the pentacyclic core of 
stemofoline by alkylating the azabicyclic ketone intermediates synthesised earlier.  
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Scheme 66 
Reagents and conditions: (a) KHMDS, allyl iodide, -78 °C, (263:264 = 80:20), 56%; (b) t-
BuOK, CH2Cl2, methanol, rt, 88%; (c) LDA, allyl bromide, -78 °C to rt, (265:266 = 65:35), 39%. 
Methyl ester (267) was reduced with DIBAL-H to give the primary alcohol followed by an 
immediate regioselective silyl ether protection to yield alcohol (268) which was directly oxidised 
to give ketone (269). Alkylation of ketone (269) with bromoacetate and potassium 
hexamethyldisilazide produced the unfavourable axial methyl ester (270), which was quickly 
corrected by epimerising the stereocentre in question to the desirable equatorial epimer (271) 
with potassium tert-butoxide. A chemo and stereoselective reduction of ketone (271) using zinc 
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borohydride provided the axially configurated alcohol (272), and upon desilylation of the silyl 
ether with tetrabutylammonium fluoride provided the hydroxylactone (273). Hydroxylactone 
(273) was converted to the primary iodide (274), but unfortunately all attempts to promote a 
lithium-halogen exchange cyclisation to lactam (275) proved to be unsuccessful (scheme 67). 
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Scheme 67 
Reagents & conditions: (a)  DIBAL-H, CH2Cl2, -78 °C, then NaBH4, 63%; (b) TBSOTf, 2,6-
lutidine, CH2Cl2, 94%; (c) PDC, CH2Cl2, 98%; (d) KHMDS, BrCH2CO2Me, -78 °C to rt, 58%; 
(e) t-BuOK, CH2Cl2, methanol, 66%; (f) ZnCl2, NaCNBH3, 74%; (g) TBAF, THF, 84%; (h) I2, 
PPh3, imid, 80%.  
In summary, Thomas and co-workers have successfully adopted a stereoselective cyclisation 
protocol as the key transformation en route to the tetracyclic core of the pyrrollizidine alkaloid 
stemofoline. Stereoselective cyclisation proceeded smoothly to deliver aza-bicyclic adducts in 
modest yields, and the third ring was installed by cyclisation of organolithium species onto the 
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carbonyl carbon of the carbamate via lithium-halogen exchange. Further elaboration of this 
tricyclic lactam to the tetracyclic ether was achieved via a regioselective remote oxidation using 
excess lead (IV) acetate. Alkylation of tricyclic intermediates proved to be less efficient, while 
the azabicyclic keto-ester (267) proved to be constructive in the assembly of lactone (273). 
Unfortunately, their quest for lactam (275) proved unsuccessful as further chemical manipulation 
of primary iodide (274) only led to a complicated mixture of unidentified products. Finally there 
is the scope for an asymmetric synthesis en route to the advanced intermediates utilising the 
iminium ion cyclisation of more complex precursors analogous to the ketoester (242). 
Gin’s approach towards stemofoline.
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Gin and co-workers envisaged the synthesis of a bridged pyrrolizidine core structure (279) of 
asparagamine A, utilising a [1,3]-dipolar cycloaddition of azomethine ylides (277). These ylides 
are derived from the sulfonylation of vinylogous amides (276) (scheme 68).  
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Scheme 68 
To obtain the azatricyclodecane core of asparagamine A, an intramolecular [1,3]-dipolar 
cycloaddition strategy would have to be adopted en route to the synthesis of this bridged 
functionalised pyrrolizidine alkaloid. The synthesis commenced with methyl ester (280) (scheme 
69)195 and it was anticipated that the stereocentre of (280) would dictate the stereochemical 
outcome in the subsequent steps. An Arndt-Eistert reaction of (280) with ethyl chloroformate and 
triethylamine and subsequent treatment with silver acetate resulted in the homologous acid (281). 
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Acid (281) was converted to lactam (282) via the formation of a Weinreb amide using N,O-
dimethylamine hydrochloride followed by hydrogenolysis of benzyl carbamate, which led to a 
spontaneous lactamisation to afford (282). N-Alkylation of lactam (282) with 
chloromethyltrimethylsilane was followed by chemoselective thionation with Lawessen’s reagent 
to provide thiolactam (283). Vinylogous amide (284) was obtained as a single stereoisomer via S-
alkylation of thiolactam (283) with bromobutanone followed by an Eschenmoser sulphide 
contraction. Treatment of the Weinreb amide functionality of the vinylogous amide (284) with 
ethynylmagnesium chloride followed by hydrolysis and conjugate addition of ethanethiol 
furnished the [1,3]-dipolar cycloaddition precursor (285), as a 6:1 mixture of (E) and (Z) 
geometric isomers. The next step of this synthetic sequence was to generate the azomethine ylide 
intermediate (286), and this was successfully accomplished by treatment of (285) with triflic 
anhydride in chloroform followed by desilylation with tetrabutylammonium 
triphenyldifluorosilicate (TBAT).196 The azomethine ylide intermediate (286) was heated at 65 
°C for 24 h, to furnish the bridged pyrrolizidine motif (287) as a single regio and stereoisomer, 
whose structure was elucidated by X-Ray crystallography.  
93 
 
MeO2C CO2H
NHCbz
MeO2C
NHCbz
CO2H
HN
O
H
O
N
MeO
Me
N
S
H
O
N
MeO
Me
TMS
N
H
O
N
MeO
Me
TMS
O
Et
N
H
O
TMS
O
Et
EtS
N
H
O
Et
EtS
OTf
N
O
OTf
Me
EtS
H
H
280 281 282 283
284 285 286
287
a, b c, d e, f
g h, i j
Scheme 69 
Reagents and conditions: (a) EtOCOCl, Et3N, THF, 0 °C; CH2N2, Et2O, 87%; (b) AgOAc, 1,4- 
dioxane, H2O, rt °C, 86%; (c) EDCI, MeONHMe, Et3N, CHCl3, rt °C, 89%; (d) H2, 10% Pd/C, 
MeOH, rt, 1 atm, 99%; (e) NaH, TMSCH2Cl, DMF, rt, 49%; (f) Lawessons reagent (0.51 eq), 
toluene, rt, 88%; (g) BrCH2COEt, then PPh3, Et3N, MeCN, rt, 92%; (h) HCCMgCl, THF, 0 °C; 
(i) EtSH, Et3N, CH2Cl2, rt, 75%; (j) Tf2O, CHCl3, rt, TBAT, 65 °C, 24 h, 51%. 
Having succeeded with an intramolecular cycloaddition route to the core structure of the stemona 
alkaloids, the group then turned their attention to an asymmetric synthesis of fully oxygenated 
tricyclic core using their already established azomethine ylide dipolar cycloaddition 
methodology.179 Two possible synthetic avenues to the tricyclc core were considered. An 
intermolecular endo selective dipolar cycloaddition between methyl acrylate (289) and the 
azomethine ylid generated from vinylogous amide (288) would give the pyrrolizidine skeleton 
(290), followed by a subsequent Dieckman condensation to furnish (291) (scheme 70a). 
Alternatively, an intramolecular approach using the functionalised vinylogous amide 
94 
 
incorporating the OR group (C2) and the dienophile (C6-C7) could be used as the azomethine 
ylide precursor (292) for the cycloaddition to provide the tricyclic core (293) of the stemona 
alkaloids (scheme 70b).   
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Scheme 70a 
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Scheme 70b 
 An intermolecular cycloaddition-Dieckmann approach was pursued and vinylogous amide (298) 
was synthesised using the chemistry described earlier. With the correctly functionalised 
vinylogous amide in hand, (298) was then treated sequentially with triflic anhydride in 
chloroform and TBAT in the presence of the dienophile methyl acrylate which underwent a [3+2] 
endo, regio-selective cycloaddition to furnish the unexpected pyrrolizidine (301) with the 
incorrect stereochemistry at C2. This unexpected stereochemical outcome was attributed to the 
epimerisation of the imminium triflate (299) at the C2 stereocentre to form the more 
thermodynamically stable cis stereoisomer (300). In this conformer, the silicon protected alcohol 
(C2) and the methyl ester (C9a) substituents adopt a favourable pseudo-equatorial arrangement 
that underwent a face-selective cycloaddition to furnish the cycloadduct (301). The structure of 
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the cycloadduct (301) was confirmed by extensive nOe studies, in particular there were signals 
between the C2 and C9a protons. There was also strong evidence for the formation of the more 
thermodynamically stable imminium triflate ion (300) by in situ 1H NMR spectroscopic studies 
that showed the emergence of a 4:1 mixture of trans and cis stereoisomers after an hour. 
Increasing reaction times led to undesirable 1:2 mixture of trans to cis imminium trfilates, 
indicating a strong thermodynamic preference for (300) (scheme 71). Unfortunately for the 
group, all attempts to prevent epimerisation at C2 of the imminium triflate (300) were 
unsuccessful, along with attempts to epimerise C2 and C9 stereocentres of the cycloadduct (301), 
which was essential for the intramolecular Dieckmann condensation. 
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Scheme 71 
After the failure of the intermolecular cycloaddition-Dieckmann strategy, the group then turned 
their attention to the alternative intramolecular cycloaddition approach. The conversion of the 
requisite vinylogous amide (306), to the azomethine ylide was achieved using similar chemical 
transformations as described earlier, setting the stage for the crucial transformation required for 
96 
 
the synthesis of the fully oxygenated tricyclic core of stemofoline alkaloids. Treatment of the 
vinylogous amide with trifilic anhydride followed by the addition of TBAT resulted in the 
formation of imminium triflate (302), which established a rapid equilibrium with its stereoisomer 
(303) at C2, presumably due to the fluoride ion acting as a base prior  to desilylation.  The 
reaction was dominated by the formation of imminium triflate (304) which suffered from severe 
1,3 diaxial interactions that led to decomposition pathways over the desired cycloaddition 
reaction (scheme 72).  
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With this problematic C2 epimerisation also occurring in the intramolecular approach, they 
needed a contingency plan in order to perform the key cycloaddition to obtain the fully 
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oxygenated tricyclic core of the stemona alkaloids. A solution to their predicament was to 
assemble an azomethine ylide cycloaddition precursor that was incapable of epimerisation. This 
ultimately led to the proposed synthesis of cis fused isopropylidene ketal (308) that could be 
converted to imminium trifilate (309) which would have a high energy barrier to inversion to a 
trans fused system (scheme 73). 
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 Synthesis of intermediate (308) began with treatment of the commercially available (-)-2,3-O-
isopropylidine-D-erythronolactone (311) with (trimethylsilyl)methylamine to afford the primary 
alcohol, which was subsequently oxidised using Parikh-Doering protocol to afford a  hemiaminal 
that was acetylated using acetic anhydride and pyridine to furnish aminal (312). Aminal (312) 
was subjected to a Lewis acid-promoted Mannich reaction with (313), which was followed by 
hydrolysis of the resulting ester to give carboxylic acid (314). Cycloaddition substrate (308) was 
obtained from carboxylic acid (314) using the previously described chemistry. Cycloaddition of 
(308) proceeded smoothly under the standard conditions previously employed by the group to 
give the desired non-racemic fully oxygenated pyrrolizidine core (316) of the stemona alkaloid 
(316) (scheme 74). 
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Scheme 74 
Reagents and conditions: (a) TMSCH2NH3Cl, Et3N, THF, 70 °C, 97%; (b) SO3, Py, Et3N, 
DMSO, rt; (c) Ac2O, Py, 69% (two steps); (d) TMSOTf, CH2Cl2, rt, 72%; (e) LiOH, THF, H2O, 
rt, 96%; (f) Tf2O, TBAT, CHCl3, -45 °C to rt, 71%. 
The cycloadduct (316) was further elaborated firstly by reduction of the enol triflate to provide 
the butyl side chain using H2 in Pd/C. This was followed by enolate alkylation of the ketone with 
LDA and ethyl iodoacetate to furnish ester (317), after epimerisation with DBU. The final 
transformation saw the deprotection of isopropylidene unit and hydrolysis of the ester using 
aqueous HCl to furnish the key intermediate (318) containing the stemofoline framework 
(scheme 75).  
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Scheme 75 
Reagents and conditions: (a) H2, 1 atm, 10% Pd/C, MeOH, rt, 89%; (b) LDA, ICH2CO2Et, 
THF, HMPA, 0 °C; (c) DBU, PhMe, 80 °C, 58% (two steps); (d) 2.5 M HCl, THF, 60 °C, 96%. 
In summary, Gin and co-workers have successfully demonstrated the utility of the [1,3]-dipolar 
cycloaddition by applying this to an intramolecular cycloaddition methodology. [3+2] 
Cycloaddition of an azomethine ylide derived from the sulfonylation of vinylogous amides led to 
the enantiospecific, fully functionalised, bridged pyrrolizidine of the stemona alkaloid 
stemofoline. This represents an enantioselective synthesis of the oxygenated tricyclic core of 
stemofoline and is produced in 11 steps from a commercially available starting material. The 
scope of this methodology can be extended to other highly functionalised pyrrolidines, 
pyrrolizidines and indolizidines. 
Olivio’s synthesis of bicyclic γ-ylidenetetronates.
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An efficient and concise synthesis of γ-ylidentetonates (319) will facilitate the syntheses of 
stemona alkaloids and other natural products containing this structural motif.  
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Olivio and co-workers developed an efficient methodology for the synthesis of bicyclic γ-
ylidentetronates using methyltetronates and lactone derivatives as coupling partners. There was 
precedent for the nucleophilic lithium enolate addition to aldehydes  and ketones.197-199 However, 
Olivio’s group found lactones to be unreactive towards such species derived from 
methyltetronates. Their investigation into the Lewis-acid promoted addition of 2-trimethylsiloxy-
4-methoxyfuran (323) to lactones was also unsuccessful and thus, subsequently more reactive 
lactones were investigated.  
The group then focused their attention toward the masked acetal lactone (322) which was 
synthesised from valerolactone (320) via the intermediate oxonium ion (321) using 
Deslongchamps protocol in 80% yield.200 Treatment of compound (322) with 2-trimethylsiloxy-
4-methoxyfuran (323), with ZnCl2 afforded a mixture of desired ketals (324), albeit in poor yields 
(< 45% scheme 76). A variety of Lewis acids such as TiCl4 and BF3.OEt2 were also investigated 
without any success.  
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Scheme 76 
Reagents & conditions: (a) Me3OBF4, rt, CH2Cl2; (b) NaOMe, MeOH, -78 °C to rt, 80%; (c) 
ZnCl2, -10 °C to rt, 43%. 
With this moderate level of success in mind the group envisioned that direct addition of (323) to 
oxonium species (325) could potentially improve the yields of ketals. After extensive studies the 
group found that mixed ethyl ketals (327) could be obtained in 70% yield by the use of excess 
triethyloxonium tetrafluoroborates with direct addition of the lithium enolate (326) (scheme 77). 
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Scheme 77 
Reagents & conditions: (a) Et3OBF4 (6 equiv), rt, CH2Cl2; (b); (325) (1.3 equiv), THF, -78 °C, 
70% 
With the optimum conditions in hand the group utilised this methodology to synthesise a number 
of mixed ethyl ketals in very good yields (65-90%). The next challenge was to perform the 
dealkoxylation reaction of such mixed ethyl ketals to form the conjugated bicyclic γ-
ylidentetronates present in the stemona alkaloids. Dealkoxylation reactions were initially 
attempted with literature procedures based on the formation of acyclic γ-ylidentetronates without 
any success.201, 202 It was only when (328) was treated with TiCl4 followed by the addition of 
Hünig’s base resulted in a successful transformation to the desired γ-ylidentetronates  (329) in 
moderate selectivity  (scheme 78).  
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Scheme 78 
Reagents & conditions: a) TiCl4, (i-Pr)2NEt, -30 °C, CH2Cl2, 89%, (6:1, Z: E)  
In summary, Olivio and co-workers have developed a methodology for the construction of 
bicyclic γ-ylidentetronates that can be applied to the syntheses of stemona alkaloids. This was 
achieved from dealkoxylation of mixed ethyl ketals, which in turn were derived from 
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valerolactone and lithium enolate of methyl tetronate in very good yields. This methodology 
provides the foundation for the challenging assembly of such motifs present in the stemona 
alkaloids. 
Smith’s approach to the synthesis of 2 substituted pyrrolidines.
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Smith and co-workers devised a route to synthesise structurally simplified compounds based on 
stemofoline such as the fused piperazine analogues (330) that can be disconnected to tetronate 
(331)
203 (X=O) and tetramate (331)204 (X=NR) (which are easily prepared according to literature 
procedures) and 2,8-diazabicyclo[3.2.1]octane (332) as the coupling partner (scheme 79). They 
envisaged doing this with three key objectives in mind: 1) maintain the structural rigidity of the 
natural product and 2) mimic the n-butyl side chains by incorporating alkyl substituents.  
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Synthesis of azabicyclic compound (336) began with ring closure of the commercially available 
diethyl meso-2,5-dibromoadipate (333) using benzylamine to deliver the cis mono-amide (334) 
and its undesired trans diastereomer which was simply removed by column chromatography. 
Pyrrolidine (334) was converted to bicycle (335) in four steps: heating to remove the ethanol, 
deprotection of the benzyl group with H2, reduction of the amide with lithium aluminium hydride 
and then Boc protection. A Pd/C hydrogenolysis of the benzyl group then furnished the desired 
diazabicyclic product (336) (scheme 80).  
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Scheme 80 
Reagents and conditions: (a) benzylamine (3.1 equiv), toluene, 85 °C; (b) benzylamine, xylene, 
reflux, (71% over two steps); (c) 230 °C, distill off EtOH, 73%; (d) H2, Pd/C, MeOH, HCl, 85%; 
(e) LiAlH4, Et2O, reflux; (f) (Boc)2O, CH2Cl2, rt, 60% over two steps; (g) H2, Pd/C, MeOH, 72%. 
Having successfully constructed the diazabicyclic motif 336) utilising the tandem cyclisation 
methodology, the next task was to incorporate an alkyl side chain that would mimic the n-butyl 
side chain of stemofoline, via a [2,3]-Stevens rearrangement strategy followed by tandem 
cyclisation.   
[2,3]-Stevens rearrangement product (338), a substituted pyrrolidine, was prepared starting from 
the meso compound (333). Compound (333) was treated with excess allylamine to yield a 3:1 
diastereomeric mixture of the Stevens rearrangement precursor pyrrolidine (337) that was 
separated by column chromatography. The desired cis pyrrolidine (337) was subjected to the 
standard Stevens rearrangement protocol205 using excess iodomethane and potassium carbonate 
in DMF at 55 °C over two days, which resulted in a separable 4:1 mixture of allyl pyrrolidine 
(338) in a modest 42% yield (scheme 81).  
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Scheme 81 
Reagents & conditions: (a) allylamine (3.1 equiv), toluene, 85 °C, 80%; (b) MeI, K2CO3, DMF, 
55 °C, 2 d, 42%. 
The rationale for this modest yield was attributed to the allyl pyrrolidine (338) quaternising under 
the reaction conditions. The group also have noticed, perhaps unsurprisingly, that a [2,3]-Stevens 
rearrangement on the diazabicyclic compound (339) only yielded 2% of the desired product 
(340). This observation can be rationalised presumably by the lack of anion formation at the 
bridgehead position of (340) (scheme 82). 
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Scheme 82 
Reagents & conditions:  a) MeI, K2CO3, DMF, 55 °C, 2 d, 2%. 
The inability to form an anion at the bridgehead position led to a slightly different approach 
towards diazabyclo ring systems. This slightly modified approach focused on a one-pot N-
methylallylamine addition to meso dibromo ester (333) followed by standard Stevens conditions 
to furnish the desired product (338) as a 13:5 separable diastereomeric mixture by column 
chromatography in an overall yield of 58%.206 This one-pot process occurred via an 
intramolecular cyclisation rather than intermolecular quaternisation. This was then followed by a 
Stevens rearrangement which occurred smoothly to provide (341). The next step in this synthetic 
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sequence was to perform an already established tandem cyclisation of (341), and further chemical 
manipulations led to diazabicyclic product (343) using the conditions described above (scheme 
83).    
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Scheme 83 
Reagents & conditions: (a) N-methylallylamine, K2CO3, DMF, rt, (13:5) 58%; (b) benzylamine, 
xylene, reflux, 2 d, 55%; (c) H2, Pd/C, EtOH, quant; (d) 230 °C, distil EtOH, 71%; (e)  LiAlH4, 
Et2O, reflux, 79%; (f) H2, Pd/C, EtOH, 3 h, 94%. 
Having the diazabicyclo-species (345) in hand, the group successfully coupled (345) with a 
number of tetronic (344) and tetramic acid derivatives with oxalyl chloride, triethylamine and 
catalytic amounts of DMF, to give the stemofoline mimic (346) as shown in scheme 84. 
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Scheme 84 
Reagents & conditions: (a) oxalyl chloride, THF, DMF (cat), rt, 1 h; (b), Et3N, rt, 4 h, 57%.  
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In conclusion, the Smith group have successfully demonstrated the tandem cyclisation and 
Stevens rearrangement methodology, followed by further chemical transformations, in acquiring 
a diazabicyclo-ring system in good yield. This was then coupled to tetronic and tetramic acid 
derivatives to furnish stemofoline mimcs. This approach can also be applied for the synthesis of 
other substituted pyrrolidines and derivatives of other cyclic amines such as proline. 
Livingstone’s stereocontrolled synthesis of bridged pyrrolizidines.
173
  
Livingstone and co-workers devised an intramolecular allylsilane addition to iminium species for 
the construction bridged pyrrolizidine core unit present in stemofoline. They commenced their 
investigation with the intention of achieving high levels of diastereoselectivity, of which their 
where a few examples in the literature.205-210  
Monodesilylative cyclisation of imine (347) was attempted with successful activation with 
titanium tetrachloride, which was followed by treatment with potassium hydrogen carbonate to 
furnish the 1,2 disubstituted pyrrolidine (349) as a single isolated diastereomer in 98% yield 
(scheme 85). Sequential treatment of (349) with formaldehyde and trifluoroacetaic acid resulted 
in the second allylsilane cyclisation via intermediate (350) to provide the azabicyclic system 
(351).  
 
107 
 
N
TMS
TMS
N
TMS
TMS
Cl4Ti HN TMS
a b
349348347
N
TMS
N
CH2
350 351
c,d
 
Scheme 85 
Reagents & conditions: (a) TiCl4, CH2Cl2, -78 °C to rt; (b) aqueous KHCO3, 98 %; (c) CH2O (2 
equiv), H2O-THF (3:1), (d) TFA (1.05 equiv), 0 °C to rt, 73%.  
This methodology was further extended to assemble the core tricyclic pyrrolizidine structure of 
stemofoline by tandem intramolecular bis-silane iminium cyclisation. Imine (351) was pre-
complexed with titanium chloride which initiated the stereoselective allylsilane-iminium 
cyclisation to provide pyrrolizidine (354) as a single isolated diastereomer (scheme 86). 
Functional group interconversion with Lawesson’s reagent provided thiolactam which was S-
alkylated followed by an additional intramolecular desilylative cyclisation delivered the tricyclic 
compound (355) in 90% isolated yield.   
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Scheme 86 
Reagents & conditions: (a) TiCl4, CH2Cl2, -78 °C to rt, then aqueous KHCO3, 80%; (b) 
Lawessons reagent (0.55 equiv), DIPEA (0.25 equiv), 97% (c) Et3OBF4, MeCN, 0 °C to rt, 90%. 
In summary, Livingstone and co-workers have demonstrated the power of 2-propylidene-1,3-
bis(silane) derivatives to act as bis-nucleophiles in forming the bridged polycyclic  units in highly 
efficient and stereoselctive manner which are prevalent in alkaloid natural products. They have 
utilised this methodology for the construction of azabicyclic and tricyclic ring systems found in 
tropane, and the more challenging stemona alkaloid natural products. 
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5. SYNTHETIC EFFORTS TOWARD STEMOFOLINE 
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Proposed synthesis of stemofoline 
As previously discussed, the key step in the proposed synthesis of stemofoline is a tandem radical 
cyclisation followed by group transfer of carbamoyl dithiocarbamate (131). Formation of 
carbamoyl radical (132) can arise by irradiation with a 500 W halogen lamp or with a chemical 
initiator such as lauroyl peroxide. Two successive radical cyclisations in a 7-endo-trig and 5-exo-
trig fashion should deliver the secondary radical (134). Finally, a dithiocarbamate group transfer 
with carbamoyl dithiocarbamate (131) should furnish the desired product (135), which can be 
further elaborated to deliver stemofoline (scheme 30). This strategy is quite unique from those 
previously discussed earlier in section 1. Therefore the primary aim of the project is the synthesis 
of cyclisation precursor (131), initially in racemic form. If the tandem cyclisation-group transfer 
strategy proves successful, an asymmetric approach can be considered. 
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Scheme 30 
Route to cyclisation precursor via carbamoyl chloride. 
The synthesis began with a Dieckmann cyclisation from the commercially available dimethyl 3,3-
thiodipropionate (356) with sodium methoxide in THF to furnish the dicarbonyl species (357) in 
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92% yield. A one pot ester hydrolysis of (387) followed by decarboxylation was achieved under 
acidic conditions by refluxing the reaction mixture in aqueous sulfuric acid to provide the desired 
tertrahydrothiopyranone (358) in 80% yield.211 With this commercially expensive material in 
hand, tetrahydrothiopyranone (358) was activated with iodomethane in acetone to deliver the 
sulphonium salt (359) in 53% yield after two days at room temperature. Under solvent free 
conditions using excess iodomethane, an isolated yield of 93% was achieved after three days at 
room temperature. Treatment of sulphonium salt (359) with Hünig’s base in a 9:1 mixture of 
acetonitrile and water afforded the conjugated enone motif (360) in 78% isolated yield after 
column chromatography (scheme 87).      
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Scheme 87 
Reagents & conditions: a) NaOMe (1.3 eq), THF, rt, 4 h, 92%; b) H2SO4 (10%), reflux, 1 h, 
80%; c) MeI (20 eq), rt, 3 d, 93%; d) DIPEA (3 eq), MeCN/H2O (9:1), rt, 2 d, 78%. 
With this key intermediate in hand, a model cross metathesis reaction was attempted with 5-
hexene-2-one, which if successful would provide a plausible pathway to our primary target (131). 
Unfortunately the attempted metathesis of enone (360) with 5-hexen-2-one, employing Grubb’s 
second generation catalyst, failed to deliver the desired compound (361).212 This lack of reactivity 
is presumably attributed to the lone pair of sulfur occupying a coordination site on ruthenium, 
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hence acting as a poison for the catalyst. Attention therefore quickly turned to an alternative 
strategy based on a 1,4-conjugate addition reaction. Enone (360) was first subjected to sodium 
nitrate and acetic acid in THF providing the β-nitro ketone (362), albeit in a very low isolated 
yield of 30% after column chromatography. Increasing the stoichiometry of reagents to two 
equivalents of sodium nitrate and acetic acid had a positive result as the desired compound was 
isolated in 75% isolated yield based on recovered starting material (scheme 88).213   
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Scheme 88 
Reagents & conditions: a) 5-hexene-2-one. Grubbs 2nd generation catalyst (5-10 mol%), DCM, 
reflux; b) NaNO2 (2 eq), AcOH (2 eq), THF, rt, 2 d, 75% BRSM. 
Having β-nitro ketone available, attention focused on the synthesis of the coupling partner, butyl 
enone (365). Treatment of commercially available acrolein (363) with n-butyllithium in THF 
proceeded smoothly through a 1,2 addition to yield the butyl allylic alcohol (364) in an excellent 
isolated yield of 92%.214 Attempted oxidation of allylic alcohol (364) with a large excess of 
activated manganese dioxide215 or under Swern216 conditions proved ineffective, leaving the 
majority of the starting material unconsumed by TLC analysis. Eventually the allylic alcohol was 
oxidised with the hypervalent iodine oxidant IBX in DMSO to gratifyingly furnish the requisite 
butyl enone (365) in 88% isolated yield (scheme 89).217 
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Scheme 89 
Reagents & conditions: a) n- BuLi, -78 °C, THF, rt, 16 h, 92%; b) IBX (2 eq), DMSO, rt, 3 h, 
88%.  
From the outset, the focus was on synthesising butyl imine species (368), which can be derived 
from β-nitro ketone (366) and keto amine (367). An initial conjugate addition of the nitronate 
anion of (362) onto butyl enone (365) should result in the functionalised β-nitro ketone (366). A 
chemoselective nitro reduction of (366) should furnish keto amine (367), which through 
intramolecular reductive amination would deliver the advanced cyclic imine intermediate (368) 
(scheme 90).  
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Scheme 90 
Having established synthetic routes to the respective coupling partners (362) and (365), 1,4-
conjugate addition step was attempted, anticipating the formation of an isolable β-nitro ketone 
(366). However, this intermediate was not observed by 1H NMR spectroscopy or isolated upon 
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treatment with basic alumina in DCM. Instead the potentially useful enone species (369) was 
isolated, albeit in poor yield after column chromatography.218, 219 The mechanism of this 
transformation is believed to occur initially by means of a 1,4-Michael addition of the nitronate 
anion of (362) onto the butyl enone (365) resulting in intermediate (366), which was 
subsequently followed by a rapid elimination of HNO2. Although this was not the desired 
outcome from the conjugate addition reaction, it was recognised that conjugate addition of 
ammonia to enone (369) should furnish keto amine (367). Pleasingly, ammonia addition onto 
enone (369) directly provided the cyclic butylimine (368) in a one pot conversion (scheme 91).  
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Scheme 91 
Reagents & conditions:  a) basic Al2O3 (40 eq), DCM, rt, 16 h, 15%; b) aq NH3, MeOH, rt, 16 
h, 88%. 
In an attempt to optimise the preparation of enone (369), various bases were screened.220-230 The 
desired enone (369) was only isolated upon treatment with a large excess of basic alumina (20 
equivalents), whereas anything less resulted in no reaction (table 1, entries 1-4). Increasing the 
stoichiometry of basic alumina to 40 equivalents furnished the required enone (369) in 15% 
isolated yield after column chromatography (table 1, entry 5). Using alternative bases such as 
DBU and sodium hydride resulted in complete decomposition of both substrates, whilst 
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employing sodium acetate in DMSO resulted in complete lack of reaction as both substrates were 
recovered (table 1, entries 6-8). The use of potassium carbonate, aqueous sodium hydroxide or 
Hünig’s base also proved unsuccessful, leading to complete decomposition of both substrates 
(table 1, entries 8-11). Despite the low yield of (369), it was decided to continue with the 
synthesis of carbamoyl dithiocarbamate (131), in order to test the key tandem radical cyclisation 
and group transfer methodology. 
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Entry  Reagents  Temperature Time (h) Outcome 
1 Enone (365) (1.5 eq), 
Al2O3 (2 eq) DCM 
rt 16 No reaction 
2 Enone (365) (1.5 eq), 
Al2O3 (4 eq) DCM 
rt 16 No reaction 
3 Enone (365) (1.5 eq), 
Al2O3 (12 eq) DCM 
rt 16 No reaction 
4 Enone (365) (1.0 eq), 
Al2O3 (20 eq) DCM 
rt 16 < 10 % 
5 Enone (365) (1.0 eq), 
Al2O3 (40 eq) DCM 
rt 16 15 % 
6 Enone (365) (1 eq), 
DBU (1 eq, MeCN 
rt 2 h decomposition 
7 Enone (365) (1 eq), 
NaH ( 10 eq), THF 
rt 16 decomposition 
8 Enone (365) (1 eq), 
sodium acetate (1 eq), 
DMSO 
rt 16 No reaction 
9 Enone (365) (1 eq), 
K2CO3 (2 eq), H2O 
rt 16 decomposition 
10 Enone (365) (1 eq),  aq 
NaOH, TBAB 
rt 16 decomposition 
11 Enone (365) (1 eq),  
DIPEA (up to 2 eq), 
CHCl3 
rt 16 decomposition 
Table 8: Attempted conjugate addition – elimination of 362 to 369 
 
Previous work within the Grainger group suggested that formation of carbamoyl chlorides from 
amines at most require 16 hours stirring at room temperature.88 Displacement of carbamoyl 
chlorides with sodium diethyldithiocarbamate trihydrate salt at ambient temperature provides 
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carbamoyl dithiocarbamates. However, acylation of cyclic imines with triphosgene followed by 
sodium diethyldithiocarbamate displacement to form carbamoyl dithiocarbamates had never been 
previously attempted within the group. On that basis, a model study was pursued to establish the 
reactivity of imines towards acylating agents, in particular with triphosgene to form carbamoyl 
chlorides followed by subsequent displacement with sodium diethyldithiocarbamates to furnish 
carbamoyl dithiocarbamates. Dimerisation of methylvinyl ketone (370) with sub-stoichiometric 
amounts of sodium nitrite and acetic acid in DMSO resulted in 1,6-diketone (371) in 86% yield in 
a one pot transformation.231 Conjugate addition with aqueous ammonia followed by dehydration 
provided the corresponding cyclic imine (372) in 71% yield.232 At this point prior to acylation 
with triphosgene, cyclic imine (372) was reacted with ethyl chloroformate which proceeded to 
deliver ethyl carbamate (373), in poor isolated yield of 28%.233 Treatment of (372) with sub-
stoichiometric amounts of triphosgene and a slight excess of pyridine in toluene at ambient 
temperatures provided carbamoyl chloride (374), which was directly used in the subsequent step 
without further purification. Displacement of chloride with sodium diethyldithiocarbamate 
trihydrate in refluxing acetone provided the desired bright yellow carbamoyl dithiocarbamate 
(375) in 52% isolated yield over two steps (scheme 92). Gratifyingly, this particular model study 
set excellent precedent for the assembly of carbamoyl dithiocarbamates from imines for 
incorporation in the real system.  
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Scheme 92 
Reagents & conditions: a) NaNO2 (5 eq), AcOH (5 eq), DMSO, 86%; b) NH3, MeOH, rt, 16 h, 
71%; c) EtOCOCl (2 eq), Et3N (2 eq), THF, -78 °C to rt, 16 h, 28%; d) triphosgene (0.33 eq), 
pyridine (1.5 eq), toluene, rt, 16 h; e) sodium diethyldithiocarbamate trihydrate (2 eq), acetone, 
reflux, 2 h, 52% over two steps. 
As before, prior to acylating cyclic imine (368) with triphosgene, (368) was treated with ethyl 
chloroformate and triethylamine in THF to furnish carbamate (376) in a very good isolated yield 
after column chromatography.233 This was encouraging precedent for imine acylation, and thus 
progressed towards the preliminary target (131) using the group’s chemistry. Cyclic imine (368) 
was treated with sub-stoichiometric amounts of triphosgene and slight excess of pyridine in 
toluene to provide carbamoyl chloride (377), which was used directly in the subsequent step. 
However, direct displacement with sodium diethyldithiocarbamate trihydrate salt in acetone at 
room temperature disappointingly failed to yield the desired carbamoyl dithiocarbamate (378). 
Fortunately, it was possible to obtain carbamoyl dithiocarbamate (378) after refluxing compound 
(377) in acetone after 4 hours. Purification by column chromatography proved difficult as the 
desired species ran extremely close to unknown impurities and product degradation was observed 
119 
 
by TLC over time. Despite these problems, carbamoyl dithiocarbamate (378) was isolated in 44% 
yield over two steps from cyclic imine (368) (scheme 93).  
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Scheme 93 
Reagents & conditions: a) EtOCOCl (2 eq), Et3N (2eq), THF, -78 °C to rt, 16 h, 80%; b) 
triphosgene (0.33 eq), pyridine (1.5 eq), toluene, rt, 16 h; c) sodium diethyldithiocarbamate 
trihydrate (4 eq), acetone, reflux, 4 h, 44% over two steps from 368. 
Proposed route to cyclisation precursor via imidazolide 
With a disappointing overall yield of carbamoyl dithiocarbamate (378), an alternative approach 
utilising carbonyl diimidazolium chemistry was investigated.103 Previous work on carbonyl 
diimidazolium chemistry in the group was established using secondary amines, but never with 
imines. It was anticipated that treatment of cyclic imine (368) with carbonyl diimidazole would 
furnish imidazolide (379), which followed by activation with iodomethane to deliver 
imidazolium salt (380). Subsequent displacement with sodium diethyldithiocarbamate trihydrate 
in refluxing acetone would provide carbamoyl dithiocarbamate (378) (scheme 94). Unfortunately, 
imine (368) proved to be completely unreactive to carbonyl diimidazole even at elevated 
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temperature using high boiling solvents (toluene, reflux), and thus, this approach was abandoned. 
Therefore, for the purpose of the synthesis of cyclisation precursor (131), the previous strategy 
was adopted. 
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At this stage of the synthesis, a sulfide oxidation to the sulfoxide followed by elimination was 
anticipated to provide the cyclisation precursor (131). A chemoselective oxidation of methyl 
sulfide (378) with an electrophilic oxidant such as mCPBA should deliver sulfoxide (381), 
although it was not clear which is the most nucleophilic sulfur. Bearing in mind the relative 
instability of carbamoyl dithiocarbamate (378), it was immediately subjected to the subsequent 
oxidation step; initially with mCPBA.234 Dropwise addition of a solution of mCPBA in DCM to a 
solution of (378) in DCM at 0 °C and subsequent warming to ambient temperature resulted in a 
complex mixture of products by TLC analysis. Unfortunately, the same outcome was observed 
with the oxidants NaIO4 and DMDO (scheme 95).
235, 236 Regrettably at this stage of the synthesis, 
it was not possible to advance any further to acquire the cyclisation precursor (131); therefore an 
alternative approach was devised.   
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Proposed route to cyclisation precursor via Wittig olefination 
A new strategy to synthesise carbamoyl dithiocarbamate (131) using a Wittig olefination as a key 
step to provide enone (382) was envisioned. This would arise from the coupling of 1,4-dicarbonyl 
(383) and triphenylphosphonium ylide (384), respectively (scheme 100). The rationale for 
pursuing this enone intermediate species 382 is largely due to the instability of carbamoyl 
dithiocarbamates. In general they rapidly degrade in the presence of light and more specifically 
carbamoyl dithiocarbamate (378), isolated in low yields, could not be effectively oxidised to the 
required sulfoxide (381). With enone (382) there is the possibility of assembling the carbamoyl 
dithiocarbamate motif as the last synthetic step en route to cyclisation precursor (131).  
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Scheme 100 
Synthesis of phosphonium ylid (384) was carried out as described in the literature.237, 238 
Conjugate addition of sodium tosylate hydrate with commercially available methylvinyl ketone 
(385) provided β-tosyl ketone (386).237 Kinetic bromination of (386) was best achieved with 
freshly prepared pyridinium perbromide239 in acetic acid to deliver the desired brominated ketone 
387) in modest yield accompanied by its regioisomer (388). Phosphorus ylide (384) was obtained 
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in excellent yield through the formation of phosphonium bromide salt (389), followed by 
deprotonation using sodium hydroxide in methanol (scheme 101).238  
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Scheme 101 
Reagents & conditions: a) NaSO2Tol, THF, rt, 16 h, 90%; b) PyHBr3, AcOH, 70 °C, 16 h, 32, 
45%; c) PPh3, toluene, 40 °C, 6 h, 87%; d) NaOH, MeOH, 0 °C, 30 min, 95%.  
Synthesis of 1,4-dicarbonyl compound (383) commenced with treatment of commercially 
available γ-butyrolactone with n-butyllithium in diethyl ether at -78 °C followed by warming to 
ambient temperature to furnish alcohol (391) in 65% yield after column chromatography.214 
Oxidation of alcohol (391) to aldehyde (383) proved to be unexpectedly complicated, as various 
oxidants failed to deliver the desired compound in respectable yields. Oxidation using Jones 
reagent240 only provided (383) in typically 15-20% isolable yield, whereas employing TPAP236 
with catalytic amounts of NMO only yielded 13% of (383) after purification. Changing oxidant to 
IBX in DMSO was particularly discouraging as it resulted in multiple spots by TLC.217 
Subjecting alcohol (391) to Swern conditions was most effective, delivering (383) in 40% yield 
(scheme 102).216 After work up, the crude yield was in excess of 80% but a closer observation of 
TLC showed there was an impurity which ran extremely close to the desired product during 
chromatography. Thus, purification of (383) proved problematic despite attempted optimisation 
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of the eluent system. Therefore, for the purposes of the synthesis only a small amount of pure 
material could be collected and carried forwards.  
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Scheme 102 
Reagents & conditions: a) n-BuLi, Et2O, -78 °C to rt, 16 h, 65%; b) DMSO (2 eq), (COCl)2, 
Et3N, DCM, -78 °C, 40%. 
With the coupling partners (383) and (384) in hand, the Wittig olefination step was attempted, 
using toluene as solvent. At room temperature there was complete lack of reactivity, but slowly 
warming the reaction mixture up to 70 °C eventually led to the consumption of both starting 
materials. The optimised conditions for this olefination were heating the reaction mixture at 70 
°C for four days, providing enone (392) in 67% isolated yield after purification. Unfortunately, 
the resultant enone (392) decomposed upon treatment with aqueous ammonia in methanol; hence 
butyl imine (393) was not obtained using this strategy. A possible factor contributing towards 
decomposition might be the ammonia promoted elimination of the tosylate group to provide an 
α,β-unsaturated system, which can also serve as a Michael acceptor site. Disappointingly, this 
failure to synthesise imine (393) prevented further study into the synthesis of cyclisation 
precursor (131) through the assembly of carbamoyl dithiocarbamate (394) and tosylate 
elimination (scheme 103).  
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Scheme 103 
Reagents & conditions: a) 383, toluene, 70 °C, 4 d, 67%; b) NH3, MeOH, rt, decomposition. 
An alternative strategy for the assembly of imine (393) was through an aza-Wittig reaction.241-243 
Conjugate addition of azide to enone (392) would deliver the azide species (395), which would 
then be converted into ylide (396) by treatment with triphenylphosphine. Finally, an 
intramolecular aza-Wittig reaction driven by the formation of triphenylphosphine oxide should 
furnish the required imine (393) (scheme 104). However, this aza-Wittig approach failed at the 
very first as treatment of enone (392) with sodium azide proved ineffective.  
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Scheme 104 
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Conclusion and future work 
In summary, significant progress has been made towards the cyclisation precursor (131), with the 
synthesis of the advanced intermediate, carbamoyl dithiocarmate species (378). Regrettably, 
(378) could not be functionalised further to the desired sulfoxide which would have undergone a 
spontaneous elimination to give (131). Alternatively, Wittig olefination and the aza-Wittig routes 
were investigated with minimal success.  
However, a potential future route to (131) can arise from S-methylation and a base promoted 
elimination of (378), as an alternative to sulfoxide elimination (an earlier adopted strategy to 
make enone (360) from tetrahydrothiopyranone (356).  
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6. STUDY OF CARBAMOYL RADICAL CYCLISATIONS ONTO NITRILES AND 
ENONES 
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Attempted carbamoyl radical cyclisation onto nitriles  
The study of carbamoyl radical cyclisation onto nitriles was initiated with a conjugate addition of 
propylamine onto acrylonitrile (397) to provide β-aminonitrile (398) in very good yield. 
Treatment of (398) with sub-stoichiometric amount of triphosgene and slight excess of pyridine 
in toluene resulted in carbamoyl chloride (399), which was subsequently treated, without further 
purification, with excess sodium diethyldithiocarbamate trihydrate to give the carbamoyl 
dithiocarbamate (400) in excellent isolated yield after column chromatography.88 Irradiation of 
(400) with a 500 W halogen lamp in cyclohexane resulted in full decomposition after 3.5 hours, 
and thus disappointingly, the desired cyclised product (401) was not obtained (scheme 105). 
Similarly, the use of a chemical initiator such as lauroyl peroxide resulted in a complicated 
mixtures by TLC analysis, and on that basis, this attempted carbamoyl radical cyclisation-
dithiocarbamate group transfer was abandoned at this stage. 
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Scheme 105 
Reagents & conditions: a) propylamine (1.1 eq), rt, 4 d, 82%; b) triphosgene (0.33 eq), pyridine 
(1.5 eq), toluene, rt, 1 h, 80%; c) sodium diethyldithiocarbamate trihydrate (4 eq), acetone, rt, 16 
h, 91%; d) hν, cyclohexane, reflux, 3.5 h, decomposition. 
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Attempted carbamoyl radical cyclisation onto enones  
With the intention of studying carbamoyl radical cyclisation onto enones (a key step in the 
previously described approach to stemofoline), another model study was undertaken to test the 
feasibility of this methodology.  Conjugate addition of propylamine onto methyl acrylate (402) 
resulted in amino ester (403) in moderate yield. Reaction of (403) with triphosgene and pyridine 
in toluene yielded carbamoyl chloride (404), which was immediately treated with sodium 
diethyldithiocarbamate trihydrate to furnish carbamoyl dithiocarbamate (405) in 61% isolated 
yield after purification.88 Transformation of ester (405) to the cyclisation precursor (406) was 
unsuccessful as treatment with vinylmagnesium bromide in THF resulted in decomposition 
(scheme 106).244  
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Scheme 106 
Reagents & conditions:  a) propylamine (1.1 eq), 0 °C to rt, 2 d, 54%; b)  triphosgene (0.33 eq), 
pyridine (1.5 eq), toluene, rt, 1 h, quant; c) sodium diethyldithiocarbamate trihydrate (4 eq), 
acetone, rt, 16 h, 61%; d) vinyl magnesiumbromide, THF, rt, 3 d, decomposition. 
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Alternative approaches to the cyclisation precursor (406) were carried out which involved the 
chemoselective reduction of carbamoyl dithiocarbamate (400) with DIBAL-H to provide 
aldehyde (407), which in turn would be treated with a vinyl Grignard reagent. However, 
chemoselective reduction of the nitrile failed to deliver aldehyde (407).245 Also, direct treatment 
of (400) with vinylmagnesium bromide led to a complicated mixture by TLC analysis, and thus, 
approaches towards cyclisation precursor (406) were abandoned at this stage.244 As a 
consequence, the intramolecular carbamoyl radical cyclisation onto an enone could not be 
investigated further (scheme 107).  
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Scheme 107 
Reagents & conditions: a) DIBAL-H (4.1 eq), DCM, -78 °C, 1 h, decomposition; b) vinyl 
magnesium bromide (2 eq), Et2O, 0 °C to rt, multiple spots.   
In summary, attempted radical cyclisation of carbamoyl radical onto nitriles failed to deliver the 
desired five-membered cyclised product via a 5-exo-dig pathway as the reaction led to 
complicated mixtures by TLC analysis. Unfortunately, synthesis of cyclisation precursor (406) 
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proved ineffective and thus, intramolecular carbamoyl radical cyclisation of onto enone was not 
attempted.  
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7. EXPERIMENTAL SECTION 
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General experimental  
1H and 13C NMR data were recorded on a Bruker AC300, Bruker AV300, Bruker AMX400 or a 
Brucker DRX500 spectrometer. Spectra were recorded in water or deuterochloroform referenced 
to residual CHCl3 (
1H, 7.26 ppm; 13C, 77.0) or D6-DMSO referenced to residual D5-DMSO (
1H, 
2.50 ppm; 13C, 39.43). Chemical shifts were measured in ppm (δ) and coupling constants (J) were 
measured in Hz. The following abbreviations are used; s-singlet, d-doublet, t-triplet, q-quartet, br-
broad, ap. apparent. Mass spectra were obtained on a Jeol AX505W spectrometer using EI or CI 
or a Micromass LCT spectrometer utilising electrospray (ESI) ionisation (and a MeOH mobile 
phase), or on a VG ProSpec mass spectrometer utilising electron impact (EI) ionisation. 
Analytical HPLC was carried out on a DIONEX summit P580 quaternary low pressure gradient 
pump with built-in vacuum degasser using a Summit UVD 170s UV/VIS multi-channel detector 
with analytical flow cell and chromeleon software and HPLC grade solvents. Melting points were 
determined using open glass capillaries on a Gallenkamp melting point apparatus and are 
uncorrected. Analytical TLC was carried out on Merck 60 F245 aluminium backed silica gel 
plates. Short wave UV (245 nm), KMnO4, anisaldehyde or vanillin were used to visualise 
components. Compounds were purified by column chromatography using Merck silica gel 60 
(0.040 - 0.063 mm), or by fractional or bulb-to-bulb distillation.  
Single crystal data for 168 and 174 was recorded at rt by Dr B. Kariuki, at the University of 
Birmingham, on a Bruker Smart 6000 diffractometer equipped with a CCD detector and a copper 
tube source. Structures were solved and refined using SHELXL (1). Non-hydrogen atoms were 
refined anisotropically and a riding model was used for C-H hydrogen atoms. 
Single crystal data for ferrugine perchlorate salt were recorded by Dr. R. A. Stephenson      at the 
University of Southampton on a Bruker instrument with an APEX CCD detector and a Bede Mo 
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Microsource. Structures were solved and refined using SHELXL (1). Non-hydrogen atoms were 
refined anisotropically. Hydrogen atoms were located from difference Fourier maps and their 
coordinates and isotropic atomic displacements were freely refined. 
Solvents and reagents were purified as follows: 
Solvents were degassed by bubbling nitrogen or argon through a needle immersed in the solvent 
for the stated length of time. n-BuLi was purchased as either 2.5 M or 1.6 M solutions in hexanes 
and the solutions were titrated with menthol in the presence of 1-(biphenyl-4-yl)-3-phenyl-2-
azapropene or 1,10-phenanthroline. CuI was subjected to continuous extraction with THF 
overnight and dried under vacuum at 35 °C. CuSO4 was dried by heating overnight in an oven set 
at 150 °C. Diisopropylamine was distilled from CaH2 and stored over KOH pellets. Et2O was 
distilled from sodium and benzophenone. NaH was freed of mineral oil by triturating three times 
with 60-80 °C pet. ether. m-CPBA was purified by washing with a pH 7 phosphate buffer (vide 
infra). Quinoline was distilled through a 30 cm vigreux column under reduced pressure. THF was 
distilled from sodium and benzophenone. TMEDA was distilled from CaH2. Toluene was 
distilled from sodium. TMSCl was distilled from CaH2. NEt3 was distilled from, and stored over, 
4 Å molecular sieves. All other reagents were purchased from Aldrich or Lancaster and were 
used as received. The following cooling baths were used; 0 °C (ice/water), – 48 °C (dry 
ice/MeCN), –78 °C (dry ice/acetone). All reactions in non-aqueous solvents were carried out 
under argon in oven-dried glassware. 
 
 
 
134 
 
N, N-Dimethyl-1-cyclopenten-1-amine (143). 
 
    
                 143 
Prepared according to the literature procedure.28 
Dimethylamine hydrochloride (40 g, 500 mmol) was dissolved in a minimum amount of water, 
and the resulting solution was added dropwise to sodium hydroxide (40 g, 1 mol) to produce 
dimethylamine as a gas which was passed through a drying tube containing sodium hydroxide 
and condensed in a flask submerged in a dry ice/acetone bath. After the addition of the solution 
was complete, the mixture was stirred for one hour and a slight vacuum was employed to transfer 
the remaining amine from the reaction flask to afford dimethylamine as a liquid (ca. 30 mL). 
Liquid dimethylamine (30 mL) and cyclopentanone (10 mL, 113 mmol) were added to a 
suspension of calcium chloride in ether (200 mL) at -78 °C. The reaction mixture was allowed to 
warm to room temperature and stirred for 60 h. The solution was filtered, and the calcium 
chloride washed with ether (3 x 100 mL).  Distillation under reduced pressure afforded enamine 
(143) (11.3 g, 90%) as a yellow oil, whose analytical data were in agreement with those reported 
in the literature.28 
δH(300 MHz; CDCl3) 1.73-1.83 (2 H, m), 1.97-2.02 (2 H, m), 2.19-2.23 (2 H, m), 2.48 (6 H, s, 
NCH3 x 2), 4.07 (1H, s, CCH).  
 
 
NO
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4-Cyclohepten-1-carboxylic acid (146). 
CO2H
N
 
                      143           146 
Prepared according to the literature procedure.28 
Freshly distilled acrolein (5.11 mL, 68.9 mmol) was added dropwise over 1 h to enamine (143) 
(7.65 g, 68.9 mmol) at 0 °C. The reaction mixture was allowed to warm to room temperature and 
stirred for 3 h. Anhydrous acetonitrile (18 mL) was added, the solution was cooled to 0 °C, and 
iodomethane (4.18 mL, 103 mmol) was added dropwise over 5 min. The reaction mixture was 
allowed to warm to room temperature and stirred for a further 2 h. An aqueous solution of 
sodium hydroxide (20%, 75 mL) was added and the resultant mixture was heated at reflux for 16 
h. The brown mixture was cooled, and the aqueous layer was extracted with CH2Cl2 (3 x 50 mL). 
Acidification (pH 1) of the aqueous layer with conc HCl (ca. 5 mL) afforded the acid (146) (2.25 
g, 23%) as yellow precipitate, whose analytical data were in agreement with those reported in the 
literature.28  
Mp 64-66 °C; δH(300 MHz; CDCl3) 1.60-1.71 (2 H, m), 1.94-2.14 (4 H, m), 2.28-2.33 (2 H, m), 
2.57-2.65 (1 H, m), 5.77 (2 H, s). 
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Cyclohept-4-enylcarbamic acid ethyl ester (154). 
 
      
                                                    146          154 
Method A: 
Prepared by modification of the literature procedure.28 
To a solution of acid (146) (1.50 g, 10.71 mmol) in 1,2-dichloroethane (22.5 mL) was added N,N-
diisopropylethylamine (1.95 mL, 21.42 mmol) and diphenyl phosphoryl azide (4.61 mL, 21.42 
mmol). The reaction mixture was stirred at room temperature for 10 min and heated at reflux for 
2 h. The mixture was allowed to cool to room temperature and concentrated under reduced 
pressure. Absolute ethanol (120 mL) was added to the reaction mixture and the resultant solution 
was heated at reflux for 3.5 d. The solvent was then removed under reduced pressure to give a 
brown oil which was purified by column chromatography (98:2 to 95:5, hexane/ethyl acetate) to 
afford the title compound (154) as a white solid (1.51 g, 77%). Rf  0.40 (4:1 hexane: ethyl 
acetate); mp 68-70 °C; νmax(KBr disc)/cm
-1 3056 (N-H), 1755 (C=O), 1633 (C=C), 1602; δH(300 
MHz; CDCl3) 1.19 (3 H, t, J 7.1, OCH2CH3); 1.28-1.33 (2 H, m), 1.87-2.13 (6 H, m), 3.70-3.73 
(1 H, m), 4.06 (2 H, q, J 7.1, OCH2CH3), 4.82 (1 H, br s, NH), 5.72-5.75 (2 H, m, HC=CH); 
δC(90 MHz; CDCl3) 14.5 (CH3), 24.2 (CH2), 33.4 (CH2), 53.5 (CH), 60.4 (CH2), 131.7 (CH), 
155.5 (C); m/z (HREI) 183.1266 (M+. C10H17NO2 requires 183.1259), (LREI) 183 (15%), 115 
(82), 94 (100) and 79 (95). 
 
CO2H N
H
O
O
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Method B: 
To a solution of acid (146) (5.0 g, 35.71 mmol) in 1,2-dichloroethane (7.5 mL) was added N,N-
diisopropylethylamine (6.52 mL, 71.42 mmol) and diphenyl phosphoryl azide (15.4 mL, 71.42 
mmol). The reaction mixture was stirred at room temperature for 10 min and heated at reflux for 
2 h. The mixture was allowed to cool to room temperature and concentrated under reduced 
pressure. Absolute ethanol (300 mL) and copper (I) chloride (3.55 g, 35.70 mmol) was added to 
the reaction mixture and the resultant solution was strirred for 16 h at room temperature. Copper 
chloride was filtered off and concentrated under reduced pressure to leave a thick residue wihich 
was purified by column chromatography (98:2 to 95:5, hexane/ethyl acetate) to afford the title 
compound (154) as a white solid (2.89 g, 45%) whose analytical data were in agreement with 
method A. 
 
5-Methylaminocycloheptene (155). 
N
H
O
O HN
Me
 
                                                      154   155 
To a suspension of LiAlH4 (1.94 g, 51.02 mmol) in dry diethyl ether (30 mL) was added dropwise 
a solution of carbamate (154) (1.0 g, 5.1 mmol) in diethyl ether (20 mL), and the resulting 
mixture was heated at reflux for 4 h. The solution was allowed to cool to room temperature and 
quenched with excess solution of saturated sodium potassium tartrate (50 mL) to leave two clear 
layers. The resulting solution was filtered and the residue was washed with diethyl ether (3 x 50 
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mL). The organic layer was separated and the aqueous layer was extracted with diethyl ether (3 x 
25 mL). The combined organic layers were washed with brine (50 mL), dried over magnesium 
sulfate and concentrated under reduced pressure at 0 °C to afford the volatile title compound 
(155) as colourless oil (crude, 640 mg, 100%). Rf 0.10 (95:5 ethyl acetate: triethylamine); 
νmax(neat)/cm
-1 2854, 2253, 1712, 1531, 1455; δH(300 MHz; CDCl3) 1.29-1.34 (3 H, m), 1.82-
1.91 (2 H, m), 1.96-2.05 (2 H, m), 2.17-2.21 (2 H, m), 2.43 (3 H, s, NCH3), 2.55-2.61 (1 H, m, 
CH2CHCH2), 5.72-5.78 (2H, m, HC=CH); δC(75 MHz; CDCl3) 24.6 (CH2), 32.8 (CH2), 34.0 
(CH3), 62.4 (CH), 131.8 (CH2); m/z (HREI)  125.1201 (M
+. C8H15N requires 125.1205), (LREI) 
and 125 (5%), 96 (15) and 57 (100), 
 
N-Methyl-N-cyclohept-4-enylcarbamoylcarbodithioate (110). 
 
 
                                155        156    110 
To a solution of triphosgene (80 mg, 27 mmol) in dry THF (10 mL), was added pyridine (0.1 
mL) dropwise and the resulting mixture was stirred at room temperature for 10 min. A solution of 
amine (155) (100 mg, 0.80 mmol) in dry THF (20 mL) was then added to the reaction mixture 
and heated at reflux for 16 h. The reaction was quenched with water (10 mL) and the aqueous 
layer was extracted with diethyl ether (3 x 30 mL). The combined organic layers were washed 
with 0.033M HCl  (20 mL), water (20 mL), brine (30 mL), dried over magnesium sulfate and 
concentrated under reduced pressure to afford the carbamoyl chloride (156) which was used 
directly in the next step without any purification (120 mg, 80%) as an orange oil. Rf 0.60 (4:1 
N
O
S
Me
S
NEt2N
O
ClMeNH
Me
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ethyl acetate: hexane). A solution of N-methyl-N-cyclohept-4-enylcarbamoyl chloride (156) (120 
mg, 0.64 mmol) in acetone (10 mL) was treated with sodium diethyldithiocarbamate trihydrate 
(0.56 g, 2.56 mmol). The reaction mixture was stirred overnight at room temperature and 
quenched with saturated aqueous solution of sodium hydrogen carbonate (5 mL). The aqueous 
layer was extracted with diethyl ether (3 x 30 mL) and the combined organic layers were washed 
with water (30 mL) and brine (30 mL). The organic phase was dried over magnesium sulfate and 
concentrated under reduced pressure and  purified by column chromatography (9:1 hexane: ethyl 
acetate) to afford the title compound (110) as a yellow oil (150 mg, 79%, 63% over two steps). Rf 
0.44 (4:1 ethyl acetate: hexane); νmax(neat)/cm
-1 2927, 2853, 1668 (C=O), 1488; δH(300 MHz; 
CDCl3) 1.13 (6 H, t, J 7.1, 2 x NCH2CH3); 1.21-1.34 (2 H, m), 1.41-1.53 (2 H, m), 1.75-1.81 (2 
H, m), 2.04-2.29 (2 H, m), 2.68 (3 H, s, NCH3), 3.14 (4 H, q, J 7.1, 2 x NCH2CH3), 3.65-3.73 (1 
H, m, CH2CHCH2), 5.80-5.84 (2 H, m, HC=CH); δC(75 MHz; CDCl3) mixture of rotamers, 11.0 
(CH3), 13.3 (CH3), 25.1 (CH2), 30.8 (CH2), 31.0 (CH), 31.8 (CH2), 42.1 (CH2), 48.7 (CH2), 49.8 
(CH2), 50.1 (CH2), 60.2 (CH3), 131.9 (CH), 161.4 (C), 185.1 (C); m/z (HRESI) 323.1236 (M
+. 
C14H24N2ONaS2 requires 323.1228) and (LRESI) 323.1 (100%). 
 
5-Methylaminocycloheptene-imidazole-1-carboxamide (157). 
HN Me N
Me
O
N N
 
          155                    157 
To a solution of 5-methylaminocycloheptene (155) (52 mg, 0.42 mmol) in THF (4 mL) was 
added in one portion carbonyldiimidazole (340 mg, 2.08 mmol) and K2CO3 (290 mg, 2.08 mmol). 
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The resulting mixture was heated at reflux for 16 h. The reaction mixture was allowed to cool to 
room temperature, water (10 mL) was added and the aqueous phase was extracted with EtOAc (3 
x 20 mL). The combined organic phases were washed with brine (20 mL), dried over MgSO4, 
concentrated under under reduced pressure and purified by column chromatography  (EtOAc) to 
afford the title compound (157) as a white solid (73 mg, 80%); Rf 0.35 (ethyl acetate); mp 67-69 
°C; νmax(neat disc)/cm
-1 2932, 1686 (C=O), 1483, 1444, 1406; δH(300 MHz; CDCl3) 1.49-1.61 (2 
H, m), 1.81-1.86 (2 H, m), 1.95-2.06 (2 H, m), 2.18-2.27 (2 H, m), 2.89 (3 H, s, NCH3), 4.01-4.09 
(1 H, m), 5.76-5.81 (2 H, m), 7.03 (1 H, s,), 7.16 (1 H, s), 7.82 (1 H, s); δC(75 MHz; CDCl3) 24.9 
(CH2), 30.9 (CH2), 31.5 (CH3), 61.7 (CH), 117.8 (CH), 129.3 (CH), 131.6 (CH), 136.7 (CH), 
150.9 (C); m/z (HREI) 219.1378 (M+. C12H17N3O requires 219.1372), LREI) and 219 (15%), 152 
(70) and 95 (100). 
 
N-Methyl-N-cyclohept-4-enylcarbamoylcarbodithioate (110). 
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         157           158     110 
To imidazolide (157) (66 mg, 0.28 mmol) was added MeI (2.0 g, 14.21 mmol) dropwise over 1 
min and the resultant mixture was stirred at room temperature for 16 h. Excess solvent was 
removed under reduced pressure and the resultant white solid, imidazolium salt (158) (95 mg, 
90%) was used in the next step without further purification. To a solution of imidazolium salt (32 
mg, 0.09 mmol) in acetone (8 mL) was added sodium diethyldithiocarbamate (40 mg, 0.18 
mmol) and the solution was heated to reflux for 5 h. The reaction mixture was cooled to room 
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temperature and water (5 mL) was added. The aqueous phase was extracted with Et2O (3 x 10 
mL) and the combined organic extracts were washed with water (20 mL) and brine (20 mL), 
dried over MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography (1:1 hexane: diethyl ether) to afford the title compound (110) (20 mg, 75%) as a 
yellow oil, whose analytical data were in agreement with the earlier procedure via carbamoyl 
chloride (156). 
 
Ethyl-cyclooct-4-enyldiene-carbamate (409). 
N
O
O
 
              409 
Prepared according to the literature procedure.104 
A solution of ethyl azidoformate (5.70 g, 49.56 mmol) and cyclo-octadiene (20 mL) was heated 
at 100 °C for 16 h. The reaction mixture was cooled to room temperature, concentrated under 
reduced pressure and purified by reduced pressure distillation (0.02 mmHg, 142-146 °C) to 
afford carbamate (409) (6.55 g, 68%) as a colourless oil whose data were in agreement with those 
reported in the literature.104  
νmax(neat)/cm
-1 2936, 2864, 1718, 1663, 1539; δH(300 MHz; CDCl3) 1.32 (3 H, t, J 7.1), 1.60-
1.64 (5 H, m), 2.15-2.42 (5 H, m), 4.20-4.27 (2 H, q, J 6.2), 5.70-5.74 (2 H, m); m/z (LREI) 195 
(60%), 194 (100) and 180 (25). 
 
142 
 
5-Methylaminocyclooctene (160). 
NHN
O
O
 
    409       160 
Prepared according to the literature procedure.104 
To a suspension of LiAlH4 (150 mg, 3.94 mmol) in dry diethyl ether (4 mL) was added dropwise 
a solution of (409) (512 mg, 2.63 mmol) in dry diethyl ether (5 mL), and the resulting mixture 
was heated at reflux for 4 h. The solution was allowed to cool to room temperature and quenched 
with excess solution of saturated sodium potassium tartrate (10 mL) to leave two clear layers. 
The resulting solution was filtered and the residue was washed with diethyl ether (3 x 20 mL). 
The organic layer was separated and the aqueous layer was extracted with diethyl ether (3 x 25 
mL). The combined organic layers were washed with brine (50 mL), dried over magnesium 
sulfate and concentrated under reduced pressure at 0 °C to afford the volatile amine (160) as 
colourless oil (320 mg, 87%) whose analytical data were in agreement with those reported in the 
literature.104  
νmax(neat)/cm
-1 2930, 2855, 1705, 1650, 1540, 1466, 1367; δH(300 MHz; CDCl3) 1.18-1.42 (2 H, 
m), 1.52-1.84 (6 H, m), 2.02-2.20 (3 H, m), 2.36 (3 H, s, NCH3), 2.44-2.48 (1 H, m), 5.56-5.70 (2 
H, m); δC(75 MHz; CDCl3) 23.6 (CH2), 25.8 (CH2), 26.6 (CH2), 32.2 (CH2), 33.9 (CH3), 35.1 
(CH2), 60.0 (CH), 129.5 (CH), 130.0 (CH); m/z (LREI) 140.6 (100%). 
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N-Methyl-N-cyclooctyl-4-enylcarbamoylchloride (161). 
N
Me
O
ClNH
Me
 
                                                      160                             161     
To a solution of triphosgene (610 mg, 2.06 mmol) in dry toluene (38 mL), was added pyridine 
(0.92 mL) dropwise and the resulting mixture was stirred at room temperature for 10 min. A 
solution of amine (160) (860 mg, 6.19 mmol) in dry toluene (24 mL) was then added to the 
reaction mixture and stirred for 1 h at room temperature. The reaction was quenched with water 
(20 mL) and the aqueous layer was extracted with diethyl ether (3 x 30 mL). The combined 
organic layers were washed with brine (50 mL), dried over magnesium sulfate and concentrated 
under reduced pressure to afford the carbamoyl chloride (161) (510 mg, 65%) as an orange oil. Rf 
0.5 (1:1 hexane: Et2O); νmax(neat)/cm
-1 2391, 2857, 1732 (CO), 1468, 1396, 1358; δH(300 MHz; 
CDCl3) 1.58-1.77 (6 H, m), 2.13-2.35 (4 H, m), 2.88 & 2.96 (mixture of rotamers, 3 H, s, NCH3), 
4.18-4.40 (1 H, m), 5.65-5.72 (2 H, m); δC(75 MHz; CDCl3) 23.0 (CH2), 25.4 (CH2), 26.3 (CH2), 
32.1 (CH2), 32.6 (CH2), 33.8 (CH3), 59.1 (CH), 129.0 (CH), 130.3 (CH). 
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N-Methyl-N-cyclooctyl-4-enylcarbamoylcarbodithioate (159). 
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        161           159 
A solution of N-methyl-N-cyclooct-4-enylcarbamoyl chloride (161) (2.10 g, 10.42 mmol) in 
acetone (100 mL) was treated with sodium dithiocarbamate trihydrate (4.40 g, 42.4 mmol). The 
reaction mixture was stirred overnight at room temperature and quenched with saturated aqueous 
solution of sodium hydrogen carbonate (20 mL). The aqueous layer was extracted with diethyl 
ether (3 x 50 mL) and the combined organic layers were washed with water (50 mL) and brine 
(50 mL). The organic phase was dried over magnesium sulfate and concentrated under reduced 
pressure and purified by column chromatography (2:1 hexane: diethyl ether) to afford the title 
compound (159) as a yellow oil. Rf 0.44 (4:1 ethyl acetate: hexane); νmax(neat)/cm
-1 2932, 2857, 
1667 (C=O), 1489, 1463, 1418; δH(300 MHz, CDCl3); 1.30 (6 H, t, J 7.2), 1.69-1.72 (6 H, m), 
2.14-2.29 (4 H, m), 2.87 (3 H, s, NCH3), 3.76-4.01 (4 H, m), 4.37-4.43 (1 H, m), 5.63-5.69 (2 H, 
m); δC(75 MHz, CDCl3) mixture of rotamers, 10.7 (CH3), 12.9 (CH3), 22.5 (CH2), 22.8 (CH2), 
25.0 (CH2), 25.4 (CH2), 25.8 (CH2), 26.0 (CH), 29.6 (CH3), 31.1 (CH3), 31.7 (CH2), 31.9 (CH2), 
32.6 (CH2), 32.8 (CH2), 48.3 (CH2), 49.5 (CH2), 56.2 (CH), 58.4 (CH), 128.4 (CH), 128.8 (CH), 
129.7 (CH), 130.1 (CH), 160.6 (C), 184.7 (C); m/z (HRESI) 337.1377 (M+. C15H26N2ONaS2 
requires 337.1384) and (LRESI) 337 (100%). 
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5-Methylaminocyclo-octene-imidazole-1-carboxamide (162). 
N
Me
O
N N
NH
Me
 
        160     162 
To a solution of 5-methylaminocyclooctene (160) (70 mg, 0.50 mmol) in THF (10 mL) was 
added in one portion carbonyldiimidazole (580 mg, 2.5 mmol) and K2CO3 (500 mg, 2.5 mmol). 
The resulting mixture was heated at reflux for 16 h. The reaction mixture was allowed to cool to 
room temperature, H2O (10 mL) was added and the aqueous phase was extracted with EtOAc (3 
x 20 mL). The combined organic phases were washed with brine (20 mL), dried over MgSO4, 
concentrated under under reduced pressure and purified by column chromatography  (EtOAc) to 
afford the title compound (162) as a viscous oil (88 mg, 75%). Rf 0.35 (ethyl acetate); νmax(neat 
disc)/cm-1 2933, 2253, 1690 (C=O), 1468, 1444, 1407; δH(300 MHz; CDCl3) 1.59-1.87 (5 H, m), 
2.09-2.39 (5 H, m), 2.94 (3 H, s, NCH3), 4.04-4.13 (1 H, m), 5.64-5.69 (2 H, m), 7.08 (1 H, s), 
7.13 (1 H, s), 7.85 (1 H, s); δC(75 MHz; CDCl3) 22.8 (CH2), 25.3 (CH2), 25.9 (CH2), 31.9 (CH3) 
32.1 (CH2), 32.6 (CH2), 57.7 (CH), 117.7 (CH), 128.7 (CH), 129.9 (CH), 130.4 (CH), 136.6 
(CH), 151.0 (C); m/z (HREI) 233.1535 (M+. C12H19N3O requires 233.1528), (LREI) 233 (25%), 
166 (70), 109 (60) and 67 (100). 
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N-Methyl-N-cyclooctyl-4-enylcarbamoylcarbodithioate (159). 
N
Me
O
N N N
Me
O
N N CH3
I
N
O
S
Me
S
NEt2
 
         162            163     159 
To imidazole-carboxamide (162) (85 mg, 0.36 mmol) was added MeI (2.5 g, 18.24 mmol) 
dropwise and the resultant mixture was stirred at room temperature for 16 h. Excess solvent was 
removed under reduced pressure and the resultant white solid, imidazolium salt (163) (131 mg, 
97%) used in next step without purification. To a solution of imidazolium salt (61 mg, 0.16 
mmol) in acetone (2 mL) was added sodium diethyldithiocarbamate (170 mg, 0.76 mmol) and the 
solution was heated at reflux for 16 h. The reaction mixture was cooled to room temperature and 
H2O (5 mL) was added. The aqueous phase was extracted with Et2O (3 x 10 mL) and the 
combined organic extracts were washed with water (20 mL) and brine (20 mL), dried over 
MgSO4 and concentrated under reduced pressure. The residue was purified by column 
chromatography (2:1 hexane : diethyl ether) to afford the title compound (159) (35 mg, 68%, 
50% over three steps) as a yellow oil, whose analytical data were in agreement with those 
reported for the earlier procedure via carbamoyl choloride (161).  
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rac-(1R, 2S, 5R)-6-Methyl-7-oxo-6-azabicyclo[3.2.2]nonan-2-yldiethylcarbamodithioate 
(164) and rac-(1R, 2R, 5R,)-6-Methyl-7-oxo-6-azabicyclo[3.2.2]nonan-2-
yldiethylcarbamodithioate (165). 
NO
S
S
NEt2
Me
NO
S
S
NEt2
Me
N
O
S
Me
S
NEt2
 
110                                         164 165 
Carbamoyl dithiocarbamate (110) (562 mg, 1.87 mmol) was dissolved in cyclohexane (17.5 mL) 
and irradiated with a 500 W halogen lamp that generated enough heat to bring the solvent to 
reflux. After 5 h the reaction mixture was allowed to cool to room temperature, concentrated 
under reduced pressure and purified by column chromatography (ethyl acetate) to afford first the 
title compound (164) (360 mg, 64%) as a yellow oil, followed by the title compound (165) (59 
mg, 10%) as a yellow oil. (164) Rf 0.35 (ethyl acetate); νmax(neat)/cm
-1 2934, 1649 (C=O), 1417; 
δH(300 MHz; CDCl3) 1.24 (6 H, t, J 7.1, 2 x CH2CH3), 1.77-2.09 (7 H, m), 2.23-2.30 (1 H, m), 
2.93-2.95 (1 H, d, J 4.9), 2.98 (3 H, s, NCH3), 3.46-3.48 (1 H, m), 3.64-3.72 (2 H, m), 3.93-4.04 
(2 H, m), 4.19-4.24 (1 H, dd, J 5.1 and 4.7); δC(75 MHz; CDCl3) mixture of rotamers, 11.5 
(CH3), 12.4 (CH3), 20.2 (CH2), 24.0 (CH2), 27.9 (CH2), 31.2 (CH2), 33.2 (CH3), 46.5 (CH2), 47.3 
(CH), 49.0 (CH2), 50.1 (CH), 55.5 (CH), 172.6 (C), 193.2 (C); m/z (HRESI) 323.1222 (M
+. 
C14H24N2ONaS2 requires 323.1228) and (LRESI) 325.1 (10%), 324.1 (15) and 323.1 (100). (165) 
Rf 0.28 (ethyl acetate); νmax(neat)/cm
-1 2922, 2853, 1658 (C=O), 1462; δH(300 MHz; CDCl3) 1.26 
(6 H, t, J 7.2), 1.58-2.28 (8 H, m), 2.99 (3 H, s, NCH3), 3.00-3.05 (1 H, m), 3.57-3.67 (2 H, m), 
3.79-3.93 (2 H, m), 4.07-4.21 (2 H, m); δC(75 MHz; CDCl3) mixture of rotamers, 11.5 (CH3), 
12.4 (CH3), 20.2 (CH2), 24.0 (CH2), 28.0 (CH2), 31.2 (CH2), 33.3 (CH3), 46.5 (CH2), 47.3 (CH), 
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49.0 (CH2), 50.1 (CH), 55.5 (CH), 172.6 (C), 193.2 (C); m/z (HRESI) 323.1223 (M
+. 
C14H24N2NaS2 requires 323.1228), (LRESI) 323.1 (100%) and 301.2 (40) 
 
rac-(1R, 2S, 5R)-6-Methyl-7-oxo-6-azabicyclo[4.2.2]nonan-2-yldiethylcarbamodithioate 
(167) and rac-(1R, 2R, 5R,)-6-Methyl-7-oxo-6-azabicyclo[4.2.2]nonan-2-
yldiethylcarbamodithioate (168). 
NO
Me
S
S
Et2N
NO
Me
S
NEt2
S
N
O
S
Me
S
NEt2
 
                              159                                               167                  168 
Carbamoyl dithiocarbamate (159) (0.733 g, 2.33 mmol) was dissolved in cyclohexane (17.5 mL) 
and irradiated with a 500 W halogen lamp that generated enough heat to bring the solvent to 
reflux. After 5 h the reaction mixture was allowed to cool to room temperature, concentrated 
under reduced pressure and purified by column chromatography (ethyl acetate) to afford first the 
title compound (167) (352 mg, 48%) as a yellow oil, followed by the title compound (168) (142 
mg, 20%) as a yellow oil.  (167) Rf 0.40 (ethyl acetate); νmax(neat)/cm
-1 2932, 2817, 1634 (C=O), 
1486, 1442, 1417, 1356; δH(300 MHz; CDCl3) 1.24 (6 H, t, J 6.9, 2 x NCH2CH3,), 1.50-1.54 (1 
H, m), 1.73-1.80 (3 H, m), 1.96-2.27 (5 H, m), 2.93 (3 H, s, NCH3), 3.12-3.17 (1 H, m), 3.65-3.74 
(4 H, m), 3.96-4.03 (2 H, m), 4.45-4.51 (1 H, m); δC(75 MHz; CDCl3) 11.5 (CH3), 12.5 (CH3), 
20.4 (CH2), 21.5 (CH2), 25.6 (CH2), 31.6 (CH2), 34.0 (CH), 34.7 (CH2), 44.4 (CH), 46.5 (CH2), 
49.1 (CH2), 56.1 (CH), 173.0 (C), 193.4 (C);   m/z (HRESI) 337.1375 (M
+. C15H26N2ONaS2 
requires 337.1384) and (LRESI) 337.2 (100%). (168) Rf 0.20; νmax(neat)/cm
-1 2932, 1633 (C=O), 
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1487, 1417, 1268; δH(300 MHz; CDCl3) 1.26 (6 H, t, J 7.1, 2 x NCH2CH3), 1.76-1.79 (6 H, m), 
2.07-2.32 (4 H, m), 3.01 (3 H, s, NCH3), 3.14-3.18 (1 H, m), 3.85-3.96 (4 H, m), 4.04-4.13 (1 H, 
m), 4.31-4.36 (1 H, m); δC(75 MHz; CDCl3) 11.5 (CH3), 12.4 (CH3), 23.0 (CH2), 23.5 (CH2), 
26.0 (CH2), 31.44 (CH2), 33.0 (CH2), 33.9 (CH), 44.8 (CH), 46.5 (CH2), 49.2 (CH2), 58.7 (CH2), 
171.5 (C), 195.2 (C) m/z (HRESI) 337.1376 (M+. C15H26N2ONaS2 requires 337.1384) and 
(LRESI) 337.1 (100%). 
 
rac-6-Methyl-7-oxo-6-azabicyclo[3.2.2]non-2-ene (173). 
NO
S
S
NEt2
Me
N
O
Me
 
         164                                  173 
Method A: from (164). 
A solution of rac-(1R, 2S, 5R)-6-methyl-7-oxo-6-azabicyclo[3.2.2]nonan-2-yl 
diethylcarbamodithioate (164) (200 mg, 0.67 mmol) in diphenyl ether (6 mL) was heated at 
reflux for 2 h. The reaction mixture was allowed to cool to room temperature and purified by 
column chromatography (1:1 hexane: ethyl acetate) to afford the title compound (173) as a brown 
solid (90 mg, 89%). Rf 0.30 (ethyl acetate); mp 53-55 °C; νmax(KBr disc)/cm
-1 2957, 1654 (C=O), 
1488; δH(300 MHz; CDCl3) 1.79-2.22 (5 H, m), 2.53-2.63 (1 H, m), 2.97 (3 H, s, NCH3), 2.97-
2.93 (1 H, m), 3.49-3.54 (1 H, m), 5.50-5.56 (1 H, m), 5.88-5.94 (1 H, m); δC(75 MHz; CDCl3) 
25.7 (CH2), 28.8 (CH2), 32.5 (CH3), 34.7 (CH2), 42.1 (CH), 55.0 (CH), 127.3 (CH), 127.9 (CH), 
150 
 
174.9 (C); m/z (HREI)  151.0994 (M+. C9H13NO requires 151.0997), (LREI) 151 (100%), 136 
(15), 79 (87), 57 (75), 42 (47). 
NO
S
S
NEt2
Me
N
O
Me
 
           165      173 
Method B: from (165). 
A solution of rac-(1R, 2R, 5R,)-6-methyl-7-oxo-6-azabicyclo[3.2.2]nonan-2-yl 
diethylcarbamodithioate (165) (62.5 mg, 0.21 mmol) in diphenyl ether (4 mL) was heated at 
reflux for 2 h. The reaction mixture was allowed to cool to room temperature and purified by 
column chromatography (1:1 hexane: ethyl acetate) afforded the title compound (173) as a brown 
solid (22.0 mg, 70%), whose analytical data were in agreement with method A.  
NO
S
S
NEt2
Me
N
O
Me
 
        164+165    173 
Method C: from a mixture of (164) and (165). 
A solution of (164) and (165) (8:1) (138.2 mg, 0.46 mmol) in diphenyl ether (5 mL) was heated 
at reflux for 2 h. The reaction was allowed to cool at room temperature and purified by column 
chromatography (1:1 hexane: ethyl acetate) to afford the title compound (173) as a brown solid 
(60 mg, 86%), whose analytical data were in agreement with method A. 
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rac-6-Methyl-7-oxo-6-azabicyclo[4.2.2]non-2-ene (174). 
NO
Me
S
S
Et2N
NO
Me
 
         167    174 
Method A: From (167) (major) 
A solution of rac-(1R, 2S, 5R)-6-methyl-7-oxo-6-azabicyclo[4.2.2]nonan-2-
yldiethylcarbamodithioate  (167) (250 mg, 079 mmol) in diphenyl ether (8 mL) was heated at 
reflux for 2 h. The reaction mixture was allowed to cool to room temperature and purified by 
column chromatography (1:1 hexane: ethyl acetate) to afford the title compound (174) as a brown 
solid (90 mg, 80%). Rf 0.30 (ethyl acetate); νmax(neat disc)/cm
-1 2930, 1640 (C=O), 1483; δH(300 
MHz; CDCl3) 1.72-1.86 (4 H, m), 1.92-1.98 (2 H, m), 2.12-2.26 (2 H, m), 2.90 (3 H, s, NCH3), 
3.21-3.23 (1 H, m), 3.66-3.72 (1 H, m), 5.46-5.52 (1 H, m), 5.75-5.84 (1 H, m); δC(75 MHz; 
CDCl3) 20.4 (CH2), 25.0 (CH2), 25.1 (CH2), 33.4 (CH), 36.0 (CH2), 44.5 (CH), 55.0 (CH), 128.9 
(CH), 129.2 (CH), 175.9 (C);  m/z (HRESI) 188.1048 (M+. C10H15NO requires 188.1051) and 
(LRESI) 188.1 (100%). 
 
   
        168                     174 
 
 
NO
Me
S
NEt2
S
NO
Me
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Method B: From (168) (minor) 
A solution of rac-(1R, 2R, 5R)-6-methyl-7-oxo-6-azabicyclo[3.2.2]nonan-2-yl 
diethylcarbamodithioate (168) (27 mg, 0.09 mmol) in diphenyl ether (1 mL) was heated at reflux 
for 2 h. The reaction mixture was allowed to cool to room temperature and purified by column 
chromatography (1:1 hexane: ethyl acetate) afforded the title compound (174) as a brown solid 
(12 mg, 81%), whose analytical data were in agreement with method A. 
NO
Me
S
S
Et2N
NO
Me
 
      167+168    174 
Method C: From a mixture of (167) and (168). 
A solution of (167) and (168) (2.5:1) (61 mg, 0.14 mmol) in diphenyl ether (2 mL) was heated at 
reflux for 2 h. The reaction was allowed to cool at room temperature and purified by column 
chromatography (1:1 hexane: ethyl acetate) to afford the title compound (174) as a brown solid 
(23 mg, 73%), whose analytical data were in agreement with method A. 
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rac-Ferrugine. 
N
O
Me
N Me
O
Ph  
      173         ferrugine 
To a stirred solution of 6-methyl-7-oxo-6-azabicyclo[4.2.2]non-2-ene (173) (35 mg, 0.185 mmol) 
in THF (2.5 ml) at 0 °C was added dropwise phenyllithium (1.8 M in THF, 1.03 mL, 1.28 mmol) 
over 5 min and stirred for 1 h. The reaction was quenched with water (10 mL), basified (pH 12-
14) with 5% sodium hydroxide solution, and stirred for 20 h at room temperature. THF was 
removed under reduced pressure, and the aqueous phase was extracted with ethyl acetate (3 x 20 
mL). The combined organic layers were dried over magnesium sulfate, concentrated under 
reduced pressure and purified by column chromatography on neutral alumina (99:1 ethyl acetate: 
triethylamine) to afford ferrugine (35 mg, 66%) as a brown oil. Rf, 0.65 (on neutral alumina, 99:1 
ethyl acetate: triethylamine); νmax(neat)/cm
-1 2959, 1675 (C=O), 1596, 1448, 1378; δH(300 MHz, 
CDCl3) 1.42-1.60 (3 H, m), 1.75-2.07 (5 H, m), 2.36 (3 H, s, NCH3), 3.18-3.20 (1 H, m), 3.35-
3.37 (1 H, m), 3.78-3.81 (1 H, m), 7.43-7.53 (3 H, m, Ar), 7.94-7.96 (2 H, m, Ar); δC(75 MHz; 
CDCl3) 18.5 (CH2), 22.8 (CH2), 26.1 (CH2), 29.9 (CH2), 40. 4 (CH3), 47.7 (CH), 61.8 (CH), 63.7 
(CH), 128.3 (CH), 128.7 (CH), 132.8 (CH), 136.4 (C), 201.6 (C); m/z (HRCI) 230.1535 (M+. 
C15H20NO requires 230.1545) and (LRCI) 230 (100%). 
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2-Ethanoyl-8-methyl-8-azabicyclo[3.2.1]octane (178). 
N
O
Me
N Me
O
Me  
         173                   178 
To a solution of 6-methyl-7-oxo-6-azabicyclo[3.2.2]non-2-ene (173) (192.6 mg, 0.54 mmol) in 
THF (10 mL) at 0 °C was added dropwise  methyllithium (1.6 M in diethyl ether, 0.81 mL, 1.08 
mmol) over 5 min,  and the resultant solution stirred for 1 h. The reaction was quenched with 
water (10 mL), basified (pH 12-14) with 5% sodium hydroxide solution, and stirred for 6 h at 
room temperature. THF was removed under reduced pressure, and the aqueous phase was 
extracted with ethyl acetate (3 x 30 mL). The combined organic layers were dried over 
magnesium sulfate, concentrated under reduced pressure and purified by column chromatography 
on basic alumina (99:1 ethyl acetate: triethylamine) to afford the title compound (178) (110 mg,  
69%) as a brown oil. Rf, 0.45 (on neutral alumina, 99:1 ethyl acetate: triethylamine); 
νmax(neat)/cm
-1 2943, 2253, 1702 (C=O), 1475, 1450, 1351; δH(300 MHz, CDCl3) 1.40-1.49 (3 
H, m), 1.57-1.75 (2 H, m), 1.69-1.75 (1 H, m), 1.87-1.94 (2 H, m), 2.11 (3 H, s, NCH3 or 
COCH3), 2.31 (3 H, s, NCH3 or COCH3), 2.77-2.83 (1 H, m), 3.10-3.12 (1 H, m), 3.38-3.40 (1H, 
d, J 6.2); δC(75 MHz; CDCl3) 18.0 (CH2), 23.3 (CH2), 25.8 (CH2), 28.4 (CH3), 29.7 (CH2), 40.2 
(CH3), 53.2 (CH), 60.8 (CH), 62.4 (CH), 209.7 (C); m/z (HREI) 167.1305 (M
+. C10H17N requires 
167.1310), (LREI) 167 (25%), 96 (70), 82 (100), 57 (68%).  
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Methyl-4-oxotetrahydro-2H-thiopyran-3-carboxylate (357). 
S
O O
OMeMeO S OMe
O O
 
                                             357 
Prepared according to the literature procedure.211 
Anhydrous MeOH (7.4 mL, 1.70 mmol) was added dropwise over 30 min to a stirred suspension 
of Na metal (4 g, 174 mmol) in THF (54 mL) at 0 °C. The ice bath was removed and the stirring 
continued at room temperature for 16 h, at which point most of the Na metal was consumed 
leaving a greyish white mixture of NaOMe in THF. The mixture was cooled in ice and the diester 
(27.67 g, 133.78 mmol) was added drop wise over 1 h. The ice bath was removed and the mixture 
was stirred at room temperature for 3 h. The mixture was then cooled at 0 °C and aqueous H2SO4 
(0.475 mol) was added slowly with stirring maintaining the temperature below 20 °C; the final 
pH was 6-7. To the resulting creamy yellow mixture was added CH2Cl2 (100 mL) after which 
Na2SO4 hydrate precipitated as granules that readily settle, leaving a pale yellow solution; a small 
amount of water (10 mL) was added to achieve desired consistency. Na2SO4 (10 g) and NaHCO3 
(10 g) were added with stirring and after 30 min, the precipitate was filtered and the residue was 
washed with CH2Cl2 (100 mL). The combined organic layers were concentrated to afford 357 
(21.31 g, 92%) as a pale yellow oil, which was used directly in the next step without further 
purification. Analytical data were in agreement with those reported in the literature.211 
νmax(neat)/cm
-1 2953, 1740, 1714, 1656, 1613, 1440, 1412; δH(300 MHz; CDCl3) of keto-enol 
2.60 (2 H, t, J 5.9), 2.78 (2 H, t, J 5.9), 3.35 (2 H, s), 3.76 (3 H, s, OCH3), 12.51 (1 H, s, OH); 
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δC(75 MHz; CDCl3) 23.4 (CH2), 30.2 (CH2), 43.4 (CH2), 51.7 (CH3), 58.5 (CH), 172.3 (C), 203.5 
(C). 
 
Dihydro-2H-thiopyran-4(3H)-one (358). 
S
O
S
O O
OMe
  
357    358 
Prepared according to the literature procedure.211 
To a solution of aqueous H2SO4 (10%, 100 mL) was added keto ester (357) (100 g, 0.57 mol) 
over 10 min at room temperature and the resultant mixture was refluxed  for 1 h. the reaction 
mixture was allowed to cool to room temperature and the aqueous layer was decanted from a 
yellow oil that separated and settled. The yellow oil was washed with water (500 mL) and the 
combined aqueous phases were extracted with CH2Cl2 (3 x 200 mL) with each extract passed 
through a column of basic alumina. The column was finally eluted with CH2Cl2 (600 mL) and the 
combined eluents were concentrated under reduced pressure and then  re-concentrated from 
hexane to give compound (358) (42.6 g, 64%) as a white free flowing crystalline solid whose 
analytical data were in agreement with those reported in the literature.211  
νmax(neat)/cm
-1 2945, 2910, 1708, 1421; δH(300 MHz; CDCl3) 2.67-2.71 (4 H, m), 2.93-2.87 (4 
H, m); δC(75 MHz; CDCl3) 29.9 (CH2), 39.9 (CH2), 208.1 (C).  
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5-(methylthio)pent-1-en-3-one (360). 
S
O
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I
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S
O
S
O
 
      358         359         360 
To a solution of (358) (1.93 g, 16.64 mmol) in acetone (2 mL) was added MeI (10.3 mL, 166.4 
mmol) portionwise and the reaction stirred at room temperature for 3 d in the dark. The resulting  
white precipitate was filtered off, washed with acetone (3 x 20 mL) and dried under vacuum to 
afford the sulfonium salt (359) (3.70 g, 92%) and was directly used in the next step. To a solution 
of sulfonium salt (359) (3.70 g, 14.33 mmol) in acetonitrile and water (9:1, 145 mL), was added 
DIPEA (7.5 mL, 43.04 mmol). The resulting mixture was stirred at room temperature for 2 d. The 
aqueous phase was extracted with EtOAc (3 x 30 mL), and the combined organic phases were 
washed with water (30 mL), brine (300 mL), dried over magnesium sulfate and concentrated 
under pressure and purified by column chromatography (4:1 hexane: EtOAc) to afford the title 
compound (360) (1.85 g, 86% over two steps). Rf 0.5 (1:1 hexane: Et2O); νmax(neat)/cm
-1 2919, 
2253, 1679, 1617 1403, 1094; δH(300 MHz; CDCl3) 2.13 (3 H, s, SCH3), 2.75-2.82 (2 H, m), 
2.89-2.92 (2 H, m), 5.86-5.90 (1 H, dd, J 1.4, 10.2), 6.22-6.28 (1 H, dd, J 1.4, 17.7), 6.33-6.42 (1 
H, dd, J 10.2, 17.7); δC(75 MHz; CDCl3) 15.64 (CH3), 27.9 (CH2), 39.2 (CH2), 128.4 (CH2), 
136.1 (CH), 198.6 (C); m/z (LREI) 130 (15%), 82 (90%), 55 (100%). 
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1-(Methylthio)-5-nitropentan-3-one (362). 
S
O
NO2
MeMe
S
O
 
         360            362 
To a solution of enone (360) (671 mg, 5.16 mmol) in THF (4 mL) was added NaNO2 (710 mg, 
10.3 mmol) and AcOH (0.59 mL, 10.3 mmol) at room temperature. The resultant mixture was 
stirred at this temperature for 16 h, diluted with water (10 mL), and extracted with ethyl acetate 
(3 x 20 mL). The combined organic layers were washed with water (20 mL), brine (20 mL), dried 
over MgSO4, concentrated under pressure and purified by column chromatography (4:1 hexane: 
EtOAc) to afford the title compound (362). Further elution gave recovered starting materials (561 
mg, 75% BRSM) as a yellow viscous oil. Rf  (0.2 hexane: EtOAc); νmax(neat)/cm
-1 2920, 1716 
(CO), 1556, 1465; δH(300 MHz; CDCl3) 2.13 (3 H, s, SCH3), 2.74-2.84 (4 H, m), 3.08-3.12 (2 H, 
m), 4.67 (2 H, t, J 6.1); δC(75 MHz; CDCl3) 15.4 (CH3), 27.3 (CH2), 38.2 (CH2), 42.1 (CH2), 68.7 
(CH2), 204.3 (C); m/z (HREI) 177.0452 (M
+. C6H11NO3S requires 177.0460), (LREI) and 177 
(50%), 74 (75%), 61 (100%), 55 (95%). 
 
Hept-1-en-3-ol 364. 
OHO
H  
       363    364 
Prepared according to the literature procedure.247 
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To a solution of  acrolein (363) (1.1 g, 19.84 mmol) in THF (10  mL) was added a solution of n-
BuLi in THF (2.0 M, 23.81 mmol, 10.4 mL) at -78 °C and the resultant solution was slowly 
warmed to room temperature over 12 h. The reaction mixture was quenched with 1M NaH2P2O4 
(10 mL). The aqueous phase was extracted with Et2O (3 x 20 mL), and the combined organic 
extracts were washed with water (10 mL), brine (10 mL), dried over MgSO4 and concentrated 
under reduced pressure to afford the allylic alcohol as a colourless oil (364) (2.08 g, 92%), whose 
analytical data were in agreement with those reported in the literature.248 
Rf 0.4 (1:1 hex: Et2O) νmax(neat)/cm
-1 3346, 2958, 2932, 1467; δH(300 MHz; CDCl3) 0.90 (3 H, t, 
J 7.3), 1.23-1.59 (7 H, m), 4.06-4.10 (1 H, m), 5.08-5.12 (1 H, dd, J 1.5 & 9.2), 5.18-5.25 (1 H, 
dd, J 1.3 & 15.7), 5.81-5.92 (1 H, m); δC(75 MHz; CDCl3) 13.8 (CH3), 22.5 (CH2), 27.4 (CH2), 
36.6 (CH2), 114.1 (C), 141.3 (C); m/z (LREI) 114.1 (10%), 72.1 (20%) and 57.1 (100%), 
 
Hept-1-en-3-one (365). 
OH O
 
          364       365 
Prepared accoding to a general procedure.217 
To a solution of IBX (62 mg, 2.24 mmol) in DMSO (6 mL) was added allylic alcohol (364) (130 
mg, 1.12 mmol) at room temperature and the reaction was stirred at this temperature for 3 h. The 
reaction mixture was quenched with water (10  mL), the aqueous phase was extracted with Et2O 
(3 x 20 mL) and the combined organic extracts were washed with water (20 mL), brine (20 mL), 
dried over MgSO4 and concentrated under reduced pressure to afford the enone (365) as a 
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colourless oil (113 mg, 88%) used directly in the next step without further purification. Rf  0.5 
hexane: EtOAc); νmax(neat)/cm
-1 2959, 2934, 2874, 1700, 1683, 1615; δH(300 MHz; CDCl3) 0.92 
(3 H, t, J 7.3), 1.30-1.38 (2 H, m), 1.58-1.63 (2 H, m), 2.58 (2 H, t, J 7.6), 5.79-5.83 (1 H, dd, J 
1.5 & 10.3), 6.18-6.24 (1 H, dd, J 1.4 & 17.7), 6.31-6.40 (1 H, dd, J 7.2 & 10.3); δC(75 MHz; 
CDCl3) 13.6 (CH3), 22.1 (CH2), 25.9 (CH2), 39.1 (CH2), 127.6 (CH2), 136.3 (CH), 200.8 (C);  
m/z (HRESI) 112.087 (M+ C7H12O requires 112.0888), (LRESI) 112.1 (10%), 70.0 (100), 55.0 
(90) and 97.1 (50). 
 
(E)-1-(Methylthio)dodec-4-ene-3,8-dione (369). 
S
O
NO2
Me Me
S
O
O  
   362       369 
To a solution of enone (365) (2.06 g, 18.10 mmol) and β-nitro ketone (362) (3.20 g, 18.10 mmol) 
in DCM (100 mL) was added basic Al2O3 (72 g, 706 mmol) at room temperature. The resultant 
mixture was stirred at this temperature for 16 h, Al2O3 filtered off and washed with excess DCM 
(100 mL), concentrated under reduced pressure and purified by column chromatography (4:1 
hexane: Et2O) to afford the title compound (369) (466 mg, 11%) as a colourless oil. Rf 0.25 (1:1 
hexane: Et2O); νmax(neat)/cm
-1 2361, 2874, 1712 (CO), 1670, 1630, 1540; δH(300 MHz; CDCl3) 
0.89 (3 H, t, J 7.3), 1.23-1.57 (4 H, m), 2.10 (3 H, s, SCH3), 2.38-2.60 (6 H, m), 2.71-2.85 (4 H, 
m), 6.06-6.12 (1 H, m), 6.78-6.87 (1 H, m); δC(75 MHz; CDCl3) 13.8 (CH3), 15.8 (CH3), 22.3 
(CH2), 25.9 (CH2), 26.2 (CH2), 28.2 (CH2), 39.4 (CH2), 40.5 (CH2), 42.6 (CH2), 130.5 (CH), 
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146.0 (CH),  198.3 (C), 209.1 (C); m/z (HRESI) 265.1242 (M+Na C13H22O2NaS requires 
265.1238) and (LRESI) 265.1 (100%). 
 
1-(5-Butyl-3,4-dihydro-2H-pyrrol-2-yl)-4-(methylthio)butan-2-one (368). 
Me
S
O
O
Me
S
O
N
 
   369             368 
To a solution of enone (369) (466 mg, 1.93 mmol) in MeOH (20 mL) was added aqueous 
ammonia (35%, 5.5 mL) dropwise over 1 min at room temperature. The resultant mixture was 
stirred at this temperature for 16 h. MeOH was removed under reduced pressure and the aqueous 
phase was extracted with DCM (3 x 10 mL), and the combined organic extracts were washed 
with water (10 mL), brine (10 mL), dried over MgSO4 and concentrated under reduced pressure 
to afford title compound as a brown oil (368) (411 mg, 88%) which was used in the next step 
without further purification. Rf 0.4 (Et2O); νmax(neat)/cm
-1 2929, 2871, 1712 (CO), 1442, 1457; 
δH(300 MHz; CDCl3) 0.91 (3 H, t, J 7.3), 1.27-1.59 (6 H, m), 2.11 (3 H, s, SCH3), 2.28-2.53 (5 
H, m), 2.72-2.78 (4 H, m), 2.89-2.96 (1 H, m), 4.30-4.35 (1 H, m); δC(75 MHz; CDCl3) 13.6 
(CH3), 15.5 (CH3), 22.3 (CH2), 27.7 (CH2), 28.3 (CH2), 28.7 (CH2), 33.3 (CH2), 37.0 (CH2), 42.8 
(CH2), 49.4 (CH2), 67.9 (CH), 178.3 (C), 207.5 (C); m/z (HRESI) 264.1393 (M+Na 
C13H23NONaS requires 264.1398) and (LRESI) 264.2 (100%). 
 
 
162 
 
Ethyl-5-butyl-2-(4-(methylthio)-2-oxobutyl)-2,3-dihydro-1H-pyrrole-1-carboxylate (376). 
Me
S
O
N
Me
S
O
N
O
O
 
   368               376 
To a solution of imine (368) (30 mg, 0.12 mmol) and triethylamine (30 mg, 0.25 mmol) in THF 
(4 mL) was added ethyl chloroformate (30 mg, 0.25 mmol) at -78 °C. The resultant mixture was 
stirred at this temperature for 1 h and slowly warmed to room temperature overnight. The 
reaction mixture was quenched with water (5 mL) and the aqueous phase was extracted with 
CH2Cl2 (3 x 10 mL). The combined organic phases were washed with brine (10 mL), dried over 
MgSO4, concentrated under reduced pressure and purified by column chromatography (1:1 Pet-
ether: Et2O) to afford the title compound (376) as a brown oil (30 mg, 80%). Rf 0.35 (1:1 hexane: 
Et2O); νmax(neat)/cm
-1 2959, 2872, 1706, 1481, 1465; δH(300 MHz; CDCl3) 0.90 (3 H, t, J 7.0 ), 
1.23-1.43 (7 H, m), 1.92-2.12 (5H, m), 2.36-2.93 (3 H, s, SCH3 & 6 H, m), 4.10-4.21 (2 H, m), 
4.47-4.72 (1 H, m); δC(75 MHz; CDCl3) 13.8 (CH3), 14.6 (CH3), 15.8 (CH3), 23.23 (CH2), 26.11 
(CH2), 27.1 (CH2), 27.91 (CH2), 31.1 (CH2), 42.9 (CH2), 46.7 (CH2), 56.1 (CH), 61.2 (CH2), 
108.3 (CH), 136.8 (C), 207.2 (C), 207.3 (C); m/z (HRESI) 336.1611 (M+Na C16H27NO3NaS 
requires 336.1609), 354.1 (100%) and (LRESI) 336.1 (50%). 
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5-Butyl-2-(4-(methylthio)-2-oxobutyl)-2,3-dihydro-1H-pyrrole-1-carboxylic-
diethylcarbamothioic-thioanhydride (378). 
Me
S
O
N
Bu Me
S
O
N
O
S
S
Et2N
Bu
Me
S
O
N
Bu
O
Cl
 
     368          377          378 
To a solution of triphosgene (50 mg, 0.17 mmol) in toluene (6 mL) was added pyridine (0.062 
mL,  0.77 mmol) dropwise at room temperature and stirred for 10 min, followed by the addition 
of a solution of imine (368) (123 mg, 0.51 mmol) in toluene (2 mL). The resultant mixture was 
stirred at room temperature for 16 h and quenched with water (2 mL). The aqueous phase was 
extracted with Et2O (3 x 10 mL) ), and the combined organic extracts were washed with water 
(10 mL), brine (10 mL), dried over MgSO4 and concentrated under reduced pressure to afford the 
crude carbamoyl chloride (377) as a brown oil (208 mg) which was used in the next step without 
further purification. To a solution of carbamoyl chloride (377) (208 mg, 0.68 mmol) in acetone (7 
mL) was added sodium diethyldithiocarbamate trihydrate (610 mg, 2.71 mmol). The resultant 
mixture was refluxed for 4 h, cooled to room temperature and quenched with water (5 mL). The 
aqueous phase was extracted with Et2O (3 x 10 mL) and the combined organic extracts were 
washed with water (10 mL), brine (10 mL), dried over MgSO4 and concentrated under reduced 
pressure and purified by column chromatography to afford the title compound (378) as a bright 
yellow oil (94 mg, 44% over two steps). Rf  0.35 (1:1 hexane:Et2O); νmax(neat)/cm
-1 2930, 1675, 
1679, 1681, 1489, 1422; δH(300 MHz; CDCl3) 0.90 (3 H, t, J 7.3), 1.20-1.57 (10 H, m), 1.97-2.11 
(2 H, m), 2.10 (3 H, s, SCH3), 2.40-3.15 (8 H, m), 3.70-4.11 (4 H, m), 4.51-4.68 (1 H, m), 4.97-
4.98 (1 H, m); δC(75 MHz; CDCl3) mixture or rotamers 11.1 (CH3), 11.2 (CH3), 13.4 (CH3), 13.5 
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(CH3), 13.81 (CH3), 13.88 (CH3), 15.7 (CH3), 22.2 (CH2), 22.8 (CH2), 26.2 (CH2), 27.5 (CH2), 
27.9 (CH2), 29.0 (CH2), 29.7 (CH2), 30.9 (CH2), 34.2 (CH2), 42.8 (CH2), 42.9 (CH2), 46.9 (CH2), 
47.7 (CH2), 48.9 (CH2), 50.1 (CH2), 50.3 (CH2), 57.7 (CH), 109.5 (CH), 137.1 (C), 144.9 (C), 
184.6 (C), 206.7 (C); m/z (HRESI) 439.1530 (M+Na C19H32N2O2NaS3 requires 439.1524), and 
(LRESI) 439.1 (100%). 
 
(E)-Oct-3-ene-2,7-dione (371). 
O
O
O
 
    370           371 
Prepared according to the literature procedure.231 
To a solution of sodium nitrite (690 mg, 0.01 mmol) and 3-butene-2-one (370) (3.5 g, 46.1 
mmol) in DMSO (10 mL) was added acetic acid (600 mg, 0.01 mmol) dropwise at room 
temperature and the resultant mixture was stirred at this temperature for 16 h. The reaction 
mixture was acidified with aqueous HCl (0.1 M, 10 mL) and extracted with ethyl acetate (3 x 20 
mL). The combined organic extracts were washed with water (20 mL), brine (20 mL), dried over 
MgSO4, concentrated under reduced pressure and purified by column chromatography to afford 
enone (371) (2.02 g, 80%) as a brown oil whose analytical data were in agreement with those 
reported in the literature.231 
 Rf  0.4 Et2O); νmax(neat)/cm
-1 2921, 1718, 1672, 1628, 1556, 1424; δH(300 MHz; CDCl3) 2.17 (3 
H, s, COCH3), 2.23 (3 H, s, COCH3), 2.45-2.65 (4 H, m), 6.03-6.09 (1 H, m), 6.73-6.83 (1 H, m); 
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δC(75 MHz; CDCl3) 25.9 (CH2), 26.7 (CH3), 30.0 (CH3), 131.4 (CH), 146.2 (CH), 198.3 (C), 
206.6 (C); m/z (LREI) 140.1 (20%) and 97.0 (100%) 
1-(5-Methyl-3,4-dihydro-2H-pyrrole-2-yl)-propan-2-one (372). 
 
       371         372 
To a solution of of enone (371) (100 mg, 0.71 mmol) in MeOH (7  mL) was added a solution of 
aqueous ammonia (35%, 2 mL) at room temperature and the resultant mixture was stirred at this 
temperature for 16 h and diluted with water (10 mL).  MeOH was removed under pressure and 
the aqueous phase was extracted with DCM (3 x 10 mL). The combined organic phases were 
washed with water (10 mL), brine (10 mL), dried over MgSO4 and concentrated under reduced 
pressure to afford the title compound (372) (120 mg, 100%) which was carried forward to the 
next step without further purification. Rf 0.5 (Et2O); νmax(neat)/cm
-1 2955, 1712 (CO), 1650, 
1431; δH(300 MHz; CDCl3) 2.02 (3 H, s, NCCH3), 2.15-2.17 (1H, m), 2.19 (3H, s, COCH3), 
2.44-2.54 (4 H, m), 2.87-2.95 (1 H, m), 4.29-4.35 (1 H, m); δC(75 MHz; CDCl3) 19.7 (CH3), 29.4 
(CH2), 30.5 (CH3), 39.0 (CH2), 50.4 (CH2), 68.4 (CH), 175.0 (C), 207.5 (C); m/z (HRESI) 
139.0452 (M+ requires C8H13NO 139.0455), (LRESI) 82 (100%), 96 (95%) and 139 (15%). 
 
 
 
 
O
O
N
O
166 
 
Diethylcarbamothioic-5-methyl-2-(2-oxopropyl)-2,3-dihydro-1H-pyrrole-1-carboxylic 
thioanhydride (375). 
N
O
Cl
O
N
O
S
O
S
Et2N
N
O
 
  372      374      375 
To a solution of triphosgene (70 mg, 0.24 mmol) in toluene (6 mL) was added pyridine (0.11 mL, 
1.08 mmol) at room temperature and the mixture was stirred at this temperature for 10 min. To 
this reaction mixture was added a solution of imine (372) (100 mg, 0.72 mmol) in toluene (4 mL) 
and the resultant mixture was stirred at room temperature for 16 h. The reaction mixture was 
quenched with water (10 mL) and the aqueous phase was extracted with Et2O (3 x 15 mL) and 
the combined organic phases were washed with water (10 mL), brine (10 mL), dried over MgSO4 
and concentrated under reduced pressure to afford the carbamoyl chloride (374) (138 mg) which 
was used directly in the next step without further purification. To a solution of carbamoyl 
chloride (374) (138 mg, 0.68 mmol) in acetone (7 mL) was added sodium diethyldithiocarbamate 
trihydrate (310 mg, 1.37 mmol) and the resultant mixture was refluxed for 2 h. The reaction 
mixture was allowed to cool to room temperature and quenched with saturated NaHCO3 (10 mL) 
and the aqueous phase was extracted with Et2O (3 x 15 mL). The combined organic phases were 
washed with water (10 mL), brine (10 mL), dried over MgSO4 and concentrated under reduced 
pressure to afford the title compound (375) (110 mg, 50% over two steps) as a bright yellow oil. 
Rf  0.25 (1:1 hexane: Et2O); νmax(neat)/cm
-1 2980, 2253, 1712, 1678, 1651, 1492, 1456; δH(300 
MHz; CDCl3) 1.26-1.35 (6 H, m), 2.16 (3 H, s, NCCH3), 2.17 (3 H, s, COCH3), 2.55-3.19 (3 H, 
m), 3.68-4.17 (5 H, m), 4.57-4.63 (1 H, m), 4.91-4.92 (1 H, m); δC(75 MHz; CDCl3) 11.0 (CH3), 
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13.3 (CH3), 15.9 (CH3), 30.4 (CH3), 34.1 (CH2), 48.2 (CH2), 48.8 (CH2), 50.0 (CH2), 57.2 (CH), 
110.2 (CH), 139.8 (C), 157.5 (C), 184.0 (C),  206.1 (C); m/z (HRESI) 337.1027 (M+Na. 
C14H22N2O2S2Na requires 337.1020) and (LRESI) 337.2 (100%).  
 
Ethyl-5-methyl-2-(2-oxopropyl)-2,3-dihydro-1H-pyrrole-1-carboxylate (373). 
N
O
N
O
O
OEt  
        372         373 
To a solution of imine (372) (120 mg, 0.86 mmol) in CH2Cl2 (10 mL) was added at -78 °C, ethyl 
chloroformate (136 mg, 1.29 mmol) and Et3N (0.72 mL, 5.16 mmol) over 1 min and the resultant 
mixture as slowly warmed to room temperature and stirred at this temperature for 16 h. The 
reaction mixture was quenched with water (10 mL) and the aqueous phase was extracted with 
CH2Cl2 (3 x 15 mL). The combined organic extracts were washed with water (10 mL), brine (10 
mL), dried over MgSO4 and concentrated under vacuo and purified by column chromatography 
(1:1 hexane: ether) to afford the title compound (373) (50 mg, 28%) as a colourless oil. Rf  0.35 
(1:1 hexane: Et2O); νmax(neat)/cm
-1 2983, 2253, 1713 (CO), 1510, 1446; δH(300 MHz; CDCl3) 
1.25 (3 H, t, J 7.1), 2.06 (3 H, s, NCCH3), 2.14 (3 H, s, COCH3), 2.59-2.96 (4 H, m), 4.09-4.16 (2 
H, q, J 7.1), 4.54-4.67 (2 H, m); δC(75 MHz; CDCl3) 14.5 (CH3), 30.5 (CH3), 33.8 (CH2), 47.4 
(CH3), 48.4 (CH2), 55.7 (CH2), 61.0 (CH), 106.2 (CH), 139.0 (C), 207.0 (C), 208.2 (C); m/z 
(HREI) 211.1216 (M+. C11H17NO3 requires 211.1208), (LREI) 43 (100%), 116 (55%) and 172 
(45%).   
 
168 
 
1-Hydroxyoctan-4-one (391). 
O
O
HO
Bu
O  
      390           391 
Prepared according to the literature procedure.214 
To a solution of γ-butyralactone (390) (1 g, 11.6 mmol) in Et2O (24 mL) was added n-BuLi (2.6 
M in toluene, 5 mL, 12.5 mmol) over 10 min at -78 °C. The resultant mixture was stirred at this 
temperature for 2 h and slowly warmed to room temperature overnight. The reaction mixture was 
quenched with saturated NH4Cl (10 mL). The aqueous phase was extracted with Et2O (3 x 15 
mL) and the the combined organic extracts were washed with brine (10 mL), dried over MgSO4 
and concentrated under vacuo and purified by column chromatography (1:1 pet-ether: EtOAc) to 
afford the title compound 391 (1.05 g, 63%) as a colourless oil whose analytical data were in 
agreement with those reported in literature.214  
νmax(neat)/cm
-1 3390, 2856, 2874, 1711, 1467; δH(300 MHz; CDCl3) 0.90 (3 H, t, J 7.3), 1.25-
1.27 (2 H, m), 1.51-1.67 (2 H, m), 1.82-1.86 (2 H, m), 2.44 (2 H, t, J 7.3), 2.56 (2 H, t, J 6.1), 
3.64-6.66 (2 H, m); δC(75 MHz; CDCl3) 13.8 (CH3), 22.3 (CH2), 25.9 (CH2), 26.5 (CH2), 39.4 
(CH2), 42.6 (CH2), 62.1 (CH2), 212.0 (C).   
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4-Oxooctanal (383). 
HO
Bu
O
O
Bu
O  
      391           383 
Prepared by modification of the literature procedure.216 
DMSO (0.21 mL, 2.98 mmol) was added dropwise to oxalyl chloride (0.12 mL, 1.39 mmol) in 
CH2Cl2 (6 mL) at -78 °C and stirred for 10 min. Keto-alcohol (391) (100 mg, 0.69 mmol) was 
then added and stirred for 30 min followed by the addition of Et3N (0.96 mL, 6.9 mmol). The 
reaction mixture was slowly warmed to room temperature and stirred for 1.5 h and quenched with 
water (10 mL). The aqueous phase was extracted with CH2Cl2 (3 x 15 mL) and the combined 
organic extracts were washed with brine (10 mL), dried over MgSO4 and concentrated under 
vacuo and purified by column chromatography (4:1 hexane: EtOAc) to afford the title compound 
(383) (38 mg, 38%) as a colourless oil whose analytical data were in agreement with those 
reported in the literature.214 
Rf 0.35 (4:1 hexane: EtOAc); νmax(neat)/cm
-1 2959, 2873, 1712, 1466, 1411; δH(300 MHz; 
CDCl3) 0.90 (3 H, t, J 7.3), 1.20-1.35 (2 H, m), 1.52-1.60 (2 H, m), 2.47 (2 H, t, J 7.3), 2.73-2.75 
(4 H, m), 9.81 (1 H, s); δC(75 MHz; CDCl3) 13.7 (CH3), 22.1 (CH2), 25.8 (CH2), 34.5 (CH2), 37.3 
(CH2), 42.3 (CH2), 200.4 (COH), 208.7 (C); m/z (LREI) and 140.1 (10%), 85 (40), and 57.1 
(100). 
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4-Tosylbutan-2-one (386). 
O O
S
O2  
    385            386 
Prepared according to the literature procedure.238 
To methyl vinyl ketone (385) (10 g, 142.86 mmol) was added a solution of sodium p-
toluenesulfinate dihydrate (38.18 g, 214.29 mmol) in ethanol (95%, 150 mL) and glacial acetic 
acid (12.66 mL, 221.4 mmol) at room temperature. The solution was stirred at this temperature 
for 16 h then extracted with CH2Cl2 (3 x 100 mL). The combined organic extracts were washed 
with saturated NaHCO3 (100 mL), dried over MgSO4 and concentrated under vacuo to give a 
viscous yellow residue which afforded crystalline sulfone (386) (27.22 g, 84%) after triturating 
with hexane. Analytical data were in agreement with those reported in literature. 238 
Mp 74-76 °C; δH(300 MHz; CDCl3) 2.18 (3 H, s, ArCH3), 2.46 (3 H, s, COCH3), 2.90-2.95 (2 H, 
m), 3.33-3.38 (2 H, m), 7.36-7.40 (2 H, d, J 3.8), 7.77-7.82 (2 H, d, J 8.4); δC(75 MHz; CDCl3) 
21.6 (CH3), 29.8 (CH3), 35.9 (CH2), 50.5 (CH2), 127.9 (CH), 129.9 (CH), 135.9 (C), 144.9 (C), 
203.7 (C).  
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1-Bromo-4-(4-methylphenyl)-sulfonyl-2-butanone (387). 
 
      386        387 
Prepared according to the literature procedure.238 
To a solution of ketone (386) (10 g, 44.25 mmol) in glacial acetic acid (92 mL), was added 
pyridinium bromide perbromide (14.38 g, 44.25 mmol) and the resultant mixture was heated at 
70 °C for 16 h. Acetic acid was removed under vacuo and the residue was purified by column 
chromatography (1:1 pet-ether: ether) to afford the bromoketone (387) (5.55 g, 42%) whose 
analytical data were in agreement with those reported in literature. 238 
Mp. 107-109°C; δH(300 MHz; CDCl3) 2.45 (3 H, s, ArCH3), 3.14 (2 H, t, J 7.2), 3.40 (2 H, t, J 
7.2), 3.91 (2 H, s, BrCH2), 7.36-7.39 (2 H, d, J 8.0), 7.76-7.79 (2 H, d, J 8.3); δC(75 MHz; 
CDCl3) 21.6 (CH3), 32.6 (CH2), 33.6 (CH2), 50.7 (CH2), 127.9 (CH), 130.0 (CH), 135.6 (C), 
145.1 (C), 198.0 (C); m/z (LRESI) 329.3 (100%) 
 
4-(4-Methylphenyl)-sulfonyl)-2-oxobutyl-(triphenylphosphonium bromide) (389). 
O
S
O2
BrPh3P
O
S
O2
Br
 
      387       389 
Prepared according to the literature procedure.238 
O
S
O2
Br
O
S
O2
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A solution of bromoketone (387) (2.5 g, 8.20 mmol) and triphenylphosphine (2.15 g, 8.20mmol) 
in toluene (10 mL) was stirred at 40 °C for 6 h. The precipitated phosphonium salt (389) (4.02 g, 
87%) salt was collected by filtration as a white solid whose analytical data were in agreement 
with those reported in literature. 238  
Mp 131-133 °C; νmax(neat disc)/cm
-1 2788, 1070, 1596, 1438; δH(300 MHz; CDCl3) 2.33 (3 H, s, 
ArCH3), 3.41-3.42 (4 H, m), 5.93-5.97 (2 H, d, J 11.6), 7.55-7.88 (19 H, m, Ar); m/z (LRESI-Br) 
487.5 (100%). 
 
4-(4-Methylphenyl)-sulfonyl)-1-(triphenylphosphoranylidene)-2-butanone (384). 
O
S
O2
BrPh3P
O
S
O2
Ph3P
 
      389        384 
Prepared according to the literature procedure.238 
To a solution of phosphonium salt (389) (3.57 g, 6.30 mmol) in methanol (20 mL) at 0 °C was 
added dropwise over 5 min an aqueous solution of sodium hydroxide (12.5 %) until pH 8-9 was 
reached. Water (100 mL) was added and the precipitated phosphorane (384) (2.89 g, 95%) was 
collected by filtration as a white solid whose analytical data were in agreement with those 
reported in literature.238 
Mp 164-166 °C; νmax(neat disc)/cm
-1 2990, 1711, 1634, 1596; δH(300 MHz; CDCl3) 2.41 (3 H, s, 
ArCH3), 2.70-2.76 (2 H, m), 3.43-3.48 (2 H, m), 7.29 (1 H, s), 7.32-7.79 (19 H, m, Ar); δC(75 
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MHz; CDCl3) 21.4 (CH3), 33.6 (CH2), 53.6 (CH2), 127.0 (C), 128.0 (CH), 128.7 (CH), 129.5 
(CH), 132.0 (CH), 132.7 (CH), 136.3 (C), 144.1 (C), 187.1 (C); m/z (LRESI) 509.4 (100%).  
 
(E)-1-Tosyldodec-4-ene-3,8-dienone (392). 
O
S
O2
Ph3P
O2
S
O
O
Bu
 
   384       392 
To a a solution of keto-aldehyde (383) (175 mg, 1.23 mmol) in toluene (4 mL) was added 
phosphonium ylid (384) (720 mg, 1.48 mmol) in toluene (6 mL) at room temperature. Tthe 
reaction mixture was slowly warmed to 70 °C over 10 min and stirred at this temperature for 4 d. 
The reaction mixture was diluted with water (5 mL) and the aqueous phase was extracted with 
EtOAc (3 x 15 mL). The combined organic extracts were washed with brine, dried over MgSO4, 
concentrated under vacuo and purified by column chromatography (1:1 pet-ether: ether) to afford 
the title compound (392) (198 mg, 67%) as a colourless oil. Rf 0.35 (1:1 pet-ether: ether); 
νmax(neat)/cm
-1 2960, 1698, 1667, 1418; δH(300 MHz; CDCl3); 091 (3 H, t, J 7.3), 1.18-1.37 (3 
H, m), 1.51-1.61 (3 H, m), 2.46 (3 H, s, CH3Tol), 2.39-1.61 (4 H, m), 3.0-3.05 (2 H, m), 3.36-
3.41 (2 H, m), 6.05-6.11 (1 H, m), 6.80-6.89 (1 H, m), 7.35-7.38 (2 H, d, J 8.4), 7.77-7.80 (2 H, 
d, J 8.4); δC(75 MHz; CDCl3) 13.8 (CH3), 21.6 (CH3), 22.3 (CH2), 25.8 (CH2), 26.2 (CH2), 32.5 
(CH2), 40.3 (CH2), 42.5 (CH2), 50.7 (CH2), 127.9 (CH), 129.8 (CH), 129.9 (CH), 136.0 (C), 
144.9 (C), 147.2 (CH), 195.1 (C), 208.9 (C); m/z (HRESI) 373.1453 (M+. C19H26O4NaS requires 
373.1450) and (LRESI) 373.1 (100%). 
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3-(Propylamino)-propanenitrile (398). 
CN
H
N
CN  
                398 
Prepared according to the literature procedure.246  
A mixture of acrylonitrile (12.41 mL, 188.5 mmol) and propylamine (16.55 mL, 207.3 mmol) 
was stirred at room temperature for 4 d and concentrated under reduced pressure. The reaction 
mixture was purified by reduced pressure distillation (2.0 mmHg, 40-42 °C) to obtain compound 
(398) (17 g, 82%) whose analytical data were in agreement with those reported in the 
literature.246  
νmax(neat)/cm
-1 2963, 2254, 1462, 1423, 1301, 1127; δH(300 MHz; CDCl3) 0.92 (3 H, t, J 7.4, 
CH3), 1.44-1.54 (2 H, m), 2.51 (2 H, t, J 6.6), 2.59 (2 H, t, J 7.1), 2.92 (2 H, t, J 6.6); δC(75 MHz; 
CDCl3) 11.4 (CH3), 18.5 (CH2), 22.9 (CH2), 44.8 (CH2), 50.8 (CH2), 118.6 (C); m/z (LREI) 112 
(5), 83 (100), 72 (40), 54 (25) and 42 (55%). 
 
2-Cyanoethyl(propyl)carbamic chloride (399). 
H
N
CN
N
CN
O Cl
 
    398        399 
To a solution of triphosgene (0.88 g, 2.98 mmol) in dry toluene (30 mL), was added pyridine (1.1 
mL) dropwise and the resulting mixture was stirred at room temperature for 10 min. A solution of 
amine (398) (1.0 g, 8.93 mmol) in dry toluene (20 mL) was then added to the reaction mixture 
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and stirred for 1 h at room temperature. The reaction was quenched with water (10 mL) and the 
aqueous layer was extracted with diethyl ether (3 x 20 mL). The combined organic layers were 
washed with brine (50 mL), dried over magnesium sulfate and concentrated under reduced 
pressure to afford the title compound (399) (1.24 g, 80%) as an orange oil. Rf 0.5 (Et2O); 
νmax(neat)/cm
-1 2969, 1726 (CO), 1463, 1404, 1376, 1212; δH(300 MHz; CDCl3) 0.91 (3 H, t, J 
7.4), 1.58-1.69 (2 H, m), 2.66-2.72 (2 H, m), 3.35-3.49 (2 H, dt, J 7.7 & 15.5), 3.56-3.73 (2 H, dt, 
J 6.9 & 13.8; δC(75 MHz; CDCl3) mixture of rotamers 10.6 (CH3), 15.8 (CH2), 17.1 (CH2), 20.4 
(CH2), 21.4 (CH2), 45.5 (CH2), 46.3 (CH2), 51.9 (CH2), 53.6 (CH2), 117.2 (C), 149.4 (C); m/z 
(HREI) 174.0552 (M+. C7H11N2OCl requires 174.0560), (LREI) 43 (60%), 97 (50), 117 (35), 134 
(55), 145 (100) and 174 (10).  
 
2-Cyanoethyl-(propyl)-carbamodiethyldithiocarbamate (400). 
N
CN
O Cl
N
CN
O S
S NEt2
 
    399          400 
A solution of carbamoyl chloride (399) (1.01 g, 5.81 mmol) in acetone (60 mL) was treated with 
sodium diethyldithiocarbamate trihydrate (5.22 g, 23.24 mmol). The reaction mixture was stirred 
overnight at room temperature and quenched with a saturated aqueous solution of sodium 
hydrogen carbonate (20 mL). The aqueous layer was extracted with diethyl ether (3 x 50 mL) and 
the combined organic layers were washed with water (50 mL) and brine (50 mL). The organic 
phase was dried over magnesium sulfate and concentrated under reduced pressure and purified by 
column chromatography (diethyl ether) to afford the title compound (400) as a yellow oil (1.53 g, 
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91%). Rf 0.30 (Et2O); νmax(neat)/cm
-1 2970, 1667 (CO), 1493, 1460, 1422, 1330; δH(300 MHz; 
CDCl3) 0.95 (3 H, t, J 7.3), 1.28-1.35 (6 H, m), 1.62-1.72 (2 H, m), 2.76 (2 H, t, J 6.9), 3.41 (2 H, 
t, J 7.6), 3.63-3.80 (4 H, m ), 3.97-4.02 (2 H, q, J 7.1); δC(75 MHz; CDCl3) 11.0 (CH3), 13.2 
(CH3), 15.9 (CH2), 22.0 (CH2), 44.3 (CH2), 48.8 (CH2), 49.8 (CH2), 52.2 (CH2), 117.7 (C), 162.3 
(C), 184.2 (C); m/z (HRESI) 310.1131 (M+. C12H21N3ONaS2 requires 310.1126) and (LRESI) 
310.1 (100%). 
 
Methyl-3-(propylamino)-propanoate (403). 
O
OMe
H
N
O
OMe
 
        403 
To methyl acrylate (5.23 mL, 58.14 mmol) was added dropwise propylamine (5.25 mL, 63.95 
mmol) at 0 °C. The resulting mixture was stirred at this temperature for 10 min and warmed to 
room temperature and stirred at this temperature for 2 d. The reaction mixture was concentrated 
under reduced pressure and purified by reduced pressure distillation (kugelrohr) (2.0 mmHg, 39-
42 °C) to obtain compound (403) (4.54 g, 54%) as a colourless oil whose analytical data were in 
agreement with those reported in the literature.246 
νmax(neat)/cm
-1  2969, 2255, 1726 (CO), 1463, 1404, 1212, 1114; δH(300 MHz; CDCl3) 0.90 (3 
H, t, J 7.4), 1.23 (1 H, s, NH), 1.44-1.52 (2 H, m), 2.51 (2 H, t, J 6.6), 2.57 (2 H, t, J 7.4), 2.86 (2 
H, t, J 6.6), 3.67 (3 H, s, OCH3); δC(75 MHz; CDCl3) 11.2 (CH3), 22.7 (CH2), 34.1 (CH2), 44.6 
(CH2), 51.0 (CH2), 51.2 (CH3), 172.7 (C); m/z (LREI) 145 (5), 116 (95), 84 (100), 72 (75) and  42 
(90%). 
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Methyl-3-(chlorocarbonyl-(propyl)-amino)-propanoate (404). 
 
H
N
O
OMe N
O
OMe
O Cl
 
  403      404 
To a solution of triphosgene (0.68 g, 2.30 mmol) in dry toluene (40 mL), was added pyridine 
(1.02 mL) dropwise and the resulting mixture was stirred at room temperature for 10 min. A 
solution of amine (403) (1.0 g, 6.90 mmol) in dry toluene (30 mL) was then added to the reaction 
mixture and stirred for 1 h at room temperature. The reaction was quenched with water (20 mL) 
and the aqueous layer was extracted with diethyl ether (3 x 30 mL). The combined organic layers 
were washed with brine (50 mL), dried over magnesium sulfate and concentrated under reduced 
pressure to afford the title compound (404) (1.46 g, 100%) as an orange oil. Rf  0.5 (1:1 hexane: 
Et2O);νmax(neat)/cm
-1 2968, 1732 (CO), 1462, 1439, 1405, 1383, 1204, 1112; δH(300 MHz; 
CDCl3) 0.89 (3 H, t, J 7.3), 1.57-1.63 (2 H, m), 2.60-2.67 (2 H, q, J 6.3), 3.27-3.60 (4 H, m), 3.64 
(3 H, s, OCH3); δC(75 MHz; CDCl3) mixture of rotamers 10.8 (CH3), 20.6 (CH2), 21.6 (CH2), 
31.9 (CH2), 33.1 (CH2), 45.6 (CH2), 46.5 (CH2), 51.7 (CH2), 53.4 (CH2), 149.1 (C), 171.44 (C); 
m/z (HRESI) 230.0563 (M+. C8H14NO3NaCl requires 230.0560) and (LRESI) 230 (100%).  
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Methyl-3-((diethylcarbamothioylthio)-carbonyl-(propyl)-amino)-propanoate (405). 
N
O
OMe
O Cl
N
O
OMe
O S
S NEt2
 
         404             405 
A solution of carbamoyl chloride (404) (1.35 g, 6.51 mmol) in acetone (60 mL) was treated with 
sodium diethyldithiocarbamate trihydrate (5.81 g, 26.04 mmol). The reaction mixture was stirred 
overnight at room temperature and quenched with saturated aqueous solution of sodium hydrogen 
carbonate (20 mL). The aqueous layer was extracted with diethyl ether (3 x 50 mL) and the 
combined organic layers were washed with water (50 mL) and brine (50 mL). The organic phase 
was dried over magnesium sulfate and concentrated under reduced pressure and purified by 
column chromatography (1:1 hexane: diethyl ether) to afford the title compound (405) as a 
yellow oil (0.86 g, 42%); Rf  0.2 (1:1 hexane: Et2O); νmax(neat)/cm
-1 2874, 1738 (CO), 1668 
(NCOS), 1491, 1421, 1380, 1356; δH(300 MHz; CDCl3)  0.91 (3 H, t, J 7.3 ), 1.30 (6 H, t, J 7.2, 2 
x NCH2CH3 ), 1.60-1.67 (2 H, m), 2.70 (2 H, t, J 6.7), 3.32 (2 H, t, J 7.0), 3.62-3.80 (4 H, m), 
3.68 (3 H, s, OCH3), 3.97-4.04 (2 H, q, J 7.0); δC(75 MHz; CDCl3) 10.8 (CH3), 13.0 (CH3), 21.7 
(CH2), 31.8 (CH2), 43.8 (CH2), 48.5 (CH2), 49.7 (CH2), 51.4 (CH3), 51.6 (CH2), 161.5 (C), 171.7 
(C), 184.5 (C); m/z (HRESI) 343.1131 ([M+Na]+. C13H24N2O3NaS2 requires 343.1126) and 
(LRESI) 343.1 (100%).  
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X-ray crystal data for 168 
Table 1.  Crystal data and structure refinement for 168 
Identification code  sa301t 
Empirical formula  C15 H28 N2 O2 S2 
Formula weight  332.51 
Temperature  296(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  Pna21 
Unit cell dimensions a = 34.451(9) Å α= 90°. 
 b = 19.752(5) Å β= 90°. 
 c = 7.442(2) Å γ = 90°. 
Volume 5064(2) Å3 
Z 12 
Density (calculated) 1.308 Mg/m3 
Absorption coefficient 2.905 mm-1 
F(000) 2160 
Crystal size 0.10 x 0.08 x 0.06 mm3 
Theta range for data collection 2.57 to 66.41°. 
Index ranges -40<=h<=38, -23<=k<=23, -8<=l<=8 
Reflections collected 33173 
Independent reflections 8354 [R(int) = 0.0900] 
Completeness to theta = 66.41° 99.0 %  
Max. and min. transmission 0.8450 and 0.7599 
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Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 8354 / 581 / 568 
Goodness-of-fit on F2 1.470 
Final R indices [I>2sigma(I)] R1 = 0.1629, wR2 = 0.3892 
R indices (all data) R1 = 0.2263, wR2 = 0.4484 
Absolute structure parameter 0.45(6) 
Largest diff. peak and hole 2.271 and -0.705 e.Å-3 
 
200 
 
Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for sa301t.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
C(1) 978(2) 8656(4) 9019(15) 61(4) 
C(2) 876(3) 8153(6) 10531(19) 112(9) 
C(3) 1210(4) 7641(4) 10749(19) 158(13) 
C(4) 1453(4) 7787(5) 12434(15) 96(6) 
C(5) 1667(3) 8468(4) 12367(10) 89(6) 
C(6) 1937(2) 8581(8) 10760(12) 96(7) 
C(7) 1714(2) 8733(6) 9024(9) 64(4) 
C(8) 1330(2) 9106(4) 9361(8) 32(3) 
C(9) 1294(3) 9481(4) 11159(7) 42(4) 
C(10) 1383(6) 9383(8) 14656(12) 133(10) 
C(11) 279(2) 8735(3) 7078(9) 122(9) 
C(12) -373(4) 8794(9) 5539(15) 125(8) 
C(13) -660(5) 8283(10) 6330(30) 210(20) 
C(14) -229(5) 9704(5) 8077(17) 142(10) 
C(15) -371(5) 9341(9) 9770(18) 105(7) 
N(1) 1390(3) 9052(4) 12808(8) 76(4) 
N(2) -125(2) 9047(6) 7099(14) 94(5) 
O(1) 1092(2) 9963(4) 11323(12) 49(3) 
S(1) 413(1) 8055(3) 5999(8) 90(2) 
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S(2) 564(1) 9199(2) 8624(6) 44(1) 
C(16) 9308(2) 6334(4) 3458(13) 40(3) 
C(17) 9203(3) 6835(6) 1922(19) 68(4) 
C(18) 9530(4) 7338(5) 1470(20) 84(7) 
C(19) 9756(4) 7156(6) -210(20) 99(7) 
C(20) 10013(3) 6528(5) 17(17) 83(6) 
C(21) 10273(3) 6457(9) 1651(18) 110(9) 
C(22) 10056(3) 6267(7) 3362(17) 85(6) 
C(23) 9667(2) 5901(5) 3088(14) 54(4) 
C(24) 9620(3) 5540(4) 1270(11) 37(4) 
C(25) 9644(5) 5691(9) -2079(15) 118(8) 
C(26) 8609(2) 6271(5) 5370(16) 63(4) 
C(27) 8100(3) 5390(6) 4626(17) 64(4) 
C(28) 7904(5) 5625(10) 2910(20) 125(9) 
C(29) 8003(4) 6116(7) 7554(18) 137(11) 
C(30) 7748(6) 6630(9) 6560(30) 141(11) 
N(3) 9785(3) 5885(5) -256(13) 72(4) 
N(4) 8231(3) 5961(6) 5791(18) 91(5) 
O(2) 9435(2) 5032(4) 1115(12) 43(2) 
S(3) 8745(1) 6964(3) 6331(9) 99(2) 
S(4) 8886(1) 5794(2) 3861(8) 66(1) 
C(31) 2351(2) 1342(4) 8727(12) 32(2) 
C(32) 2445(3) 1883(5) 7292(17) 53(4) 
C(33) 2105(3) 2350(5) 6831(18) 57(4) 
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C(34) 1879(4) 2145(6) 5162(18) 90(6) 
C(35) 1635(3) 1502(5) 5348(15) 69(5) 
C(36) 1385(3) 1406(8) 6998(16) 84(5) 
C(37) 1610(3) 1212(6) 8692(15) 58(4) 
C(38) 2002(2) 887(5) 8331(12) 42(3) 
C(39) 2055(3) 536(5) 6521(11) 36(3) 
C(40) 2020(4) 718(9) 3187(13) 90(6) 
C(41) 3061(2) 1283(5) 10533(15) 55(4) 
C(42) 3569(3) 413(6) 9642(15) 60(4) 
C(43) 3746(5) 643(9) 7870(20) 112(8) 
C(44) 3688(5) 1125(8) 12566(19) 151(12) 
C(45) 3926(6) 1657(9) 11520(30) 174(15) 
N(5) 1877(3) 880(4) 5025(10) 42(3) 
N(6) 3444(3) 979(7) 10838(19) 98(6) 
O(3) 2241(2) 32(4) 6322(12) 44(2) 
S(5) 2920(1) 1955(3) 11611(8) 82(2) 
S(6) 2782(1) 815(2) 9006(7) 61(1) 
O(1A) 495(9) 9175(12) 13650(80) 370(20) 
O(2A) 8895(3) 5827(6) -1501(18) 85(4) 
O(3A) 2770(3) 787(5) 3703(15) 71(3) 
________________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for sa301t. 
_____________________________________________________ 
C(1)-C(8)  1.525(8) 
C(1)-C(2)  1.541(2) 
C(1)-S(2)  1.808(4) 
C(2)-C(3)  1.539(2) 
C(3)-C(4)  1.536(2) 
C(4)-C(5)  1.535(2) 
C(5)-C(6)  1.532(2) 
C(5)-N(1)  1.533(2) 
C(6)-C(7)  1.534(2) 
C(7)-C(8)  1.533(2) 
C(8)-C(9)  1.534(2) 
C(9)-O(1)  1.186(8) 
C(9)-N(1)  1.527(2) 
C(10)-N(1)  1.524(2) 
C(11)-N(2)  1.523(2) 
C(11)-S(1)  1.632(4) 
C(11)-S(2)  1.768(4) 
C(12)-N(2)  1.526(2) 
C(12)-C(13)  1.530(2) 
C(14)-N(2)  1.530(2) 
C(14)-C(15)  1.530(2) 
C(16)-C(23)  1.528(9) 
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C(16)-C(17)  1.554(9) 
C(16)-S(4)  1.829(7) 
C(17)-C(18)  1.539(9) 
C(18)-C(19)  1.517(10) 
C(19)-C(20)  1.534(9) 
C(20)-N(3)  1.508(9) 
C(20)-C(21)  1.516(9) 
C(21)-C(22)  1.524(9) 
C(22)-C(23)  1.535(8) 
C(23)-C(24)  1.538(8) 
C(24)-O(2)  1.194(9) 
C(24)-N(3)  1.440(8) 
C(25)-N(3)  1.491(9) 
C(26)-N(4)  1.474(8) 
C(26)-S(3)  1.614(8) 
C(26)-S(4)  1.749(8) 
C(27)-N(4)  1.492(8) 
C(27)-C(28)  1.520(10) 
C(29)-C(30)  1.537(10) 
C(29)-N(4)  1.559(10) 
C(31)-C(38)  1.529(9) 
C(31)-C(32)  1.546(8) 
C(31)-S(6)  1.825(7) 
C(32)-C(33)  1.531(9) 
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C(33)-C(34)  1.520(9) 
C(34)-C(35)  1.530(9) 
C(35)-N(5)  1.504(9) 
C(35)-C(36)  1.512(9) 
C(36)-C(37)  1.529(9) 
C(37)-C(38)  1.519(8) 
C(38)-C(39)  1.526(8) 
C(39)-O(3)  1.194(8) 
C(39)-N(5)  1.442(8) 
C(40)-N(5)  1.489(9) 
C(41)-N(6)  1.469(8) 
C(41)-S(5)  1.626(8) 
C(41)-S(6)  1.752(8) 
C(42)-N(6)  1.491(8) 
C(42)-C(43)  1.521(10) 
C(44)-C(45)  1.542(10) 
C(44)-N(6)  1.562(10) 
 
C(8)-C(1)-C(2) 115.8(7) 
C(8)-C(1)-S(2) 108.0(5) 
C(2)-C(1)-S(2) 108.7(5) 
C(3)-C(2)-C(1) 109.3(5) 
C(4)-C(3)-C(2) 111.7(6) 
C(5)-C(4)-C(3) 113.6(5) 
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C(6)-C(5)-N(1) 115.8(6) 
C(6)-C(5)-C(4) 116.5(6) 
N(1)-C(5)-C(4) 110.6(7) 
C(5)-C(6)-C(7) 112.4(4) 
C(8)-C(7)-C(6) 112.9(4) 
C(1)-C(8)-C(7) 112.2(5) 
C(1)-C(8)-C(9) 111.3(7) 
C(7)-C(8)-C(9) 116.3(5) 
O(1)-C(9)-N(1) 119.3(6) 
O(1)-C(9)-C(8) 121.6(6) 
N(1)-C(9)-C(8) 114.6(6) 
N(2)-C(11)-S(1) 126.6(5) 
N(2)-C(11)-S(2) 106.9(4) 
S(1)-C(11)-S(2) 126.2(4) 
N(2)-C(12)-C(13) 106.6(2) 
N(2)-C(14)-C(15) 94.0(8) 
C(10)-N(1)-C(9) 118.9(8) 
C(10)-N(1)-C(5) 121.8(9) 
C(9)-N(1)-C(5) 112.3(5) 
C(11)-N(2)-C(12) 111.9(8) 
C(11)-N(2)-C(14) 124.2(8) 
C(12)-N(2)-C(14) 120.5(9) 
C(11)-S(2)-C(1) 103.7(4) 
C(23)-C(16)-C(17) 114.3(7) 
207 
 
C(23)-C(16)-S(4) 110.2(5) 
C(17)-C(16)-S(4) 107.8(6) 
C(18)-C(17)-C(16) 113.7(9) 
C(19)-C(18)-C(17) 113.8(10) 
C(18)-C(19)-C(20) 113.3(9) 
N(3)-C(20)-C(21) 109.8(8) 
N(3)-C(20)-C(19) 111.4(9) 
C(21)-C(20)-C(19) 120.3(10) 
C(20)-C(21)-C(22) 113.8(9) 
C(21)-C(22)-C(23) 115.6(8) 
C(16)-C(23)-C(22) 114.7(8) 
C(16)-C(23)-C(24) 109.4(7) 
C(22)-C(23)-C(24) 115.3(8) 
O(2)-C(24)-N(3) 122.1(8) 
O(2)-C(24)-C(23) 122.1(7) 
N(3)-C(24)-C(23) 115.6(7) 
N(4)-C(26)-S(3) 121.0(6) 
N(4)-C(26)-S(4) 113.3(6) 
S(3)-C(26)-S(4) 125.7(5) 
N(4)-C(27)-C(28) 113.2(11) 
C(30)-C(29)-N(4) 90.6(11) 
C(24)-N(3)-C(25) 117.9(9) 
C(24)-N(3)-C(20) 119.9(8) 
C(25)-N(3)-C(20) 120.6(9) 
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C(26)-N(4)-C(27) 117.2(8) 
C(26)-N(4)-C(29) 122.8(9) 
C(27)-N(4)-C(29) 119.1(9) 
C(26)-S(4)-C(16) 103.0(4) 
C(38)-C(31)-C(32) 116.0(7) 
C(38)-C(31)-S(6) 109.0(5) 
C(32)-C(31)-S(6) 107.6(6) 
C(33)-C(32)-C(31) 114.2(8) 
C(34)-C(33)-C(32) 114.4(9) 
C(33)-C(34)-C(35) 115.4(9) 
N(5)-C(35)-C(36) 110.1(8) 
N(5)-C(35)-C(34) 111.0(9) 
C(36)-C(35)-C(34) 119.4(10) 
C(35)-C(36)-C(37) 114.3(8) 
C(38)-C(37)-C(36) 114.3(8) 
C(37)-C(38)-C(39) 117.0(7) 
C(37)-C(38)-C(31) 114.6(7) 
C(39)-C(38)-C(31) 110.1(7) 
O(3)-C(39)-N(5) 121.7(7) 
O(3)-C(39)-C(38) 123.6(7) 
N(5)-C(39)-C(38) 114.6(7) 
N(6)-C(41)-S(5) 121.7(6) 
N(6)-C(41)-S(6) 112.3(6) 
S(5)-C(41)-S(6) 126.0(5) 
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N(6)-C(42)-C(43) 114.1(11) 
C(45)-C(44)-N(6) 89.8(11) 
C(39)-N(5)-C(40) 117.9(8) 
C(39)-N(5)-C(35) 119.8(7) 
C(40)-N(5)-C(35) 120.4(8) 
C(41)-N(6)-C(42) 118.1(8) 
C(41)-N(6)-C(44) 122.4(9) 
C(42)-N(6)-C(44) 118.4(9) 
C(41)-S(6)-C(31) 102.7(4) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms:  
 
X-ray crystal data for 174 
Table 1.  Crystal data and structure refinement for 174. 
Identification code  sa300 
Empirical formula  C10 H15 N O 
Formula weight  165.23 
Temperature  296(2) K 
Wavelength  1.54178 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 6.2729(13) Å α= 90°. 
 b = 11.291(2) Å β= 90°. 
 c = 12.464(3) Å γ = 90°. 
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Volume 882.8(3) Å3 
Z 4 
Density (calculated) 1.243 Mg/m3 
Absorption coefficient 0.628 mm-1 
F(000) 360 
Crystal size 0.30 x 0.25 x 0.20 mm3 
Theta range for data collection 7.11 to 66.46°. 
Index ranges -7<=h<=7, -11<=k<=13, -13<=l<=14 
Reflections collected 5489 
Independent reflections 1460 [R(int) = 0.0671] 
Completeness to theta = 66.46° 96.5 %  
Absorption correction Empirical 
Max. and min. transmission 0.8847 and 0.8340 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 1460 / 0 / 111 
Goodness-of-fit on F2 0.944 
Final R indices [I>2sigma(I)] R1 = 0.0356, wR2 = 0.0736 
R indices (all data) R1 = 0.0501, wR2 = 0.0793 
Absolute structure parameter 0.3(4) 
Extinction coefficient 0.0109(12) 
Largest diff. peak and hole 0.121 and -0.131 e.Å-3 
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Table 2.  Atomic coordinates ( x 104) and equivalent isotropic displacement parameters (Å2x 103) 
for sa300m.  U(eq) is defined as one third of the trace of the orthogonalized Uij tensor. 
________________________________________________________________________________ 
 x y z U(eq) 
________________________________________________________________________________ 
N(1) -36(2) 5851(1) 1519(1) 40(1) 
O(1) 3405(2) 6439(1) 1379(1) 67(1) 
C(5) -1532(3) 4907(2) 1848(1) 41(1) 
C(1) 2038(3) 5814(2) 1810(1) 43(1) 
C(4) -1282(3) 4583(2) 3035(1) 47(1) 
C(2) 2562(3) 5011(2) 2743(1) 45(1) 
C(3) 735(3) 5047(2) 3549(1) 49(1) 
C(9) -1371(3) 3852(2) 1081(2) 51(1) 
C(7) 2345(3) 3120(2) 1637(2) 57(1) 
C(6) 3088(3) 3756(2) 2445(2) 51(1) 
C(8) 890(4) 3503(2) 756(2) 56(1) 
C(10) -662(3) 6565(2) 602(1) 55(1) 
________________________________________________________________________________
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Table 3.   Bond lengths [Å] and angles [°] for sa300m. 
_____________________________________________________ 
N(1)-C(1)  1.351(2) 
N(1)-C(10)  1.453(2) 
N(1)-C(5)  1.478(2) 
O(1)-C(1)  1.234(2) 
C(5)-C(9)  1.531(3) 
C(5)-C(4)  1.532(3) 
C(1)-C(2)  1.511(3) 
C(4)-C(3)  1.512(3) 
C(2)-C(6)  1.502(3) 
C(2)-C(3)  1.525(2) 
C(9)-C(8)  1.527(3) 
C(7)-C(6)  1.322(3) 
C(7)-C(8)  1.492(3) 
 
C(1)-N(1)-C(10) 119.27(16) 
C(1)-N(1)-C(5) 120.93(15) 
C(10)-N(1)-C(5) 116.57(15) 
N(1)-C(5)-C(9) 110.22(14) 
N(1)-C(5)-C(4) 112.08(15) 
C(9)-C(5)-C(4) 114.21(16) 
O(1)-C(1)-N(1) 122.28(16) 
O(1)-C(1)-C(2) 121.83(17) 
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N(1)-C(1)-C(2) 115.80(16) 
C(3)-C(4)-C(5) 114.30(15) 
C(6)-C(2)-C(1) 115.05(15) 
C(6)-C(2)-C(3) 110.70(16) 
C(1)-C(2)-C(3) 109.09(15) 
C(4)-C(3)-C(2) 109.94(13) 
C(8)-C(9)-C(5) 115.32(16) 
C(6)-C(7)-C(8) 128.2(2) 
C(7)-C(6)-C(2) 128.60(19) 
C(7)-C(8)-C(9) 116.61(16) 
_____________________________________________________________ 
Symmetry transformations used to generate equivalent atoms: 
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Table 4.   Anisotropic displacement parameters (Å2x 103)for sa300m.  The anisotropic 
displacement factor exponent takes the form: -2π2[ h2a*2U11 + ... + 2 h k a* b* U12 ] 
______________________________________________________________________________ 
 U11 U22 U33 U23 U13 U12 
______________________________________________________________________________ 
N(1) 37(1)  42(1) 40(1)  5(1) -1(1)  -2(1) 
O(1) 52(1)  65(1) 83(1)  17(1) 8(1)  -15(1) 
C(5) 31(1)  50(1) 43(1)  0(1) 0(1)  -2(1) 
C(1) 41(1)  40(1) 50(1)  -3(1) 5(1)  -5(1) 
C(4) 39(1)  59(1) 43(1)  4(1) 5(1)  -1(1) 
C(2) 34(1)  49(1) 51(1)  -1(1) -8(1)  -3(1) 
C(3) 51(1)  56(1) 40(1)  0(1) -7(1)  1(1) 
C(9) 53(1)  54(1) 47(1)  -3(1) -3(1)  -12(1) 
C(7) 53(1)  45(1) 72(1)  -1(1) 16(1)  6(1) 
C(6) 36(1)  52(1) 66(1)  10(1) 2(1)  7(1) 
C(8) 66(2)  47(1) 55(1)  -12(1) 11(1)  -2(1) 
C(10) 66(2)  54(1) 45(1)  9(1) -4(1)  0(1) 
______________________________________________________________________________
215 
 
Table 5.   Hydrogen coordinates ( x 104) and isotropic displacement parameters (Å2x 103) 
for sa300m. 
________________________________________________________________________________ 
 x  y  z  U(eq) 
________________________________________________________________________________ 
 
H(5) -2971 5232 1765 49 
H(4A) -2498 4890 3427 56 
H(4B) -1302 3727 3102 56 
H(2) 3820 5342 3100 54 
H(3A) 1091 4568 4169 59 
H(3B) 512 5855 3789 59 
H(9A) -2047 3174 1417 61 
H(9B) -2172 4037 437 61 
H(7) 2785 2333 1615 68 
H(6) 4066 3375 2887 62 
H(8A) 795 2864 238 67 
H(8B) 1539 4173 395 67 
H(10A) 131 7292 603 82 
H(10B) -2158 6738 645 82 
H(10C) -373 6138 -48 82 
________________________________________________________________________________ 
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X-ray data for ferrugine perchlorate salt 
Table 1. Crystal data and structure refinement. 
 
Identification code  2008src0691     
Empirical formula  C15H20ClNO5 
Formula weight  329.77 
Temperature  120(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c  
Unit cell dimensions a = 9.9385(4) Å α = 90° 
 b = 10.4713(3) Å β = 93.959(2)° 
 c = 29.9752(11) Å γ  = 90° 
Volume 3112.05(19) Å3 
Z 8 
Density (calculated) 1.408 Mg / m3 
Absorption coefficient 0.269 mm−1 
F(000) 1392 
Crystal Plate; colourless 
Crystal size 0.10 × 0.04 × 0.02 mm3 
θ range for data collection 2.94 − 27.57° 
Index ranges −12 ≤ h ≤ 12, −12 ≤ k ≤ 13, −38 ≤ l ≤ 38 
Reflections collected 35133 
Independent reflections 7131 [Rint = 0.1569] 
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Completeness to θ = 27.57° 99.0 %  
Absorption correction Semi−empirical from equivalents 
Max. and min. transmission 0.9947 and 0.9736 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 7131 / 0 / 400 
Goodness-of-fit on F2 0.958 
Final R indices [F2 > 2σ(F2)] R1 = 0.0818, wR2 = 0.1800 
R indices (all data) R1 = 0.1934, wR2 = 0.2366 
Extinction coefficient 0.0026(6) 
Largest diff. peak and hole 0.416 and −0.512 e Å−3 
 
Diffractometer: Nonius KappaCCD area detector (φ scans and ω scans to fill asymmetric unit sphere). Cell determination: 
DirAx (Duisenberg, A.J.M.(1992). J. Appl. Cryst. 25, 92-96.) Data collection: Collect (Collect: Data collection software, R. 
Hooft, Nonius B.V., 1998). Data reduction and cell refinement: Denzo (Z. Otwinowski & W. Minor, Methods in Enzymology 
(1997) Vol. 276: Macromolecular Crystallography, part A, pp. 307−326; C. W. Carter, Jr. & R. M. Sweet, Eds., Academic Press). 
Absorption correction: SORTAV (R. H. Blessing, Acta Cryst. A51 (1995) 33−37; R. H. Blessing, J. Appl. Cryst. 30 (1997) 
421−426). Structure solution: SHELXS97 (G. M. Sheldrick, Acta Cryst. (1990) A46 467−473). Structure refinement: 
SHELXL97 (G. M. Sheldrick (1997), University of Göttingen, Germany). Graphics: ORTEP3 for Windows (L. J. Farrugia, J. 
Appl. Crystallogr. 1997, 30, 565). 
 
Special details:  
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Table 2. Atomic coordinates [× 104], equivalent isotropic displacement parameters [Å2 × 103] 
and site occupancy factors. Ueq is defined as one third of the trace of the orthogonalized U
ij 
tensor. 
 
Atom  x y z Ueq S.o.f. 
 
C1 1249(4) 5335(4) 3366(1) 32(1) 1 
C2 149(4) 6176(4) 3149(2) 36(1) 1 
C3 −1126(5) 5322(4) 3104(2) 41(1) 1 
C4 −699(4) 4056(4) 3316(2) 33(1) 1 
C5 −779(5) 4029(4) 3822(2) 39(1) 1 
C6 −40(4) 5149(4) 4054(2) 35(1) 1 
C7 1359(4) 5354(4) 3877(1) 29(1) 1 
C8 1059(5) 3681(4) 2762(1) 41(1) 1 
C9 2005(4) 6599(4) 4038(2) 31(1) 1 
C10 2312(4) 6831(4) 4524(1) 31(1) 1 
C11 2645(4) 5847(4) 4827(2) 37(1) 1 
C12 3002(5) 6128(5) 5270(2) 43(1) 1 
C13 3000(5) 7367(5) 5416(2) 42(1) 1 
C14 2652(5) 8349(4) 5119(2) 41(1) 1 
C15 2315(4) 8087(4) 4677(2) 34(1) 1 
C16 5345(4) 8205(4) 3327(2) 35(1) 1 
C17 6176(5) 9145(4) 3071(2) 45(1) 1 
C18 5325(5) 10368(4) 3016(2) 48(1) 1 
C19 4029(5) 10072(4) 3238(2) 39(1) 1 
C20 4108(5) 10349(4) 3733(2) 39(1) 1 
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C21 5369(5) 9749(4) 3972(2) 36(1) 1 
C22 5516(4) 8348(4) 3835(1) 31(1) 1 
C23 3442(5) 8196(4) 2731(2) 44(1) 1 
C24 6867(5) 7820(4) 4017(2) 38(1) 1 
C25 7189(4) 7849(4) 4504(2) 34(1) 1 
C26 6236(5) 7652(4) 4815(2) 39(1) 1 
C27 6594(5) 7699(4) 5268(2) 42(1) 1 
C28 7902(5) 7970(4) 5422(2) 44(1) 1 
C29 8864(5) 8176(5) 5115(2) 50(1) 1 
C30 8526(5) 8098(5) 4664(2) 46(1) 1 
O1 2270(3) 7422(3) 3770(1) 40(1) 1 
O2 7685(3) 7433(3) 3763(1) 52(1) 1 
O3 5134(4) 10166(3) 1155(1) 68(1) 1 
O4 5409(3) 9977(3) 1929(1) 52(1) 1 
O5 3994(3) 8544(3) 1521(1) 54(1) 1 
O6 6325(3) 8440(3) 1471(1) 54(1) 1 
O7 10447(6) 5126(5) 1219(2) 116(2) 1 
O8 9245(4) 4399(3) 1810(1) 67(1) 1 
O9 10881(3) 5974(3) 1931(1) 55(1) 1 
O10 8857(3) 6436(3) 1516(1) 49(1) 1 
N1 782(3) 4009(3) 3229(1) 34(1) 1 
N2 3915(3) 8640(3) 3185(1) 31(1) 1 
Cl1 5201(1) 9283(1) 1517(1) 37(1) 1 
Cl2 9877(1) 5469(1) 1616(1) 46(1) 1 
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Table 3. Bond lengths [Å] and angles [°]. 
 
C1−N1 1.511(5) 
C1−C2 1.516(6) 
C1−C7 1.527(5) 
C1−H1 1.0000 
C2−C3 1.549(6) 
C2−H2A 0.9900 
C2−H2B 0.9900 
C3−C4 1.517(6) 
C3−H3A 0.9900 
C3−H3B 0.9900 
C4−N1 1.514(5) 
C4−C5 1.525(6) 
C4−H4 1.0000 
C5−C6 1.527(6) 
C5−H5A 0.9900 
C5−H5B 0.9900 
C6−C7 1.538(6) 
C6−H6A 0.9900 
C6−H6B 0.9900 
C7−C9 1.518(6) 
C7−H7 1.0000 
C8−N1 1.485(5) 
C8−H8A 0.9800 
C8−H8B 0.9800 
C8−H8C 0.9800 
C9−O1 1.221(5) 
C9−C10 1.487(6) 
C10−C15 1.392(6) 
C10−C11 1.397(6) 
C11−C12 1.382(6) 
C11−H11 0.9500 
C12−C13 1.369(6) 
C12−H12 0.9500 
C13−C14 1.389(6) 
C13−H13 0.9500 
C14−C15 1.374(6) 
C14−H14 0.9500 
C15−H15 0.9500 
C16−N2 1.525(5) 
C16−C22 1.526(6) 
C16−C17 1.526(6) 
C16−H16 1.0000 
C17−C18 1.538(6) 
C17−H17A 0.9900 
C17−H17B 0.9900 
C18−C19 1.521(6) 
2 
 
C18−H18A 0.9900 
C18−H18B 0.9900 
C19−C20 1.508(6) 
C19−N2 1.512(5) 
C19−H19 1.0000 
C20−C21 1.535(6) 
C20−H20A 0.9900 
C20−H20B 0.9900 
C21−C22 1.533(6) 
C21−H21A 0.9900 
C21−H21B 0.9900 
C22−C24 1.518(6) 
C22−H22 1.0000 
C23−N2 1.484(5) 
C23−H23A 0.9800 
C23−H23B 0.9800 
C23−H23C 0.9800 
C24−O2 1.222(5) 
C24−C25 1.471(6) 
C25−C26 1.391(6) 
C25−C30 1.406(6) 
C26−C27 1.380(6) 
C26−H26 0.9500 
C27−C28 1.379(6) 
C27−H27 0.9500 
C28−C29 1.388(7) 
C28−H28 0.9500 
C29−C30 1.374(7) 
C29−H29 0.9500 
C30−H30 0.9500 
O3−Cl1 1.424(3) 
O4−Cl1 1.436(3) 
O5−Cl1 1.427(3) 
O6−Cl1 1.438(3) 
O7−Cl2 1.399(4) 
O8−Cl2 1.427(4) 
O9−Cl2 1.429(3) 
O10−Cl2 1.450(3) 
N1−H1A 0.9300 
N2−H2 0.9300 
 
N1−C1−C2 102.6(3) 
N1−C1−C7 106.5(3) 
C2−C1−C7 115.0(4) 
N1−C1−H1 110.8 
C2−C1−H1 110.8 
C7−C1−H1 110.8 
C1−C2−C3 105.2(3) 
C1−C2−H2A 110.7 
2 
 
C3−C2−H2A 110.7 
C1−C2−H2B 110.7 
C3−C2−H2B 110.7 
H2A−C2−H2B 108.8 
C4−C3−C2 105.4(3) 
C4−C3−H3A 110.7 
C2−C3−H3A 110.7 
C4−C3−H3B 110.7 
C2−C3−H3B 110.7 
H3A−C3−H3B 108.8 
N1−C4−C3 101.7(3) 
N1−C4−C5 106.8(3) 
C3−C4−C5 113.6(4) 
N1−C4−H4 111.4 
C3−C4−H4 111.4 
C5−C4−H4 111.4 
C4−C5−C6 112.6(4) 
C4−C5−H5A 109.1 
C6−C5−H5A 109.1 
C4−C5−H5B 109.1 
C6−C5−H5B 109.1 
H5A−C5−H5B 107.8 
C7−C6−C5 111.5(3) 
C7−C6−H6A 109.3 
C5−C6−H6A 109.3 
C7−C6−H6B 109.3 
C5−C6−H6B 109.3 
H6A−C6−H6B 108.0 
C9−C7−C1 109.3(3) 
C9−C7−C6 112.4(3) 
C1−C7−C6 110.0(3) 
C9−C7−H7 108.3 
C1−C7−H7 108.3 
C6−C7−H7 108.3 
N1−C8−H8A 109.5 
N1−C8−H8B 109.5 
H8A−C8−H8B 109.5 
N1−C8−H8C 109.5 
H8A−C8−H8C 109.5 
H8B−C8−H8C 109.5 
O1−C9−C10 119.5(4) 
O1−C9−C7 120.1(4) 
C10−C9−C7 120.5(4) 
C15−C10−C11 119.3(4) 
C15−C10−C9 118.1(4) 
C11−C10−C9 122.6(4) 
C12−C11−C10 120.0(4) 
C12−C11−H11 120.0 
C10−C11−H11 120.0 
C13−C12−C11 120.3(5) 
3 
 
C13−C12−H12 119.9 
C11−C12−H12 119.9 
C12−C13−C14 120.1(4) 
C12−C13−H13 119.9 
C14−C13−H13 119.9 
C15−C14−C13 120.3(4) 
C15−C14−H14 119.9 
C13−C14−H14 119.9 
C14−C15−C10 120.0(4) 
C14−C15−H15 120.0 
C10−C15−H15 120.0 
N2−C16−C22 106.7(3) 
N2−C16−C17 101.1(3) 
C22−C16−C17 114.3(4) 
N2−C16−H16 111.4 
C22−C16−H16 111.4 
C17−C16−H16 111.4 
C16−C17−C18 106.2(4) 
C16−C17−H17A 110.5 
C18−C17−H17A 110.5 
C16−C17−H17B 110.5 
C18−C17−H17B 110.5 
H17A−C17−H17B 108.7 
C19−C18−C17 105.0(4) 
C19−C18−H18A 110.7 
C17−C18−H18A 110.7 
C19−C18−H18B 110.7 
C17−C18−H18B 110.7 
H18A−C18−H18B 108.8 
C20−C19−N2 107.0(3) 
C20−C19−C18 113.7(4) 
N2−C19−C18 102.5(3) 
C20−C19−H19 111.1 
N2−C19−H19 111.1 
C18−C19−H19 111.1 
C19−C20−C21 111.5(4) 
C19−C20−H20A 109.3 
C21−C20−H20A 109.3 
C19−C20−H20B 109.3 
C21−C20−H20B 109.3 
H20A−C20−H20B 108.0 
C20−C21−C22 110.9(4) 
C20−C21−H21A 109.5 
C22−C21−H21A 109.5 
C20−C21−H21B 109.5 
C22−C21−H21B 109.5 
H21A−C21−H21B 108.0 
C24−C22−C16 111.0(4) 
C24−C22−C21 110.5(4) 
C16−C22−C21 110.8(4) 
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C24−C22−H22 108.2 
C16−C22−H22 108.2 
C21−C22−H22 108.2 
N2−C23−H23A 109.5 
N2−C23−H23B 109.5 
H23A−C23−H23B 109.5 
N2−C23−H23C 109.5 
H23A−C23−H23C 109.5 
H23B−C23−H23C 109.5 
O2−C24−C25 121.1(4) 
O2−C24−C22 120.4(4) 
C25−C24−C22 118.4(4) 
C26−C25−C30 118.0(4) 
C26−C25−C24 123.4(4) 
C30−C25−C24 118.6(4) 
C27−C26−C25 120.9(4) 
C27−C26−H26 119.5 
C25−C26−H26 119.5 
C26−C27−C28 120.7(5) 
C26−C27−H27 119.7 
C28−C27−H27 119.7 
C27−C28−C29 119.1(5) 
C27−C28−H28 120.5 
C29−C28−H28 120.5 
C30−C29−C28 120.7(5) 
C30−C29−H29 119.6 
C28−C29−H29 119.6 
C29−C30−C25 120.6(5) 
C29−C30−H30 119.7 
C25−C30−H30 119.7 
C8−N1−C1 113.3(3) 
C8−N1−C4 114.6(3) 
C1−N1−C4 102.0(3) 
C8−N1−H1A 108.9 
C1−N1−H1A 108.9 
C4−N1−H1A 108.9 
C23−N2−C19 115.0(3) 
C23−N2−C16 113.2(3) 
C19−N2−C16 101.8(3) 
C23−N2−H2 108.8 
C19−N2−H2 108.8 
C16−N2−H2 108.8 
O3−Cl1−O5 111.3(2) 
O3−Cl1−O4 108.9(2) 
O5−Cl1−O4 109.8(2) 
O3−Cl1−O6 108.8(2) 
O5−Cl1−O6 109.11(19) 
O4−Cl1−O6 109.0(2) 
O7−Cl2−O8 111.1(3) 
O7−Cl2−O9 110.6(3) 
5 
 
O8−Cl2−O9 109.1(2) 
O7−Cl2−O10 108.8(3) 
O8−Cl2−O10 108.1(2) 
O9−Cl2−O10 108.92(19) 
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Symmetry transformations used to generate equivalent atoms:  
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Table 4. Anisotropic displacement parameters [Å2× 103]. The anisotropic displacement 
factor exponent takes the form: −2π 2[h2a*2U11 + ... + 2 h k a* b* U12 ]. 
 
Atom U11 U22 U33 U23 U13 U12 
 
C1 37(3)  30(2) 28(2)  −1(2) −1(2)  1(2) 
C2 43(3)  32(2) 30(3)  6(2) −9(2)  1(2) 
C3 37(3)  43(3) 41(3)  −10(2) −5(2)  5(2) 
C4 30(2)  34(2) 36(3)  −5(2) −1(2)  −1(2) 
C5 36(3)  43(3) 38(3)  −2(2) 6(2)  −8(2) 
C6 33(3)  38(3) 34(3)  −4(2) 0(2)  −2(2) 
C7 29(2)  31(2) 26(2)  3(2) −3(2)  −1(2) 
C8 51(3)  45(3) 27(3)  −6(2) 5(2)  2(2) 
C9 27(2)  30(2) 37(3)  0(2) 0(2)  2(2) 
C10 27(2)  34(3) 31(3)  −2(2) −1(2)  −2(2) 
C11 42(3)  33(3) 36(3)  1(2) −2(2)  −3(2) 
C12 46(3)  48(3) 34(3)  1(2) −6(2)  −5(2) 
C13 42(3)  54(3) 30(3)  −7(2) −4(2)  −11(2) 
C14 44(3)  37(3) 43(3)  −8(2) 4(2)  −4(2) 
C15 32(3)  34(3) 36(3)  3(2) 1(2)  0(2) 
C16 36(3)  33(2) 36(3)  0(2) 1(2)  5(2) 
C17 43(3)  55(3) 36(3)  −3(2) 13(2)  −7(3) 
C18 66(4)  41(3) 38(3)  1(2) 11(3)  −12(3) 
C19 55(3)  27(2) 33(3)  1(2) 4(2)  7(2) 
C20 51(3)  31(2) 35(3)  −2(2) −2(2)  7(2) 
C21 41(3)  34(3) 34(3)  −7(2) 1(2)  −2(2) 
8 
 
C22 35(3)  31(2) 26(2)  0(2) 1(2)  1(2) 
C23 56(3)  43(3) 31(3)  −5(2) −4(2)  2(2) 
C24 37(3)  31(2) 44(3)  −8(2) −2(2)  2(2) 
C25 31(3)  38(3) 31(3)  −4(2) −4(2)  7(2) 
C26 32(3)  43(3) 42(3)  −3(2) −6(2)  4(2) 
C27 38(3)  53(3) 35(3)  1(2) −3(2)  5(2) 
C28 54(3)  43(3) 33(3)  −1(2) −5(2)  13(3) 
C29 37(3)  59(3) 53(4)  −1(3) −6(3)  4(2) 
C30 35(3)  59(3) 44(3)  −6(3) −2(2)  10(2) 
O1 44(2)  36(2) 38(2)  7(2) −3(2)  −8(2) 
O2 42(2)  68(2) 44(2)  −13(2) 4(2)  18(2) 
O3 98(3)  60(2) 44(2)  19(2) −7(2)  −7(2) 
O4 66(2)  57(2) 34(2)  −16(2) 5(2)  −4(2) 
O5 26(2)  56(2) 79(3)  3(2) −3(2)  −10(2) 
O6 33(2)  37(2) 94(3)  −15(2) 9(2)  2(2) 
O7 157(5)  140(4) 55(3)  −8(3) 38(3)  67(4) 
O8 80(3)  38(2) 78(3)  18(2) −26(2)  −14(2) 
O9 45(2)  47(2) 71(3)  9(2) −18(2)  −2(2) 
O10 52(2)  33(2) 58(2)  7(2) −11(2)  4(2) 
N1 37(2)  33(2) 30(2)  1(2) 0(2)  3(2) 
N2 36(2)  32(2) 25(2)  0(2) −5(2)  1(2) 
Cl1 39(1)  35(1) 37(1)  −1(1) −1(1)  −1(1) 
Cl2 57(1)  42(1) 40(1)  1(1) 1(1)  9(1) 
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Table 5. Hydrogen coordinates [× 104] and isotropic displacement parameters [Å2 × 103]. 
 
Atom  x y z Ueq S.o.f.
 
 
H1 2140 5532 3246 38 1 
H2A 394 6471 2851 43 1 
H2B −4 6932 3337 43 1 
H3A −1866 5709 3263 49 1 
H3B −1435 5203 2786 49 1 
H4 −1205 3327 3169 40 1 
H5A −384 3220 3941 47 1 
H5B −1738 4049 3892 47 1 
H6A −584 5935 4006 42 1 
H6B 64 4984 4380 42 1 
H7 1958 4635 3985 35 1 
H8A 656 2850 2683 61 1 
H8B 2036 3641 2736 61 1 
H8C 669 4336 2558 61 1 
H11 2625 4984 4728 45 1 
H12 3251 5460 5473 52 1 
H13 3236 7554 5722 51 1 
H14 2646 9207 5223 49 1 
H15 2084 8763 4474 41 1 
H16 5504 7305 3233 42 1 
H17A 6361 8791 2775 53 1 
H17B 7046 9326 3240 53 1 
H18A 5801 11100 3165 58 1 
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H18B 5131 10575 2696 58 1 
H19 3240 10514 3081 46 1 
H20A 3294 10009 3863 47 1 
H20B 4128 11285 3780 47 1 
H21A 5305 9802 4299 43 1 
H21B 6179 10231 3896 43 1 
H22 4787 7846 3968 37 1 
H23A 3998 8584 2510 66 1 
H23B 2498 8448 2667 66 1 
H23C 3517 7264 2716 66 1 
H26 5326 7482 4715 47 1 
H27 5933 7544 5476 50 1 
H28 8142 8016 5734 52 1 
H29 9765 8373 5219 60 1 
H30 9202 8213 4458 55 1 
H1A 1211 3418 3421 40 1 
H2 3332 8330 3389 38 1 
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Table 6. Hydrogen bonds [Å and °]. 
 
 D−H···A d(D−H) d(H···A) d(D···A) ∠(DHA) 
 
 N2−H2...O1 0.93 1.87 2.786(5) 169.8 
 N1−H1A...O6i 0.93 2.45 3.012(5) 119.1 
 N1−H1A...O10i 0.93 2.08 2.817(5) 134.6  
Symmetry transformations used to generate equivalent atoms:  
(i) −x+1,y−1/2,−z+1/2   
 
 
 
 
 
 
